0001628280-26-030885.txt : 20260506 0001628280-26-030885.hdr.sgml : 20260506 20260506064827 ACCESSION NUMBER: 0001628280-26-030885 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 78 CONFORMED PERIOD OF REPORT: 20260331 FILED AS OF DATE: 20260506 DATE AS OF CHANGE: 20260506 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TIC Solutions, Inc. CENTRAL INDEX KEY: 0002032966 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] ORGANIZATION NAME: 07 Trade & Services EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-42524 FILM NUMBER: 26945716 BUSINESS ADDRESS: STREET 1: 200 SOUTH PARK ROAD STREET 2: SUITE 350 CITY: HOLLYWOOD STATE: FL ZIP: 33021 BUSINESS PHONE: 954-495-2112 MAIL ADDRESS: STREET 1: 200 SOUTH PARK ROAD STREET 2: SUITE 350 CITY: HOLLYWOOD STATE: FL ZIP: 33021 FORMER COMPANY: FORMER CONFORMED NAME: ACUREN CORP DATE OF NAME CHANGE: 20240806 10-Q 1 tic-20260331.htm 10-Q tic-20260331
0002032966--12-31Q1false2026P2Yxbrli:sharesiso4217:USDiso4217:USDxbrli:sharesiso4217:EURtic:businessutr:Dxbrli:puretic:rsutic:segment00020329662026-01-012026-03-3100020329662026-05-0100020329662026-03-3100020329662025-12-3100020329662025-01-012025-03-310002032966us-gaap:CommonStockMember2026-01-012026-03-310002032966us-gaap:CommonStockMember2025-01-012025-03-310002032966us-gaap:SeriesAPreferredStockMember2026-01-012026-03-310002032966us-gaap:SeriesAPreferredStockMember2025-01-012025-03-310002032966us-gaap:CommonStockMember2025-12-310002032966us-gaap:PreferredStockMember2025-12-310002032966us-gaap:AdditionalPaidInCapitalMember2025-12-310002032966us-gaap:RetainedEarningsMember2025-12-310002032966us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-12-310002032966us-gaap:RetainedEarningsMember2026-01-012026-03-310002032966us-gaap:AdditionalPaidInCapitalMember2026-01-012026-03-310002032966us-gaap:CommonStockMember2026-01-012026-03-310002032966us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-01-012026-03-310002032966us-gaap:CommonStockMember2026-03-310002032966us-gaap:PreferredStockMember2026-03-310002032966us-gaap:AdditionalPaidInCapitalMember2026-03-310002032966us-gaap:RetainedEarningsMember2026-03-310002032966us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-03-310002032966us-gaap:CommonStockMember2024-12-310002032966us-gaap:PreferredStockMember2024-12-310002032966us-gaap:AdditionalPaidInCapitalMember2024-12-310002032966us-gaap:RetainedEarningsMember2024-12-310002032966us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-3100020329662024-12-310002032966us-gaap:RetainedEarningsMember2025-01-012025-03-310002032966us-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-310002032966us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-03-310002032966us-gaap:CommonStockMember2025-03-310002032966us-gaap:PreferredStockMember2025-03-310002032966us-gaap:AdditionalPaidInCapitalMember2025-03-310002032966us-gaap:RetainedEarningsMember2025-03-310002032966us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-03-3100020329662025-03-3100020329662026-04-012026-03-310002032966tic:A2026BusinessAcquisitionsMember2026-01-012026-03-310002032966tic:A2026BusinessAcquisitionsMember2026-03-310002032966tic:NV5GlobalInc.Member2025-05-142025-05-140002032966us-gaap:RevolvingCreditFacilityMembertic:NV5GlobalInc.Memberus-gaap:LineOfCreditMember2025-05-140002032966tic:NV5GlobalInc.Member2025-05-140002032966us-gaap:RevolvingCreditFacilityMembertic:NV5GlobalInc.Member2025-05-142025-05-140002032966us-gaap:RevolvingCreditFacilityMembertic:NV5GlobalInc.Member2025-05-140002032966tic:NV5GlobalInc.Membertic:InspectionAndMitigationSegmentMember2025-05-140002032966tic:NV5GlobalInc.Membertic:ConsultingEngineeringSegmentMember2025-05-140002032966tic:NV5GlobalInc.Membertic:GeospatialSegmentMember2025-05-140002032966us-gaap:CustomerRelationshipsMembertic:NV5GlobalInc.Member2026-03-310002032966us-gaap:CustomerListsMembertic:NV5GlobalInc.Member2026-03-310002032966us-gaap:TradeNamesMembertic:NV5GlobalInc.Member2026-03-310002032966us-gaap:TechnologyBasedIntangibleAssetsMembertic:NV5GlobalInc.Member2026-03-310002032966tic:NV5GlobalInc.Member2026-03-310002032966us-gaap:CustomerRelationshipsMembertic:NV5GlobalInc.Member2025-05-140002032966us-gaap:CustomerListsMembertic:NV5GlobalInc.Member2025-05-140002032966us-gaap:TradeNamesMembertic:NV5GlobalInc.Member2025-05-140002032966us-gaap:DevelopedTechnologyRightsMembertic:NV5GlobalInc.Member2025-05-140002032966tic:A2025BusinessAcquisitionsMember2025-01-012025-12-310002032966tic:A2025BusinessAcquisitionsMember2025-12-310002032966tic:A2025BusinessAcquisitionsMembertic:InspectionAndMitigationSegmentMember2025-12-310002032966tic:A2025BusinessAcquisitionsMembertic:ConsultingEngineeringSegmentMember2025-12-310002032966tic:A2025BusinessAcquisitionsMembertic:GeospatialSegmentMember2025-12-3100020329662024-12-160002032966us-gaap:PreferredStockMember2024-12-160002032966us-gaap:SeriesAPreferredStockMember2024-12-160002032966us-gaap:SeriesAPreferredStockMember2026-03-3100020329662025-01-012025-12-310002032966us-gaap:SeriesAPreferredStockMember2025-01-012025-12-310002032966us-gaap:CommonStockMemberus-gaap:PrivatePlacementMember2025-10-052025-10-050002032966us-gaap:CommonStockMemberus-gaap:PrivatePlacementMember2025-10-050002032966tic:PreFundedWarrantsMemberus-gaap:PrivatePlacementMember2025-10-050002032966us-gaap:PrivatePlacementMember2025-10-052025-10-050002032966tic:PreFundedWarrantsMembersrt:MinimumMemberus-gaap:PrivatePlacementMember2025-10-050002032966tic:PreFundedWarrantsMembersrt:MaximumMemberus-gaap:PrivatePlacementMember2025-10-050002032966tic:CommonStockAndSeriesAPreferredStockMembertic:InitialPublicStockOfferingMember2023-05-310002032966tic:CommonStockAndSeriesAPreferredStockMembersrt:DirectorMembertic:InitialPublicStockOfferingMember2023-05-310002032966tic:CommonStockAndSeriesAPreferredStockMembersrt:MinimumMembertic:InitialPublicStockOfferingMember2023-05-310002032966tic:CommonStockAndSeriesAPreferredStockMembersrt:MaximumMembertic:InitialPublicStockOfferingMember2023-05-310002032966us-gaap:CommonStockMember2026-03-100002032966us-gaap:EmployeeStockOptionMember2026-01-012026-03-310002032966us-gaap:EmployeeStockOptionMember2025-01-012025-03-310002032966us-gaap:WarrantMember2026-01-012026-03-310002032966us-gaap:WarrantMember2025-01-012025-03-310002032966us-gaap:RestrictedStockMember2026-01-012026-03-310002032966us-gaap:RestrictedStockMember2025-01-012025-03-310002032966us-gaap:RestrictedStockUnitsRSUMember2026-01-012026-03-310002032966us-gaap:RestrictedStockUnitsRSUMember2025-01-012025-03-310002032966us-gaap:SeriesAPreferredStockMember2026-01-012026-03-310002032966us-gaap:SeriesAPreferredStockMember2025-01-012025-03-310002032966us-gaap:LandMember2026-03-310002032966us-gaap:LandMember2025-12-310002032966tic:BuildingAndLeaseholdImprovementsMember2026-03-310002032966tic:BuildingAndLeaseholdImprovementsMember2025-12-310002032966srt:MinimumMembertic:ComputerSoftwareAndOfficeEquipmentMember2026-03-310002032966srt:MaximumMembertic:ComputerSoftwareAndOfficeEquipmentMember2026-03-310002032966tic:ComputerSoftwareAndOfficeEquipmentMember2026-03-310002032966tic:ComputerSoftwareAndOfficeEquipmentMember2025-12-310002032966srt:MinimumMemberus-gaap:MachineryAndEquipmentMember2026-03-310002032966srt:MaximumMemberus-gaap:MachineryAndEquipmentMember2026-03-310002032966us-gaap:MachineryAndEquipmentMember2026-03-310002032966us-gaap:MachineryAndEquipmentMember2025-12-310002032966srt:MinimumMembertic:VehiclesAircraftAndVesselsMember2026-03-310002032966srt:MaximumMembertic:VehiclesAircraftAndVesselsMember2026-03-310002032966tic:VehiclesAircraftAndVesselsMember2026-03-310002032966tic:VehiclesAircraftAndVesselsMember2025-12-310002032966us-gaap:ConstructionInProgressMember2026-03-310002032966us-gaap:ConstructionInProgressMember2025-12-310002032966us-gaap:CostOfSalesMember2026-01-012026-03-310002032966us-gaap:CostOfSalesMember2025-01-012025-03-310002032966us-gaap:SellingGeneralAndAdministrativeExpensesMember2026-01-012026-03-310002032966us-gaap:SellingGeneralAndAdministrativeExpensesMember2025-01-012025-03-310002032966tic:InspectionAndMitigationSegmentMember2025-12-310002032966tic:ConsultingEngineeringSegmentMember2025-12-310002032966tic:GeospatialSegmentMember2025-12-310002032966tic:InspectionAndMitigationSegmentMember2026-01-012026-03-310002032966tic:ConsultingEngineeringSegmentMember2026-01-012026-03-310002032966tic:GeospatialSegmentMember2026-01-012026-03-310002032966tic:InspectionAndMitigationSegmentMember2026-03-310002032966tic:ConsultingEngineeringSegmentMember2026-03-310002032966tic:GeospatialSegmentMember2026-03-310002032966us-gaap:CustomerRelationshipsMember2026-01-012026-03-310002032966us-gaap:CustomerRelationshipsMember2026-03-310002032966us-gaap:CustomerRelationshipsMember2025-12-310002032966us-gaap:CustomerListsMember2026-01-012026-03-310002032966us-gaap:CustomerListsMember2026-03-310002032966us-gaap:CustomerListsMember2025-12-310002032966us-gaap:TradeNamesMember2026-01-012026-03-310002032966us-gaap:TradeNamesMember2026-03-310002032966us-gaap:TradeNamesMember2025-12-310002032966us-gaap:TechnologyBasedIntangibleAssetsMember2026-01-012026-03-310002032966us-gaap:TechnologyBasedIntangibleAssetsMember2026-03-310002032966us-gaap:TechnologyBasedIntangibleAssetsMember2025-12-310002032966tic:A2026BusinessAcquisitionsMember2026-01-012026-03-310002032966tic:A2026BusinessAcquisitionsMember2026-03-310002032966tic:NV5GlobalInc.Member2025-12-310002032966us-gaap:SecuredDebtMember2026-03-310002032966us-gaap:SecuredDebtMember2025-12-310002032966us-gaap:RevolvingCreditFacilityMember2026-03-310002032966us-gaap:RevolvingCreditFacilityMember2025-12-310002032966tic:UncollateralizedPromissoryNoteMember2026-03-310002032966tic:UncollateralizedPromissoryNoteMember2025-12-310002032966us-gaap:SecuredDebtMembertic:A2024CreditAgreementMembertic:TermLoan2024Member2026-03-310002032966us-gaap:SecuredDebtMembertic:A2024CreditAgreementMembertic:TermLoan2024Member2026-01-012026-03-310002032966us-gaap:RevolvingCreditFacilityMembertic:A2024CreditAgreementMemberus-gaap:LineOfCreditMember2026-03-310002032966us-gaap:RevolvingCreditFacilityMembertic:A2024CreditAgreementMemberus-gaap:LineOfCreditMember2026-01-012026-03-310002032966us-gaap:LetterOfCreditMembertic:A2024CreditAgreementMemberus-gaap:LineOfCreditMember2026-03-310002032966us-gaap:RevolvingCreditFacilityMembertic:A2024CreditAgreementMember2026-03-310002032966us-gaap:SecuredDebtMemberus-gaap:BaseRateMembertic:A2024CreditAgreementMembertic:TermLoan2024Member2025-01-312025-01-310002032966us-gaap:SecuredDebtMemberus-gaap:BaseRateMembertic:A2024CreditAgreementMembertic:TermLoan2024Member2026-01-012026-03-310002032966us-gaap:SecuredDebtMemberus-gaap:SecuredOvernightFinancingRateSofrMembertic:A2024CreditAgreementMembertic:TermLoan2024Member2025-01-312025-01-310002032966us-gaap:SecuredDebtMemberus-gaap:SecuredOvernightFinancingRateSofrMembertic:A2024CreditAgreementMembertic:TermLoan2024Member2026-01-012026-03-310002032966us-gaap:SecuredDebtMembertic:A2024CreditAgreementMembertic:TermLoan2024Member2025-01-310002032966us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2025-08-040002032966us-gaap:RevolvingCreditFacilityMembertic:A2024CreditAgreementMemberus-gaap:LineOfCreditMember2025-08-030002032966us-gaap:RevolvingCreditFacilityMembertic:A2024CreditAgreementMemberus-gaap:LineOfCreditMember2025-08-040002032966tic:NewTermLoansMemberus-gaap:LineOfCreditMember2025-08-042025-08-040002032966tic:NewTermLoansMemberus-gaap:LineOfCreditMember2026-01-012026-03-310002032966tic:TermLoan2024Member2026-03-310002032966tic:TermLoan2024Member2026-01-012026-03-310002032966us-gaap:RevolvingCreditFacilityMemberus-gaap:BaseRateMembertic:A2024CreditAgreementMembertic:TermLoan2024Member2026-01-012026-03-310002032966us-gaap:RevolvingCreditFacilityMemberus-gaap:SecuredOvernightFinancingRateSofrMembertic:A2024CreditAgreementMembertic:TermLoan2024Member2026-01-012026-03-310002032966us-gaap:RevolvingCreditFacilityMemberus-gaap:SecuredOvernightFinancingRateSofrMembertic:A2024CreditAgreementMembersrt:MinimumMembertic:TermLoan2024Member2026-01-012026-03-310002032966us-gaap:RevolvingCreditFacilityMemberus-gaap:SecuredOvernightFinancingRateSofrMembertic:A2024CreditAgreementMembersrt:MaximumMembertic:TermLoan2024Member2026-01-012026-03-310002032966us-gaap:RevolvingCreditFacilityMembertic:A2024CreditAgreementMembertic:TermLoan2024Member2026-01-012026-03-310002032966us-gaap:RevolvingCreditFacilityMembertic:A2024CreditAgreementMembertic:TermLoan2024Member2026-03-310002032966us-gaap:RevolvingCreditFacilityMembertic:A2024CreditAgreementMembertic:TermLoan2024Member2025-12-310002032966us-gaap:StandbyLettersOfCreditMember2026-03-310002032966us-gaap:SuretyBondMemberus-gaap:LineOfCreditMember2026-03-310002032966tic:UncollateralizedPromissoryNoteMember2026-03-310002032966us-gaap:RestrictedStockUnitsRSUMember2026-01-012026-03-310002032966us-gaap:RestrictedStockUnitsRSUMembertic:TimeVestingUnitsMember2026-01-012026-03-310002032966us-gaap:RestrictedStockUnitsRSUMembertic:PerformanceBasedRSUsMember2026-01-012026-03-310002032966us-gaap:RestrictedStockUnitsRSUMembertic:TimeVestingUnitsMember2025-12-310002032966us-gaap:RestrictedStockUnitsRSUMembertic:MarketVestingUnitsMember2025-12-310002032966us-gaap:RestrictedStockUnitsRSUMembertic:PerformanceBasedRSUsMember2025-12-310002032966us-gaap:RestrictedStockUnitsRSUMembertic:MarketVestingUnitsMember2026-01-012026-03-310002032966us-gaap:RestrictedStockUnitsRSUMembertic:TimeVestingUnitsMember2026-03-310002032966us-gaap:RestrictedStockUnitsRSUMembertic:MarketVestingUnitsMember2026-03-310002032966us-gaap:RestrictedStockUnitsRSUMembertic:PerformanceBasedRSUsMember2026-03-310002032966tic:LiabilityBasedAwardsMember2026-01-012026-03-310002032966us-gaap:RestrictedStockMember2026-01-012026-03-310002032966srt:MinimumMemberus-gaap:RestrictedStockMember2026-01-012026-03-310002032966srt:MaximumMemberus-gaap:RestrictedStockMember2026-01-012026-03-310002032966us-gaap:RestrictedStockMember2025-12-310002032966us-gaap:RestrictedStockMember2026-03-310002032966tic:EmployeeStockPurchasePlanMemberus-gaap:EmployeeStockMember2026-01-012026-03-310002032966us-gaap:OperatingSegmentsMembertic:InspectionAndMitigationSegmentMember2026-01-012026-03-310002032966us-gaap:OperatingSegmentsMembertic:ConsultingEngineeringSegmentMember2026-01-012026-03-310002032966us-gaap:OperatingSegmentsMembertic:GeospatialSegmentMember2026-01-012026-03-310002032966srt:ConsolidationEliminationsMember2026-01-012026-03-310002032966us-gaap:OperatingSegmentsMembertic:InspectionAndMitigationSegmentMember2026-03-310002032966us-gaap:OperatingSegmentsMembertic:ConsultingEngineeringSegmentMember2026-03-310002032966us-gaap:OperatingSegmentsMembertic:GeospatialSegmentMember2026-03-310002032966srt:ConsolidationEliminationsMember2026-03-310002032966us-gaap:OperatingSegmentsMembertic:InspectionAndMitigationSegmentMember2025-01-012025-03-310002032966us-gaap:OperatingSegmentsMembertic:ConsultingEngineeringSegmentMember2025-01-012025-03-310002032966us-gaap:OperatingSegmentsMembertic:GeospatialSegmentMember2025-01-012025-03-310002032966srt:ConsolidationEliminationsMember2025-01-012025-03-310002032966us-gaap:OperatingSegmentsMembertic:InspectionAndMitigationSegmentMember2025-03-310002032966us-gaap:OperatingSegmentsMembertic:ConsultingEngineeringSegmentMember2025-03-310002032966us-gaap:OperatingSegmentsMembertic:GeospatialSegmentMember2025-03-310002032966srt:ConsolidationEliminationsMember2025-03-310002032966us-gaap:OperatingSegmentsMembercountry:UStic:InspectionAndMitigationSegmentMember2026-01-012026-03-310002032966us-gaap:OperatingSegmentsMembercountry:UStic:ConsultingEngineeringSegmentMember2026-01-012026-03-310002032966us-gaap:OperatingSegmentsMembercountry:UStic:GeospatialSegmentMember2026-01-012026-03-310002032966us-gaap:OperatingSegmentsMembercountry:US2026-01-012026-03-310002032966us-gaap:OperatingSegmentsMembercountry:CAtic:InspectionAndMitigationSegmentMember2026-01-012026-03-310002032966us-gaap:OperatingSegmentsMembercountry:CAtic:ConsultingEngineeringSegmentMember2026-01-012026-03-310002032966us-gaap:OperatingSegmentsMembercountry:CAtic:GeospatialSegmentMember2026-01-012026-03-310002032966us-gaap:OperatingSegmentsMembercountry:CA2026-01-012026-03-310002032966us-gaap:OperatingSegmentsMembertic:OtherForeignCountriesMembertic:InspectionAndMitigationSegmentMember2026-01-012026-03-310002032966us-gaap:OperatingSegmentsMembertic:OtherForeignCountriesMembertic:ConsultingEngineeringSegmentMember2026-01-012026-03-310002032966us-gaap:OperatingSegmentsMembertic:OtherForeignCountriesMembertic:GeospatialSegmentMember2026-01-012026-03-310002032966us-gaap:OperatingSegmentsMembertic:OtherForeignCountriesMember2026-01-012026-03-310002032966us-gaap:OperatingSegmentsMember2026-01-012026-03-310002032966us-gaap:OperatingSegmentsMembercountry:UStic:InspectionAndMitigationSegmentMember2025-01-012025-03-310002032966us-gaap:OperatingSegmentsMembercountry:UStic:ConsultingEngineeringSegmentMember2025-01-012025-03-310002032966us-gaap:OperatingSegmentsMembercountry:UStic:GeospatialSegmentMember2025-01-012025-03-310002032966us-gaap:OperatingSegmentsMembercountry:US2025-01-012025-03-310002032966us-gaap:OperatingSegmentsMembercountry:CAtic:InspectionAndMitigationSegmentMember2025-01-012025-03-310002032966us-gaap:OperatingSegmentsMembercountry:CAtic:ConsultingEngineeringSegmentMember2025-01-012025-03-310002032966us-gaap:OperatingSegmentsMembercountry:CAtic:GeospatialSegmentMember2025-01-012025-03-310002032966us-gaap:OperatingSegmentsMembercountry:CA2025-01-012025-03-310002032966us-gaap:OperatingSegmentsMembertic:OtherForeignCountriesMembertic:InspectionAndMitigationSegmentMember2025-01-012025-03-310002032966us-gaap:OperatingSegmentsMembertic:OtherForeignCountriesMembertic:ConsultingEngineeringSegmentMember2025-01-012025-03-310002032966us-gaap:OperatingSegmentsMembertic:OtherForeignCountriesMembertic:GeospatialSegmentMember2025-01-012025-03-310002032966us-gaap:OperatingSegmentsMembertic:OtherForeignCountriesMember2025-01-012025-03-310002032966us-gaap:OperatingSegmentsMember2025-01-012025-03-310002032966us-gaap:OperatingSegmentsMembertic:PublicAndQuasiPublicSectorMembertic:InspectionAndMitigationSegmentMember2026-01-012026-03-310002032966us-gaap:OperatingSegmentsMembertic:PublicAndQuasiPublicSectorMembertic:ConsultingEngineeringSegmentMember2026-01-012026-03-310002032966us-gaap:OperatingSegmentsMembertic:PublicAndQuasiPublicSectorMembertic:GeospatialSegmentMember2026-01-012026-03-310002032966us-gaap:OperatingSegmentsMembertic:PublicAndQuasiPublicSectorMember2026-01-012026-03-310002032966us-gaap:OperatingSegmentsMembertic:PrivateSectorMembertic:InspectionAndMitigationSegmentMember2026-01-012026-03-310002032966us-gaap:OperatingSegmentsMembertic:PrivateSectorMembertic:ConsultingEngineeringSegmentMember2026-01-012026-03-310002032966us-gaap:OperatingSegmentsMembertic:PrivateSectorMembertic:GeospatialSegmentMember2026-01-012026-03-310002032966us-gaap:OperatingSegmentsMembertic:PrivateSectorMember2026-01-012026-03-310002032966us-gaap:OperatingSegmentsMembertic:PublicAndQuasiPublicSectorMembertic:InspectionAndMitigationSegmentMember2025-01-012025-03-310002032966us-gaap:OperatingSegmentsMembertic:PublicAndQuasiPublicSectorMembertic:ConsultingEngineeringSegmentMember2025-01-012025-03-310002032966us-gaap:OperatingSegmentsMembertic:PublicAndQuasiPublicSectorMembertic:GeospatialSegmentMember2025-01-012025-03-310002032966us-gaap:OperatingSegmentsMembertic:PublicAndQuasiPublicSectorMember2025-01-012025-03-310002032966us-gaap:OperatingSegmentsMembertic:PrivateSectorMembertic:InspectionAndMitigationSegmentMember2025-01-012025-03-310002032966us-gaap:OperatingSegmentsMembertic:PrivateSectorMembertic:ConsultingEngineeringSegmentMember2025-01-012025-03-310002032966us-gaap:OperatingSegmentsMembertic:PrivateSectorMembertic:GeospatialSegmentMember2025-01-012025-03-310002032966us-gaap:OperatingSegmentsMembertic:PrivateSectorMember2025-01-012025-03-310002032966us-gaap:OperatingSegmentsMembertic:CostReimbursableContractsMembertic:InspectionAndMitigationSegmentMember2026-01-012026-03-310002032966us-gaap:OperatingSegmentsMembertic:CostReimbursableContractsMembertic:ConsultingEngineeringSegmentMember2026-01-012026-03-310002032966us-gaap:OperatingSegmentsMembertic:CostReimbursableContractsMembertic:GeospatialSegmentMember2026-01-012026-03-310002032966us-gaap:OperatingSegmentsMembertic:CostReimbursableContractsMember2026-01-012026-03-310002032966us-gaap:OperatingSegmentsMembertic:FixedUnitPriceContractsMembertic:InspectionAndMitigationSegmentMember2026-01-012026-03-310002032966us-gaap:OperatingSegmentsMembertic:FixedUnitPriceContractsMembertic:ConsultingEngineeringSegmentMember2026-01-012026-03-310002032966us-gaap:OperatingSegmentsMembertic:FixedUnitPriceContractsMembertic:GeospatialSegmentMember2026-01-012026-03-310002032966us-gaap:OperatingSegmentsMembertic:FixedUnitPriceContractsMember2026-01-012026-03-310002032966us-gaap:OperatingSegmentsMembertic:CostReimbursableContractsMembertic:InspectionAndMitigationSegmentMember2025-01-012025-03-310002032966us-gaap:OperatingSegmentsMembertic:CostReimbursableContractsMembertic:ConsultingEngineeringSegmentMember2025-01-012025-03-310002032966us-gaap:OperatingSegmentsMembertic:CostReimbursableContractsMembertic:GeospatialSegmentMember2025-01-012025-03-310002032966us-gaap:OperatingSegmentsMembertic:CostReimbursableContractsMember2025-01-012025-03-310002032966us-gaap:OperatingSegmentsMembertic:FixedUnitPriceContractsMembertic:InspectionAndMitigationSegmentMember2025-01-012025-03-310002032966us-gaap:OperatingSegmentsMembertic:FixedUnitPriceContractsMembertic:ConsultingEngineeringSegmentMember2025-01-012025-03-310002032966us-gaap:OperatingSegmentsMembertic:FixedUnitPriceContractsMembertic:GeospatialSegmentMember2025-01-012025-03-310002032966us-gaap:OperatingSegmentsMembertic:FixedUnitPriceContractsMember2025-01-012025-03-310002032966tic:MariposaCapitalLLCMember2024-07-302024-07-3000020329662025-07-302025-07-300002032966tic:MariposaCapitalLLCMember2026-01-012026-03-310002032966tic:MariposaCapitalLLCMember2025-01-012025-03-31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
xQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2026
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                      to                     
Commission File Number 001-42524
TIC Solutions, Inc.
(Exact name of registrant as specified in its charter)
Delaware
66-1076867
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)
200 South Park Road, Suite 350, Hollywood, Florida
33021
(Address of principal executive offices)(Zip Code)
(954) 495-2112
Registrant’s telephone number, including area code
_______________________________________________________
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading symbol
Name of each exchange on which registered
Common stock, par value $0.0001 per shareTICNew York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑   No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☑   No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “non-accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filerAccelerated filerxNon-accelerated filer
Smaller reporting companyEmerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐   No
The number of shares of the registrant’s common stock outstanding as of May 1, 2026, was 221,042,604.


TABLE OF CONTENTS
Page
 
i

PART I – FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
TIC Solutions, Inc.
Condensed Consolidated Balance Sheets
(amounts in thousands, except par and share data)
(Unaudited)
March 31, 2026December 31, 2025
Assets
Current assets
Cash and cash equivalents$426,564 $439,536 
Accounts receivable, net344,243 366,293 
Contract assets, net182,732 154,439 
Prepaid expenses and other current assets66,821 60,768 
Total current assets1,020,360 1,021,036 
Property and equipment, net245,601 255,625 
Operating lease right-of-use assets, net54,919 60,209 
Goodwill1,647,534 1,649,595 
Intangible assets, net1,351,980 1,391,382 
Deferred tax assets
1,423 1,438 
Other assets10,319 17,024 
Total assets$4,332,136 $4,396,309 
Liabilities and Stockholders' Equity
Current liabilities
Accounts payable$57,505 $60,426 
Accrued expenses and other current liabilities168,237 151,626 
Contract liabilities52,000 47,846 
Current portion of long-term debt23,460 25,511 
Current portion of lease obligations32,215 33,584 
Total current liabilities333,417 318,993 
Long-term debt, net of current portion1,585,424 1,587,686 
Non-current lease obligations61,401 66,049 
Deferred tax liabilities205,155 222,955 
Other non-current liabilities12,880 20,710 
Total liabilities2,198,277 2,216,393 
Commitments and contingencies (Note 15)
Stockholders' Equity
Series A Preferred Stock, $0.0001 par value, 1,000,000 shares issued and outstanding
  
Common stock, $0.0001 par value, 221,039,674 and 220,485,045 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively
21 21 
Additional paid-in capital2,371,142 2,362,943 
Accumulated deficit(235,654)(194,105)
Accumulated other comprehensive income (loss)(1,650)11,057 
Total stockholders' equity2,133,859 2,179,916 
Total liabilities and stockholders' equity$4,332,136 $4,396,309 
See accompanying notes to unaudited condensed consolidated financial statements.
1

TIC Solutions, Inc.
Condensed Consolidated Statements of Operations and Comprehensive Loss
(amounts in thousands, except share and per share data)
(Unaudited)
Three Months Ended
March 31, 2026March 31, 2025
Revenue
$488,029 $234,215 
Cost of revenue326,728 190,546 
Gross profit161,301 43,669 
Selling, general and administrative expenses150,328 39,872 
Depreciation and amortization40,036 13,237 
Loss from operations
(29,063)(9,440)
Interest expense, net29,021 16,007 
Other income, net
(77)(1,119)
Loss before income tax benefit
(58,007)(24,328)
Income tax provision (benefit)
(16,458)1,465 
Net loss
(41,549)(25,793)
Undistributed loss allocated to Series A Preferred Stock190 211 
Net loss allocated to common stockholders$(41,359)$(25,582)
Other comprehensive income (loss):
Net loss$(41,549)$(25,793)
Foreign currency translation adjustment
(12,707)2,561 
Total other comprehensive loss
$(54,256)$(23,232)
Basic and diluted loss per share:
Common stock, basic and diluted$(0.19)$(0.21)
Series A Preferred Stock, basic and diluted$(0.19)$(0.21)
Weighted-average shares outstanding:
Common stock, basic217,251,178121,476,215
Common stock, diluted218,251,178122,476,215
Series A Preferred Stock, basic and diluted1,000,0001,000,000
See accompanying notes to unaudited condensed consolidated financial statements.
2

TIC Solutions, Inc.
Condensed Consolidated Statements of Stockholders’ Equity
(amounts in thousands, except share data)
(Unaudited)
Common Stock
Series A Preferred Stock
 SharesAmountSharesAmountAdditional
Paid-In
Capital
Accumulated
Deficit
Accumulated
Other
Comprehensive
Income (Loss)
Total
Balances at December 31, 2025
220,485,045$21 1,000,000$ $2,362,943 $(194,105)$11,057 $2,179,916 
Net loss— — — (41,549)— (41,549)
Share-based compensation expense— — 8,728 — — 8,728 
Restricted stock issuances and restricted stock unit vestings, net(113,718)— — (529)— (529)
Issuance of common shares in conjunction with the Series A Preferred Stock Dividend668,347 — — — — — — 
Other comprehensive loss
— — — — (12,707)(12,707)
Balances at March 31, 2026221,039,674$21 1,000,000$ $2,371,142 $(235,654)$(1,650)$2,133,859 
Common Stock
Series A Preferred Stock
 SharesAmountSharesAmountAdditional
Paid-In
Capital
Accumulated
Deficit
Accumulated
Other
Comprehensive
Income (Loss)
Total
Balances at December 31, 2024
121,476,215$12 1,000,000$ $1,293,638 $(106,989)$(35,489)$1,151,172 
Net loss— — — (25,793)— (25,793)
Share-based compensation expense— — 1,107 — — 1,107 
Other comprehensive income
— — — — 2,561 2,561 
Balances at March 31, 2025121,476,215$12 1,000,000$ $1,294,745 $(132,782)$(32,928)$1,129,047 
See accompanying notes to unaudited condensed consolidated financial statements.
3

TIC Solutions, Inc.
Condensed Consolidated Statements of Cash Flows
(amounts in thousands)
(Unaudited)
Three Months Ended
 March 31, 2026March 31, 2025
Cash flows from operating activities:
Net loss
$(41,549)$(25,793)
Adjustments to reconcile net loss to cash flows from operating activities:
Depreciation and amortization58,880 28,599 
Noncash lease expense6,035 2,491 
Share-based compensation expense12,912 1,107 
Amortization of deferred financing costs1,883 828 
Deferred taxes(17,334)(4,320)
Other1,189 (899)
Changes in operating assets and liabilities, net of effects of acquisitions:
Accounts receivable22,092 40,254 
Contract assets(27,886)(8,395)
Prepaid expenses and other current assets(5,635)4,306 
Accounts payable(7,402)3,433 
Accrued expenses and other current liabilities7,391 (5,708)
Operating lease obligations(5,801)(2,352)
Contract liabilities4,161 (213)
Other assets and liabilities989 (546)
Net cash provided by operating activities
9,925 32,792 
Cash flows from investing activities:
Business acquisitions, net of cash acquired
(3,884)(8,030)
Purchases of property and equipment
(5,697)(4,476)
Proceeds from sale of property and equipment
1,287 293 
Net cash used in investing activities(8,294)(12,213)
Cash flows from financing activities:
Payments on long-term borrowings
(4,131)(1,932)
Payments of debt issuance costs
 (1,165)
Payments on finance lease obligations and other long-term debt
(8,776)(2,508)
Net cash used in financing activities
(12,907)(5,605)
Net effect of exchange rate fluctuations on cash and cash equivalents
(1,696)1,631 
Net change in cash and cash equivalents(12,972)16,605 
Beginning of period439,536 139,134 
End of period$426,564 $155,739 
See accompanying notes to unaudited condensed consolidated financial statements.

4

TIC Solutions, Inc.
Condensed Consolidated Statements of Cash Flows
(amounts in thousands)
(Unaudited)
Supplemental cash flow information and schedules of non-cash investing and financing activities for the periods indicated were as follows:
Three Months Ended
 March 31, 2026March 31, 2025
Supplemental disclosure of cash flow information
Interest paid
$26,673 $14,332 
Income taxes paid
$4,022 $6,172 
Supplemental disclosure of non-cash operating, investing and financing activities:
Purchases of property and equipment accrued and not yet paid
$4,472 $3,461 
Notes payable and other obligations issued for acquisitions$3,000 $ 
See accompanying notes to unaudited condensed consolidated financial statements.
5

TIC Solutions, Inc.
Notes to Condensed Consolidated Financial Statements
(table amounts in thousands, except share and per share data)
(Unaudited)
NOTE 1. BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES
Description of Business
TIC Solutions, Inc. (formerly Acuren Corporation and hereinafter referred to as “we,” “our,” “us,” “TIC Solutions,” or the “Company”) is a leading provider of tech-enabled Testing, Inspection, Certification and Compliance (“TICC”), engineering and consulting, and geospatial services. On August 4, 2025 (the “NV5 Closing Date”), the Company completed its acquisition of NV5 Global, Inc. (“NV5” and such acquisition, the “NV5 Acquisition”), an engineering and consulting services company. The Company operates primarily in North America and serves both private and public-sector clients. On October 10, 2025, the Company changed its name from Acuren Corporation to TIC Solutions, Inc.
The Company’s private-sector clients span industrial, infrastructure, construction, and commercial real estate end markets and its public-sector clients include federal, state, and municipal agencies, public utilities, transportation authorities, and environmental regulators. Within industrial markets, the Company’s services address energy processing and refining, pipeline and midstream infrastructure, chemicals and industrial processing, manufacturing and industrial services, power generation and utilities, and companies in aerospace, automotive, renewable energy, pulp and paper, and mining. The Company provides mission-critical services that are essential to the safety, reliability, and efficiency of industrial assets, buildings and public infrastructure. The Company’s services are often non-discretionary and are driven by regulatory requirements, customer risk management policies, and the need to extend the useful life of critical assets.
Basis of Presentation
The accompanying interim unaudited condensed consolidated financial statements (the “interim statements”) have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) and the rules and regulations of the Securities and Exchange Commission (the “SEC”) and do not include all of the information and footnotes required by U.S. GAAP for complete financial statements as certain information has been condensed or omitted. All intercompany accounts and transactions have been eliminated in consolidation. Certain amounts in prior periods have been reclassified to conform to the current period presentation. Such reclassifications did not have a material effect on the Company's financial condition or results of operations as previously reported. The results of operations of companies acquired are included from the date of acquisition. In the opinion of management, these interim statements include all adjustments, which are of a normal recurring nature, necessary for a fair statement of the results for the interim periods presented. The results of operations for any interim period are not necessarily indicative of results for the full year. These interim statements should be read in conjunction with the audited consolidated financial statements and notes contained in the Company’s Annual Report on Form 10-K for the period ended December 31, 2025, as filed with the SEC (the “2025 Annual Report”).
Significant Accounting Policies
The Company’s significant accounting policies are disclosed in “Note 2. Summary of Significant Accounting Policies” in our 2025 Annual Report and are supplemented by the notes included in this Quarterly Report on Form 10-Q (the “Quarterly Report”).
Revenue Recognition
The Company recognizes revenue in accordance with ASC Topic 606, Revenue from Contracts with Customers, by following the five-step model: the Company identifies a contract with a customer, identifies the performance obligation(s) in the contract, determines the transaction price, allocates the transaction price to each performance obligation in the contract and recognizes revenues as the Company satisfies the performance obligation(s).
6

Nature of Services and Performance Obligations
The Company provides TICC, engineering, geospatial and other services to customers under a variety of contract types. Contracts are evaluated to determine whether they should be combined and whether they contain one or multiple performance obligations. Most contracts contain a single performance obligation, as the promise to transfer individual services is not separately identifiable from other promises in the contract and, therefore, is not distinct. For contracts with multiple performance obligations, the Company allocates the contract’s transaction price to each performance obligation utilizing several different pricing scenarios and is able to discretely price out each individual component based on its nature and relation to the overall performance obligation.
Performance obligations are generally satisfied over time as work progresses or services are rendered, because the customer simultaneously receives and consumes the benefits of the Company’s performance. Revenue may be recognized over time based on time and material incurred to date, which best portrays the transfer of control to the customer, or based on progress measured using an input method by comparing direct costs incurred to date to the estimated total direct costs for the completion of the services. Contract costs include labor, sub-consultant services and other direct costs. For contracts that meet the required conditions, the Company applies the as-invoiced practical expedient and recognizes revenue based on its right to invoice for services performed.
Performance obligations in certain contracts are satisfied at a point in time. Revenue for these services is recognized when control of the promised deliverable transfers to the customer, which is generally upon completion, delivery or customer acceptance of reports or analyses.
The Company enters into contracts with its clients that contain two principal types of pricing provisions: cost-reimbursable and fixed-unit price. Cost-reimbursable contracts consist of the following:
time and material contracts, which are common for professional and technical consulting and certification services projects. Under these types of contracts, there is no predetermined fee. Instead, the Company negotiates hourly billing rates and charges the clients based upon actual hours expended on a project. In addition, any direct project expenditures are passed through to the client and are typically reimbursed. These contracts may have an initial not-to-exceed or guaranteed maximum price provision.
cost-plus contracts are the predominant contracting method used by the Company to charge clients for its costs, including both direct and indirect costs, plus a negotiated fee. The total estimated cost plus the negotiated fee represents the total contract value.
lump-sum contracts typically require the performance of all of the work under the contract for a specified lump-sum fee, subject to price adjustments if the scope of the project changes or unforeseen conditions arise. Many of the Company’s lump-sum contracts are negotiated and arise in the design of projects with a specified scope and project deliverables. In most cases, we can bill additional fees if the construction schedule is modified and lengthened.
Fixed-unit price contracts typically require the performance of an estimated number of units of work at an agreed price per unit, with the total payment under the contract determined by the actual number of units performed.
As of March 31, 2026, the Company had $1.1 billion of remaining performance obligations, of which $860.2 million is expected to be recognized over the next 12 months. Performance obligations include only those amounts that have been funded and authorized and does not reflect the full amounts the Company may receive over the term of such contracts. In the case of non-government contracts and project awards, performance obligations include future revenue at contract or customary rates, excluding contract renewals or extensions that are at the discretion of the client. For contracts with a not-to-exceed maximum amount, the Company includes revenue from such contracts in performance obligations to the extent of the remaining estimated amount.
Contract estimates are based on various assumptions to project the outcome of future events. These assumptions are dependent upon the accuracy of a variety of estimates, including engineering progress, achievement of milestones, labor productivity and cost estimates. Due to uncertainties inherent in the estimation process, it is possible that actual completion costs may vary from estimates. If estimated total costs on contracts indicate a loss or reduction to the percentage of total contract revenues recognized to date, these losses or reductions are recognized in the period in which the revisions are known. The effect of revisions to revenues and estimated costs to complete contracts, including penalties, incentive awards, change orders, claims and anticipated losses, are recorded on a cumulative catch-up basis in the period in which the revisions are identified and the loss can be reasonably estimated. Such revisions could occur in any reporting period and the effects on the results of operations for that reporting period may be material depending on the size of the project or the adjustment.
7

Contract Balances
The timing of revenue recognition, billings and cash collections results in, and are reflected within, “Accounts receivable, net,” “Contract assets, net,” and “Contract liabilities” on the condensed consolidated balance sheets.
“Accounts receivable, net” represents amounts billed to clients that remain uncollected as of the balance sheet date. The amounts are stated at their estimated realizable value. The Company maintains an allowance for credit losses to provide for the estimated amount of receivables that will not be collected. See further discussion in “Note 5. Accounts Receivable and Contract Assets.”
“Contract assets, net” represent recognized amounts pending billing pursuant to contract terms or accounts billed after period end and are expected to be billed and collected within the next 12 months. Generally, billing occurs subsequent to revenue recognition, resulting in contract assets that are classified as current.
In certain circumstances, the contract may allow for billing terms that result in cumulative amounts billed in excess of revenues recognized. “Contract liabilities” represent billings in excess of revenues recognized on these contracts as of the reporting date that are generally classified as current. During the three months ended March 31, 2026, revenue recognized related to the Company’s contract liabilities that existed as of December 31, 2025 was not material.
Contract Modifications
Contract modifications may occur in the normal course of business and typically result from changes in scope, specifications or performance period. In most cases, such modifications are not distinct and are accounted for as part of the existing contract. If a modification adds distinct goods or services at a price that reflects their standalone selling prices, it is accounted for as a separate contract.
Federal Acquisition Regulations
Federal Acquisition Regulations (“FAR”), which are applicable to the Company’s federal government contracts and may be incorporated in local and state agency contracts, limit the recovery of certain specified indirect costs on contracts. Cost-plus contracts covered by FAR or certain state and local agencies also may require an audit of actual costs and provide for upward or downward adjustments if actual recoverable costs differ from billed recoverable costs.
Recent Accounting Pronouncements Not Yet Adopted
The Company has not adopted any new accounting pronouncements since the audited consolidated financial statements for the year ended December 31, 2025. See the 2025 Annual Report for information pertaining to the effects of recently adopted and other recent accounting pronouncements.
In September 2025, the FASB issued ASU 2025-06, Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-40), Targeted Improvements to the Accounting for Internal-Use Software, to modernize the accounting for software costs that are accounted for under Subtopic 350-40. The amendments in this update remove all references to prescriptive and sequential software development stages. Under this ASU, capitalization of internal-use software begins when management authorizes and commits to funding the project and it is probable that the project will be completed. ASU 2025-06 is effective for annual periods beginning after December 15, 2027, and interim reporting periods within those annual reporting periods; however early adoption is permitted either prospectively or retrospectively. The Company is currently evaluating the impact the adoption of this guidance will have on its financial statements and related disclosures.
In November 2024, the FASB issued ASU 2024-03, Income Statement — Reporting Comprehensive Income — Expense Disaggregation Disclosures (Subtopic 220-40), requiring disclosure in the notes to the financial statements for specified information about certain costs and expenses. The ASU is effective for annual periods beginning after December 15, 2026, and interim periods beginning after December 15, 2027; however early adoption is permitted and can be applied either prospectively or retrospectively. The Company is currently evaluating the impact the adoption of this guidance will have on its financial statements and related disclosures.
NOTE 2. BUSINESS COMBINATIONS
2026 Acquisitions
During the three months ended March 31, 2026, the Company completed one business combination, which was not significant to the consolidated financial statements. Total consideration for the acquisition was approximately $5.0 million. The Company recorded approximately $2.0 million of goodwill related to the acquisition. The final determination of the fair value of assets and liabilities will be completed within the one-year measurement period as required by ASC 805.
8

2025 Acquisitions
NV5 Acquisition
On August 4, 2025, the Company completed its acquisition of NV5 pursuant to the Agreement and Plan of Merger dated May 14, 2025.
In conjunction with the NV5 Acquisition, in 2025 the Company completed a reorganization of the Company’s reportable segments to align with the service offerings of the combined entity. Accordingly, the post-acquisition results of NV5 are reported within the Company’s Consulting Engineering and Geospatial reportable segments, and the Company’s historical United States and Canada reportable segments have been combined into the Inspection and Mitigation reportable segment. “See Note 16. Segment Reporting” for further discussion regarding the Company’s reorganization and revised reportable segments.
The aggregate purchase consideration paid to the stockholders of NV5 totaled $1.7 billion, including: (i) a cash payment at the NV5 Closing Date of $870.9 million, (ii) the issuance of 73.2 million shares of common stock to NV5 stockholders with an estimated fair value of $768.3 million, and, (iii) the replacement of $76.5 million of unvested NV5 share-based awards, of which $29.7 million was attributable to pre-combination services. The Company funded the cash portion of the purchase price with a new term loan in an aggregate principal amount of $875.0 million and cash on hand. In conjunction with the debt financing, the Company incurred $21.9 million in debt issuance costs that were capitalized and will be amortized using the effective interest method over the remaining term of the Term Loans (as defined in “Note 11. Long-Term Debt”). The Company also increased the amount of its existing senior secured revolving credit facility to $125.0 million (the “Revolving Credit Facility”) and incurred debt issuance costs of $1.3 million related to the Revolving Credit Facility which will be amortized on a straight-line basis over the remaining term of the Revolving Credit Facility.
The NV5 Acquisition was accounted for under the acquisition method of accounting. The purchase price has been preliminarily allocated to the tangible assets and identifiable intangible assets acquired and liabilities assumed based upon their estimated fair values. In order to determine the fair values of tangible and intangible assets acquired and liabilities assumed, the Company engaged an independent third-party valuation specialist to assist in the determination of the fair values. The final determination of the fair values of assets and liabilities will be completed within the one-year measurement period as required by ASC 805. The NV5 Acquisition will necessitate the use of this measurement period to adequately analyze and assess the factors used in establishing the asset and liability fair values as of the relevant acquisition date, including intangible assets, contract assets and liabilities, certain lease-related assets and liabilities, indemnification assets, and deferred tax assets and liabilities.
The excess of the purchase price over the preliminary fair value of the tangible and intangible net assets acquired and liabilities assumed has been recorded as goodwill. The goodwill balance is primarily attributed to the assembled workforce, expansion of service offerings, market opportunities and synergies expected to be achieved from the combined operations of the Company and NV5. The Company has preliminarily assigned goodwill amounts of approximately $15.4 million, $515.3 million, and $233.1 million to the Inspection and Mitigation, Consulting Engineering and Geospatial segments, respectively. Goodwill of $76.1 million is expected to be deductible for income tax purposes.
9

The following table summarizes the preliminary estimated fair value of consideration transferred and the preliminary estimated fair values of the assets acquired and liabilities assumed at the date of the NV5 Acquisition:
Total
Cash consideration$870,911 
Equity consideration768,304 
Replacement of share-based awards29,744 
Total consideration
$1,668,959 
Recognized amounts of identifiable assets acquired and liabilities assumed:
Cash and cash equivalents$58,958 
Accounts receivables186,228 
Contract assets123,428 
Prepaid expenses and other current assets33,536 
Plant and equipment80,557 
Other assets4,560 
Operating lease right-of-use assets33,464 
Intangible assets720,000 
Accounts payable(40,350)
Accrued expenses and other current liabilities(99,123)
Contract liabilities(47,694)
Other liabilities(10,569)
Deferred tax liabilities
(97,935)
Lease liabilities(39,908)
Total identifiable net assets acquired
$905,152 
Goodwill$763,807 
Measurement period adjustments made during the three months ended March 31, 2026 were immaterial.
As part of the purchase price allocation, the Company determined the identifiable intangible assets included customer relationships, customer backlog, trade name, and developed technology. Management used the multi-period excess earnings method to estimate the fair value of the customer relationships, which utilized the following significant assumptions and inputs: revenue growth rates, EBITDA margins, attrition rates, probability of renewal, contributory asset charges, income tax rates, depreciation and discount rates.
The following table summarizes the preliminary fair value of the identifiable intangible assets:
Fair Value as of March 31, 2026
Customer relationships$590,000 
Customer backlog88,000 
Trade name39,000 
Developed technology3,000 
Total intangible assets
$720,000 
The weighted useful lives over which the intangible assets will be amortized are estimated as follows: 15 years for customer relationships, 2 years for customer backlog, 10 years for the trade name, and 3 years for developed technology.
In conjunction with the NV5 Acquisition, the Company incurred transaction costs of $24.7 million, which were expensed and included in “Selling, general and administrative expenses” in the condensed consolidated statements of operations.
10

Pro Forma Consolidated Financial Information
The following pro forma consolidated financial information reflects the results of operations of the Company for the three months ended March 31, 2025 as if the NV5 Acquisition and related financing had occurred as of January 1, 2024, after giving effect to certain purchase accounting and financing adjustments. These amounts are based on financial information of the NV5 business and are not necessarily indicative of what the Company’s operating results would have been had the NV5 Acquisition and related financing taken place on January 1, 2024.
Three Months Ended
March 31, 2025
Net Revenue$468,260 
Net Loss$(43,109)
Pro forma financial information is presented as if the operations of NV5 had been included in the consolidated results of the Company since January 1, 2024, and gives effect to transactions that are directly attributable to the NV5 Acquisition and related financing. Adjustments, net of related tax impacts, include: additional depreciation and amortization expense related to the fair value of acquired property and equipment and intangible assets as if such assets were acquired on January 1, 2024; movement of transaction costs between reporting periods; interest expense under the Company’s Term Loans (defined in “Note 11. Long-Term Debt”) as if the amount borrowed to partially finance the purchase price was borrowed on January 1, 2024.
Other 2025 Acquisition Activity
During the year ended December 31, 2025, the Company completed seven other business combinations, which were not significant to the consolidated financial statements, either individually or in the aggregate. Total aggregate consideration was $45.8 million. The Company recorded a total $17.9 million of goodwill related to these acquisitions, of which $9.8 million was assigned to the Inspection and Mitigation reportable segment, $1.9 million was assigned to the Consulting Engineering reportable segment, and $6.2 million was assigned to the Geospatial reportable segment. The final determination of the fair values of assets and liabilities will be completed within the one-year measurement period as required by ASC 805. The measurement period adjustments were not material.
NOTE 3. STOCKHOLDERS’ EQUITY
The Company has authorized shares consisting of two classes: 500,000,000 shares of common stock, $0.0001 par value per share, and 5,000,000 shares of preferred stock, $0.0001 par value per share, of which 1,000,000 shares are designated as “Series A Preferred Stock” (the “Series A Preferred Stock”). As of March 31, 2026, the Company had 221,039,674 shares of common stock and 1,000,000 shares of Series A Preferred Stock issued and outstanding.
Series A Preferred Stock
The Company has 1,000,000 shares of Series A Preferred Stock issued and outstanding as of March 31, 2026. Shares of the Series A Preferred Stock are not mandatorily redeemable and do not embody an unconditional obligation to settle in a variable number of equity shares and are not unconditionally redeemable or conditionally puttable by the holder for cash. As such, shares of Series A Preferred Stock are classified as permanent equity in the accompanying condensed consolidated balance sheets.
The holder of the Series A Preferred Stock are entitled to receive an annual dividend in the form of shares of common stock once the Average Price (as defined in our certificate of incorporation) of the common stock is at least $11.50 per share for any 10 consecutive trading days (the “Annual Dividend Amount”), with such condition having been satisfied during the year ended December 31, 2025.
The Annual Dividend Amount for the first Dividend Period (the year ended December 31, 2025) was equal to 20 percent of the increase in the volume-weighted average market price per share of the Company’s common stock for the last 10 trading days of the calendar year (the “Dividend Price”) over $10.00 per share multiplied by 121,476,215 shares. In subsequent years, the Annual Dividend Amount will be calculated based on the appreciated Dividend Price compared to the highest Dividend Price previously used in calculating the Annual Dividend Amount.
As of December 31, 2025, the Dividend Price was $10.28. The annual dividend was declared as of December 31, 2025, and the Company issued 668,347 shares of our common stock to the holder of the Series A Preferred Stock in January 2026.
11

Upon the liquidation of the Company, an Annual Dividend Amount shall be payable for the shortened Dividend Period and the holder of the Series A Preferred Stock shall have the right to a pro rata share (together with holders of the common stock) in the distribution of the surplus assets of the Company. In the event of a Change of Control, the holder of the Series A Preferred Stock will be entitled to receive, in the aggregate, a one-time dividend equal to the Change of Control Dividend Amount (as defined in our certificate of incorporation).
Holder of the Series A Preferred Stock will participate in any dividends on the common stock on an as converted basis. Specifically, if the Company pays a dividend on its common stock, the holder of the Series A Preferred Stock will also receive an amount equal to 20 percent of the dividend which would be distributable on 121,476,215 shares of common stock as of March 31, 2026. All such dividends on the Series A Preferred Stock will be paid at the same time as the dividends on the common stock.
Shares of Series A Preferred Stock will be automatically converted into shares of common stock on a one-for-one basis on December 31, 2034 (the “Conversion”). At the option of the holder, each share of Series A Preferred Stock is convertible into one share of common stock until the Conversion. The holder of the Series A Preferred Stock is entitled to one vote per share on all matters submitted to a vote of stockholders of the Company, voting together with the holders of common stock as a single class.
The Company followed ASC 718, Compensation — Stock Compensation, to account for the issuance of the Series A Preferred Stock. See “Note 17. Share-Based Compensation” in the 2025 Annual Report for further discussion.
Warrants
Pre-Funded Warrant
On October 5, 2025, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with the investor named therein (the “Investor”), for the private placement (the “Private Placement”), of (i) 17,708,333 shares of the Company’s common stock, par value $0.0001 per share, at $12.00 per share and (ii) a pre-funded warrant (the “Pre-Funded Warrant”) to purchase 3,125,000 shares of common stock, at $11.9999 per share. The aggregate gross proceeds of the Private Placement were approximately $250.0 million, before deducting placement agent fees and other expenses. The Private Placement closed on October 7, 2025.
The Pre-Funded Warrant has an exercise price of $0.0001 per share of common stock, is immediately exercisable and will remain exercisable until exercised in full. The Pre-Funded Warrant is exercisable in cash or by means of a cashless exercise. The Investor may not exercise the Pre-Funded Warrant if the Investor, together with its affiliates, would beneficially own more than 9.99% of the number of shares of common stock outstanding immediately after giving effect to such exercise; provided, however, that a holder may increase or decrease such percentage by giving 61 days’ notice to the Company, but not to any percentage in excess of 19.99%.
The Pre-Funded Warrant was classified as a component of permanent stockholders’ equity within additional paid-in capital and was recorded at the issuance date using a relative fair value allocation method.
The Pre-Funded Warrant is equity classified because it (i) is a freestanding financial instrument that is legally detachable and separately exercisable from the equity instrument, (ii) is immediately exercisable, (iii) does not embody an obligation for the Company to repurchase its shares, (iv) permits the holders to receive a fixed number of shares of common stock upon exercise, (v) is indexed to the Company’s common stock and (vi) meets the equity classification criteria. The Company valued the Pre-Funded Warrant at issuance, concluding that its sales price approximated its fair value, and allocated net proceeds from the Private Placement proportionately to the Company's common stock and Pre-Funded Warrant.
Public Warrants
In May 2023, in connection with the Company’s initial IPO, the Company issued 54,975,000 Public Warrants to the purchasers of both common shares and Series A Preferred Stock (including 25,000 Warrants that were issued to the then independent non-founder directors in connection with their fees). Each Public Warrant is exercisable until July 30, 2027. The Public Warrants are exercisable in multiples of four-for-one share of common stock at an exercise price of $11.50 per whole share of common stock.
12

The Public Warrants are mandatorily redeemable by the Company at a price of $0.01 should the average market price per share of the common stock exceed $18.00 for 10 consecutive trading days (subject to any prior adjustment in accordance with the terms of the Public Warrants). The Public Warrants expire worthless on July 30, 2027, if not exercised or redeemed. The Public Warrants were determined to be equity classified in accordance with ASC 815, Derivatives and Hedging, and ASC 480, Distinguishing Liabilities from Equity. During the three months ended March 31, 2026, no Public Warrants were exercised for shares of commons stock. As of March 31, 2026 and May 1, 2026, the Company had 14,952,860 Public Warrants outstanding for approximately 3,738,215 shares of common stock.
Share Repurchase Program
On March 10, 2026, the Company’s Board of Directors approved a share repurchase program of up to $200.0 million of the Company’s common stock through open market repurchases (including pursuant to Rule 10b-18 under the Securities Exchange Act of 1934) and/or in privately negotiated transactions, at management’s discretion and subject to market and business conditions, applicable legal requirements, and other factors. As of March 31, 2026, the Company has not repurchased any common stock under the share repurchase program. The Company’s share repurchase program does not obligate the Company to purchase any shares. Repurchased shares will be retired. The program has no expiration date and may be modified, suspended, or terminated at any time by the Board of Directors in its sole discretion.
NOTE 4. EARNINGS PER SHARE
Net income is allocated between the Company’s common stock and other participating securities (excluding unvested restricted stock awards) based on their participation rights. The Company has determined that its Series A Preferred Stock represent participating securities and are a class of common stock. As such, the Company uses the two-class method of computing earnings per share. Under this method, net income (or loss) is allocated between the holders of common stock and the holders of the Series A Preferred Stock based on their respective participation rights.
Given that holders of Series A Preferred Stock participate in net losses on a 1:1 basis with holders of common stock, the allocation of net losses under the two-class method is equivalent to the allocation of net losses that would result under the if-converted method. Consequently, there is no difference between basic and diluted net loss per share of common stock, which also excludes all potential common stock equivalents as their impact on diluted net loss per share would be anti-dilutive.
13

The following table sets forth the computations of basic and diluted loss per share of common stock and Series A Preferred Stock using the two-class method and the if-converted method, respectively, for the three months ended March 31, 2026 and March 31, 2025.
Three Months Ended
March 31, 2026March 31, 2025
Basic shares:
 
Numerator: 
Net loss
$(41,549)$(25,793)
Undistributed loss allocated to Series A Preferred Stock
190 211 
Net loss available to holders of common stock
$(41,359)$(25,582)
Denominator: 
Weighted average common stock outstanding – basic
217,251,178 121,476,215 
Weighted average Series A Preferred Stock outstanding – basic
1,000,000 1,000,000 
Basic loss per common stock
$(0.19)$(0.21)
Basic loss per Series A Preferred Stock
$(0.19)$(0.21)
Dilutive shares:
 
Numerator: 
Undistributed loss allocated to common stock$(41,359)$(25,582)
Undistributed loss allocated to Series A Preferred Stock
(190)(211)
Total undistributed loss
$(41,549)$(25,793)
Denominator:
Weighted average common stock outstanding – basic
217,251,178 121,476,215 
Add: dilutive securities 
Series A Preferred Stock1,000,000 1,000,000 
Weighted average common stock outstanding – diluted
218,251,178 122,476,215 
Weighted average Series A Preferred Stock outstanding – diluted
1,000,000 1,000,000 
Diluted loss per common stock
$(0.19)$(0.21)
Diluted loss per Series A Preferred Stock
$(0.19)$(0.21)
For the three months ended March 31, 2026 and March 31, 2025, the Company excluded the following potentially dilutive shares from the computation of diluted loss per common stock as the impact would have been anti-dilutive:
Three Months Ended
Potentially dilutive securitiesMarch 31, 2026March 31, 2025
Stock options(1)
 125,000 
Warrants(1)
 212,901 
Restricted stock awards3,390,276  
Restricted stock units1,145,327 973,092 
Shares issuable pursuant to the Series A Preferred Stock dividend(2)
 3,196,648 
(1) For the three months ended March 31, 2026, the stock options and warrants were out of the money.
(2) See discussion of the Annual Dividend Amount in “Note 3. Stockholders’ Equity.”
14

NOTE 5. ACCOUNTS RECEIVABLE AND CONTRACT ASSETS
Accounts receivable and contract assets are recorded net of allowances for credit losses. Accounts receivable represent invoiced and accrued revenue while contract assets represent accrued revenue that has yet to be invoiced to the customer. The Company’s accounts receivable, contract assets and allowance for credit losses consisted of the following as of the below dates:
March 31, 2026December 31, 2025
Accounts receivables$347,195 $369,669 
Contract assets182,802 154,510 
Allowance for credit losses(3,022)(3,447)
Total accounts receivables, net$526,975 $520,732 
The Company records an allowance for credit losses for accounts receivable based on management’s expected credit losses. Management’s estimate of expected credit losses is based on its assessment of the business environment, customers’ financial condition, historical collection experience, accounts receivable aging and customer disputes.
Changes to the allowance for credit losses are adjusted through credit loss expense, which is included within “Selling, general and administrative expenses” in the condensed consolidated statements of operations and comprehensive income (loss).
NOTE 6. PROPERTY AND EQUIPMENT
Property and equipment consists of the following:
 Useful Life (Years)March 31, 2026December 31, 2025
Land $6,117 $6,179 
Buildings and leasehold improvements2525,908 25,364 
Computer, software, and office equipment
3 – 5
24,560 23,279 
Machinery and equipment
3 – 10
186,145 181,437 
Vehicles, aircrafts and vessels
5 - 15
97,781 96,192 
Construction in progress 12,222 11,238 
Total property and equipment 352,733 343,689 
Accumulated depreciation (107,132)(88,064)
Property and equipment, net $245,601 $255,625 
Total depreciation expense for property and equipment was recognized as follows for the following periods:
Three Months Ended
March 31, 2026March 31, 2025
Cost of revenue
$18,843 $15,362 
Selling, general and administrative expenses
3,083 235 
Total depreciation expense
$21,926 $15,597 
NOTE 7. GOODWILL
The changes in the carrying amount of goodwill by reportable segment for the three months ended March 31, 2026 were as follows:
Inspection and MitigationConsulting EngineeringGeospatialTotal
Balance at December 31, 2025$895,533 $516,873 $237,189 1,649,595 
Acquisitions
 2,069  2,069 
Measurement period adjustments102 292 2,147 2,541 
Currency adjustments(6,671)  (6,671)
Balance at March 31, 2026$888,964 $519,234 $239,336 $1,647,534 
15

NOTE 8. INTANGIBLE ASSETS
The gross carrying amounts and accumulated amortization of intangible assets were as follows:
Weighted
Average
Remaining
Life (Years)
March 31, 2026December 31, 2025
Gross Carrying Amount
Accumulated
Amortization
Net Carrying AmountGross Carrying AmountAccumulated
Amortization
Net Carrying Amount
Customer relationships13.3$1,279,417 $(104,950)$1,174,467 $1,282,032 $(82,609)$1,199,423 
Customer backlog1.488,741 (42,215)46,526 88,466 (31,126)57,340 
Tradenames12.3138,946 (13,621)125,325 139,498 (11,059)128,439 
Technology2.97,993 (2,331)5,662 8,019 (1,839)6,180 
$1,515,097 $(163,117)$1,351,980 $1,518,015 $(126,633)$1,391,382 
Amortization expense recognized on intangible assets was $37.0 million and $13.0 million for the three months ended March 31, 2026 and March 31, 2025, respectively.
NOTE 9. ACCRUED EXPENSES AND OTHER LIABILITIES
Accrued Expenses and Other Current Liabilities
The Company’s accrued expenses and other current liabilities consisted of the following as of the below dates:
March 31, 2026December 31, 2025
Accrued salaries, wages and related employee benefits$76,617 $58,655 
Accrued trade payables28,220 32,090 
Accrued operating expenses15,528 21,718 
Accrued indirect taxes4,334 4,676 
Accrued sales discounts1,986 3,094 
Current portion of contingent consideration12,670 8,608 
Other accrued expenses28,882 22,785 
Total accrued expenses and other current liabilities$168,237 $151,626 
Contingent Consideration
Contingent consideration arrangements are included as part of the purchase price of acquired companies on their respective acquisition dates. The Company estimates the fair value of contingent earn-out payments as part of the initial purchase price and records the estimated fair value of contingent consideration as a liability on the consolidated balance sheet. Changes in the estimated fair value of contingent consideration payments are included in “Selling, general and administrative expenses” in the consolidated statements of operations. During the three months ended March 31, 2026 the Company recorded contingent consideration of $1.0 million related to 2026 acquisitions and made payments of $1.3 million. Fair value re-measurements were $1.9 million during the three months ended March 31, 2026. Accordingly, as of March 31, 2026, the Company had $15.2 million of contingent consideration recorded on the condensed consolidated balance sheet, including $12.7 million reflected as current. As of December 31, 2025, the Company had $13.6 million of contingent consideration recorded on the consolidated balance sheet, including $8.6 million reflected as current
16

NOTE 10. FAIR VALUE MEASUREMENTS
The Company performs fair value measurements by determining the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. It also establishes a three-level hierarchy that prioritizes the inputs used to measure fair value. The three levels of the hierarchy are defined as follows:
Level 1Unadjusted quoted prices in active markets that are accessible at the measurement dates for identical, unrestricted assets or liabilities.
Level 2Quoted prices for markets that are not active, or inputs that are observable either directly or indirectly, for substantially the full term of the asset or liability.
Level 3Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e., supported with little or no market activity).
If the inputs used to measure the financial assets and liabilities fall within the different levels described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.
The carrying values of cash and cash equivalents, accounts receivable, prepaid expenses and other current assets, accounts payable, and accrued expenses and other current liabilities approximate their fair values because of their short maturity. The fair values of the Company’s revolving line of credit facilities and long-term debt approximate their carrying value as they are based on current lending rates for similar borrowings, assuming the debt is outstanding through maturity, and considering the collateral. The fair values of the Company’s finance lease obligations approximate their carrying amounts based on anticipated interest rates which management believes would currently be available to the Company for similar issuances of debt.
The Company reviews and re-assesses the estimated fair value of contingent consideration liabilities on a quarterly basis and the updated fair value could differ from the initial estimates. The Company measures contingent consideration recognized in connection with business combinations at fair value on a recurring basis using significant unobservable inputs classified as Level 3 inputs. The Company generally uses an option-based model or a probability-weighted approach to determine the fair value of earn-outs based on key inputs requiring significant judgments and estimates to be made by the Company, including projections of future earnings over the earn-out period. Significant increases or decreases to these inputs could result in a significantly higher or lower liability with a higher liability capped by the contractual maximum. Ultimately, the liability will be equivalent to the amount paid, and the difference between the fair value estimate as of the acquisition date and amount paid will be recorded in earnings.
The fair value of interest rate swap agreements are determined using standard pricing models and market-based assumptions for all significant inputs, such as yield curves and quoted spot and forward exchange rates. This fair value measurement is based on inputs that are observable either directly or indirectly and thus represents a Level 2 measurement within the fair value hierarchy. Refer to “Note 12. Financial Instruments” for further details on the accounting treatment of swap agreements.
NOTE 11. LONG-TERM DEBT
The Company’s long-term debt obligations consisted of the following:
Maturity DateMarch 31, 2026December 31, 2025
Term LoansJuly 30, 2031$1,631,804 $1,635,935 
Revolving credit facilityJuly 30, 2029  
Promissory notes13,389 15,273 
Less: Unamortized deferred financing costs(36,309)(38,011)
Total debt, net1,608,884 1,613,197 
Less:
Current portion of Term Loans(16,525)(16,525)
Current portion of promissory notes(6,935)(8,986)
Long-term debt, net of current portion$1,585,424 $1,587,686 
17

2024 Credit Agreement
The Company is party to a credit agreement by and among Acuren Delaware Holdco, Inc. (f/k/a AAL Delaware Holdco, Inc.), a wholly-owned subsidiary of the Company, as the initial borrower, Acuren Holdings, Inc. (f/k/a ASP Acuren Holdings, Inc.), a wholly-owned subsidiary of the Company, as a borrower, and any other subsidiaries of the Company from time to time party thereto as borrowers, (collectively, the “Borrowers”), the guarantors from time to time party thereto, the lenders from time to time party thereto, and Jefferies Finance LLC, as administrative agent and collateral agent (the “Credit Agreement”). The Credit Agreement provides for a $775.0 million seven-year senior secured term loan (the “2024 Term Loan”) under the senior secured term loan facility (the “Term Loan Facility”) and a $75.0 million five-year senior Revolving Credit Facility, of which up to $20.0 million can be used for the issuance of letters of credit (together with the Term Loan Facility, the “Credit Facility”).
The Credit Facility contains certain customary negative operating covenants (certain of which are not applicable depending on net leverage ratios), customary restrictive covenants and other customary provisions relating to events of default, including non-payment of principal, interest or fees, breach of covenants, misrepresentations, insolvency proceedings, cross default to other indebtedness of the Borrowers and its subsidiaries in excess of $40.0 million or judgments from creditors of such amount, change of control, and certain events relating to Employee Retirement Income Security Act plans. 
Solely with respect to the Revolving Credit Facility, the Credit Facility contains a financial covenant for the First Lien Net Leverage Ratio to be tested as of the last day of any such fiscal quarter only in the event that the total outstanding (excluding undrawn Letters of Credit) is greater than 35% of the total Revolving Credit Commitment, in which case the First Lien Net Leverage Ratio may exceed 5.85 to 1.00. As of March 31, 2026, the Company was in compliance with the covenants under the Credit Facility.
Obligations under the Credit Agreement are guaranteed on a senior secured basis, jointly and severally, by the Company and substantially all of its U.S. and Canadian subsidiaries. Amounts borrowed under the Credit Facility are secured on a first priority basis by a perfected security interest in substantially all of the present and future property (subject to certain exceptions) of the Borrower and each guarantor.
Repricing of Term Loan
On January 31, 2025, the Company entered into the First Amendment to the Credit Agreement, pursuant to which the interest rate margins for the Term Loan decreased from 2.50% to 1.75% for the base rate and from 3.50% to 2.75% for the secured overnight financing rate (“SOFR”), adjusted for statutory reserves. All other material terms of the Credit Agreement, including the aggregate principal amount, repayment terms, and interest rate applicable on the revolving credit facility available under the Credit Agreement (the “Revolving Credit Facility”) remained the same. The Company evaluated the change of terms under ASC 470-50, Debt–Modifications and Extinguishments, and concluded the change in terms did not result in significant and consequential changes to the economic substance of the debt and thus resulted in a modification of the debt and not an extinguishment of the debt. As such, the financing costs of $1.2 million were reflected as additional debt issuance costs and are amortized to interest expense over the term of the Term Loan.
Second Amendment to Credit Agreement
On August 4, 2025, in connection with the NV5 Acquisition, the Company entered into the Second Amendment to the Credit Agreement (the “Second Amendment”). The Second Amendment amended the Credit Agreement to: (i) include new term loans in an aggregate principal amount of $875.0 million (the “2025 Term Loans,” and together with the 2024 Term Loans, the “Term Loans”), and (ii) increase the aggregate amount of the Revolving Credit Facility from $75.0 million to $125.0 million. Principal payments on the Term Loans, commenced on September 30, 2025 and will be made in quarterly installments on the last day of each fiscal quarter in an amount equal to $4.1 million, subject to adjustments in accordance with the Credit Agreement. Accordingly, as of March 31, 2026, the Company has reflected $16.5 million of principal payments as current in the condensed consolidated balance sheet.
As of March 31, 2026, the Company had $1.6 billion of principal outstanding under the Term Loans. The interest rate applicable to the Term Loans is, at the Company’s option, either: (1) a base rate plus an applicable margin equal to 1.75% or (2) SOFR plus an applicable margin equal to 2.75%. For the three months ended March 31, 2026, the Company recorded $1.7 million of amortization expense related to debt issuance costs incurred in connection with the Term Loans. The Term Loans will mature on July 30, 2031.
18

Revolving Credit Facility 
The interest rate applicable to borrowings under the Revolving Credit Facility is, at the Company’s option, either: (1) a base rate plus an applicable margin equal to 2.50% or (2) SOFR (adjusted for statutory reserves) plus an applicable margin equal to 3.50%. The unused portion of the Revolving Credit Facility is subject to a commitment fee of 0.375% or 0.50% based on the Company’s first lien net leverage ratio. For the three months ended March 31, 2026, the amortization expense related to debt issuance costs incurred in connection with the Revolving Credit Facility was immaterial. As of March 31, 2026 and December 31, 2025, the Company had no amounts outstanding under its Revolving Credit Facility.
Letters of Credit and Surety Bonds  
As of March 31, 2026, the Company had $14.1 million in stand-by letters of credit issued (as a component of the Revolving Credit Facility), but did not withdraw any amount against the letters of credit. Additionally, the Company had $71.0 million in surety bonds outstanding, which are not a component of the Revolving Credit Facility.
Promissory Notes
The Company has outstanding uncollateralized promissory notes due to sellers issued in connection with prior acquisitions completed by NV5 prior to the NV5 Acquisition. As of March 31, 2026, the short-term and long-term outstanding balances of these promissory notes totaled $6.9 million and $6.5 million, respectively. As of March 31, 2026, the Company’s weighted average interest rate on promissory notes was 1.4%.
NOTE 12. FINANCIAL INSTRUMENTS
The Company’s risk management strategy from time to time utilizes interest rate swap agreements to mitigate interest rate exposure on its variable rate debt. The Company has not historically designated these derivatives as hedging instruments and reported these agreements at fair value with unrealized gains and losses recorded within “Interest expense, net” within the condensed consolidated statements of operations and comprehensive income (loss) in the reporting period in which the unrealized gains and losses occurred. During the three months ended March 31, 2026 and March 31, 2025, the Company had no interest rate swap agreements.
NOTE 13. INCOME TAXES
Income taxes are accounted for under the asset and liability method as required by ASC 740, Income Taxes. Deferred income tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred income tax assets and liabilities are measured at the enacted income tax rates expected to apply in the taxable year that the asset or liability is expected to be recovered or settled.
The Company recorded an income tax benefit of $16.5 million for the three months ended March 31, 2026 and an income tax provision of $1.5 million for the three months ended March 31, 2025. The effective tax rate, inclusive of discrete items, was 28.4% and (6.0)% for the three months ended March 31, 2026 and March 31, 2025, respectively, which was driven by a combination of the disparity between results of operations as well as the tax jurisdictions across the United States and Canada, permanent non-deductible expenses, and the valuation allowance discussed in further detail below.
The Company evaluated and considered all available evidence, both positive and negative, to determine whether, based on the weight of that evidence, a valuation allowance for its deferred tax assets was needed. The deferred tax assets are composed primarily of net operating loss carryforwards and 163(j) interest limitation carryforwards. The Company primarily relies on reversing taxable temporary differences to support the realization of its deferred tax assets. Based on available evidence and limitations on interest deductions under the tax law, the Company previously had a valuation allowance of $10.5 million as of March 31, 2025, primarily against the interest expense carryforward. However, the deferred tax liability recorded in connection with the NV5 Acquisition provided a source of future taxable income which supports the realizability of the interest expense carryforward asset and therefore the valuation allowance was reversed during the three months ended September 30, 2025. The deferred tax liability continues to support the realizability of the interest expense carryforward asset and no valuation allowance has been recorded during the three months ended March 31, 2026.
19

NOTE 14. STOCK-BASED COMPENSATION
Restricted Stock Units
Awards of Restricted Stock Units (“RSUs”) are independent of stock option grants and are generally subject to forfeiture if employment terminates prior to vesting. Forfeitures are recognized as they occur. The Company’s RSU’s consist of three types: time-based units, market-based units and performance-based units, that are settled in shares of the Company’s common stock upon vesting.
The time-based awards issued to the Company’s employees vest either (i) in equal installments over a three-year service period from the grant date or (ii) cliff vest at the end of a one to three-year service period from the grant date. The time-based RSUs issued to the Company’s directors vest at the end of the anniversary date of their grant date. The market-based RSUs issued to the Company’s employees vest upon the later of the (i) first anniversary of the grant date and (ii) the calendar day following the 10 consecutive trading day period during which the VWAP of the Company’s common stock reaches $20.00 per share, which must be achieved before the fifth anniversary of the grant date. The performance-based RSUs issued to the Company’s employees vest based on the attainment of performance-based targets as outlined in the award grant notice over a three-year performance period.
The grant-date fair values of the time-based units and the performance-based units were determined based on the fair value of the underlying common stock on the grant date. The grant-date fair value of the market-based units was determined using a Monte Carlo simulation method which takes into consideration different stock price paths.
Below is a summary of RSU activity for the three months ended March 31, 2026:
Time Vesting UnitsMarket Vesting UnitsPerformance Vesting
Number of UnitsWeighted Average Grant Date Fair ValueNumber of UnitsWeighted Average Grant Date Fair ValueNumber of UnitsWeighted Average Grant Date Fair Value
Unvested as of December 31, 2025
944,202$9.76555,000$5.35984,321$9.38
Granted
3,577,1607.602,564,1797.60
Forfeited
(18,677)9.30(15,000)5.35(83,001)9.19
Units Vested
(146,667)9.60
Unvested as of March 31, 20264,356,018$8.40540,000$5.353,465,499$8.27
Share-based compensation expense is recorded in “Selling, general and administrative expenses” in the condensed consolidated statements of operations and comprehensive income (loss). Share-based compensation expense for the Company’s RSUs during the three months ended March 31, 2026 was $7.8 million, consisting of $6.6 million for time-based RSU’s, $0.3 million for market-based RSUs, and $0.9 million for performance-based RSU’s. Share-based compensation expense includes $4.2 million of expense related to the Company’s liability-classified awards during the three months ended March 31, 2026. The total estimated amount of the liability-classified awards is approximately $17.4 million.
As of March 31, 2026, the total unrecognized compensation expense for time-based RSUs was $43.5 million, which is expected to be recognized over a weighted average period of approximately 2.1 years. As of March 31, 2026, the total unrecognized compensation expense for market-based RSUs was $1.1 million, which is expected to be recognized over a weighted average period of approximately 1.0 years. As of March 31, 2026, the total unrecognized compensation expense for performance-based RSUs was $24.8 million, which is expected to be recognized over a weighted average period of approximately 2.7 years. The aggregate intrinsic value of RSUs vested during the three months ended March 31, 2026 was $1.0 million.
Restricted Stock Awards
NV5 historically granted Restricted Stock Awards (“RSAs”) to its employees. The RSAs generally provided for service-based cliff vesting two to four years following the grant date. In connection with the NV5 Acquisition, all outstanding unvested RSAs otherwise not accelerated upon the NV5 Closing Date were converted into RSAs of the Company with substantially similar terms and conditions of the previously existing awards, including future service requirements. The RSAs were replaced based on an exchange ratio of 2.0387, which was calculated in the same manner as the exchange ratio that was applicable to the NV5 common stock outstanding on the NV5 Closing Date and that received merger consideration on the NV5 Closing Date.
20

The following summarizes the activity of restricted stock awards during the three months ended March 31, 2026:
Number of Unvested Restricted Stock Awards    Weighted Average Grant Date Fair Value
Unvested as of December 31, 2025
6,958,429 $10.50 
Forfeited
(180,010)10.50 
Vested
(385,558)10.50 
Unvested as of March 31, 20266,392,861 $10.50 
Share-based compensation expense relating to RSAs during the three months ended March 31, 2026 was $5.1 million. As of March 31, 2026, the total unrecognized share-based compensation expense for RSAs was $29.8 million, which is expected to be recognized over a weighted average period of approximately 1.4 years. The aggregate intrinsic value of RSAs vested during the three months ended March 31, 2026 was $3.5 million.
Employee Stock Purchase Plan
The Company’s Employee Stock Purchase Plan (“ESPP”) allows qualified employees to purchase designated shares of the Company’s common stock at a price equal to 85% of the lesser of the fair market value of common stock at the beginning or end of each semi-annual stock purchase period. The Company did not issue any shares of common stock pursuant to the ESPP during the three months ended March 31, 2026. Share-based compensation expense for the Company’s ESPP during the three months ended March 31, 2026 was not material.
NOTE 15. COMMITMENTS AND CONTINGENCIES
Legal Proceedings
The Company is involved in matters that involve various claims which have arisen in the normal course of business. The Company does not believe any liabilities that may arise as a result of such claims will have a material adverse effect, individually or in the aggregate, on its business, results of operations, cash flows or financial condition.
NOTE 16. SEGMENT REPORTING
The Company reports segment information in accordance with ASC Topic No. 280 “Segment Reporting” (“Topic No. 280”). The Company’s Chief Executive Officer is the Company’s chief operating decision-maker (“CODM”). The Company is organized into three reportable segments as follows:
Inspection and Mitigation, which includes the Company’s legacy testing, inspection, certification and compliance services in the United States, Canada, and United Kingdom;
Consulting Engineering, which includes the Company’s engineering, civil program management, utility services, conformity assessment, clean energy consulting, data center commissioning and consulting, buildings and program management, MEP & technology design, and environmental health science services; and
Geospatial, which includes the Company’s geospatial solution services.
The Company’s reportable segments are strategic business units that offer different products and services. The accounting policies of the reportable segments are the same as those described under “Note 1. Basis of Presentation and Significant Accounting Policies.” The CODM evaluates the performance of these reportable segments based on their respective gross profit. The CODM considers budget-to-actual and forecast-to-actual variances on a monthly basis when making decisions about allocating resources. The CODM does not regularly review capital expenditures by segment.
21

The following tables set forth certain financial information for each of the Company’s reportable segments for the periods indicated:
Three Months Ended March 31, 2026
Inspection and MitigationConsulting Engineering
Geospatial
Corporate and EliminationsTotal
Revenue$234,827 $187,341 $65,861 $ $488,029 
Cost of revenue$194,066 $98,191 $34,471 $ $326,728 
Gross profit$40,761 $89,150 $31,390 $ $161,301 
Depreciation and amortization$16,723 $1,686 $2,714 $37,757 $58,880 
Total assets$1,982,840 $1,160,672 $626,315 $562,309 $4,332,136 
Long-lived assets (1)
$163,822 $10,700 $44,481 $26,598 $245,601 
(1) Long-lived assets consist of property and equipment, net as identified in “Note 6. Property and equipment.”
Three Months Ended March 31, 2025
Inspection and MitigationConsulting Engineering
Geospatial
Corporate and EliminationsTotal
Revenue
$234,215 $ $ $ $234,215 
Cost of revenue$190,546 $ $ $ $190,546 
Gross profit$43,669 $ $ $ $43,669 
Depreciation and amortization$15,597 $ $ $13,002 $28,599 
Total assets$1,986,435 $ $ $193,845 $2,180,280 
Long-lived assets (1)
$183,473 $ $ $ $183,473 
(1) Long-lived assets consist of property and equipment, net as identified in “Note 6. Property and equipment.”
The Company disaggregates its revenues from contracts with customers by geographic location, customer type, and contract type for each of its reportable segments. Disaggregated revenues include inter-segment revenues which are ultimately eliminated within Corporate and Eliminations. The Company believes this best depicts how the nature, amount, timing and uncertainty of its revenues and cash flows are affected by economic factors.
Revenues, classified by the major geographic areas in which the Company's customers are located, were as follows:
Three Months Ended March 31, 2026
Inspection and MitigationConsulting Engineering
Geospatial
Total
United States$134,044 $156,286 $62,416 $352,746 
Canada98,013  228 98,241 
Other foreign2,770 31,055 3,217 37,042 
Total segment revenues$234,827 $187,341 $65,861 $488,029 
Three Months Ended March 31, 2025
Inspection and MitigationConsulting Engineering
Geospatial
Total
United States$145,321 $ $ $145,321 
Canada86,528   86,528 
Other foreign2,366   2,366 
Total segment revenues$234,215 $ $ $234,215 
22

Revenues by customer were as follows:
Three Months Ended March 31, 2026
Inspection and MitigationConsulting Engineering
Geospatial
Total
Public and quasi-public sector$6,876 $89,505 $55,394 $151,775 
Private sector227,951 97,836 10,467 336,254 
Total segment revenues$234,827 $187,341 $65,861 $488,029 
Three Months Ended March 31, 2025
Inspection and MitigationConsulting Engineering
Geospatial
Total
Public and quasi-public sector$5,903 $ $ $5,903 
Private sector228,312   228,312 
Total segment revenues$234,215 $ $ $234,215 
Revenues by contract type were as follows:
Three Months Ended March 31, 2026
Inspection and MitigationConsulting Engineering
Geospatial
Total
Cost-reimbursable contracts$224,526 $170,311 $64,278 $459,115 
Fixed-unit price contracts10,301 17,030 1,583 28,914 
Total segment revenues$234,827 $187,341 $65,861 $488,029 
Three Months Ended March 31, 2025
Inspection and MitigationConsulting Engineering
Geospatial
Total
Cost-reimbursable contracts$220,772 $ $ $220,772 
Fixed-unit price contracts13,443   13,443 
Total segment revenues$234,215 $ $ $234,215 
NOTE 17. RELATED PARTIES
On July 30, 2024, the Company entered into a Consulting Services Agreement with Mariposa Capital, LLC, an entity owned by the Co-Chairman of the Company’s board of directors. Under this agreement, Mariposa Capital, LLC agreed to provide certain services, including corporate development and consulting services, consulting services with respect to mergers and acquisitions, investor relations services, strategic planning consulting services, capital expenditure allocation consulting services, strategic treasury consulting services and such other services relating to the Company as may from time to time be mutually agreed. In connection with these services, Mariposa Capital, LLC is entitled to receive an annual fee equal to $2.0 million, payable in quarterly installments. The initial term of this agreement was for the one-year period ended July 30, 2025. The agreement was automatically renewed and automatically renews for successive one-year terms unless either party notifies the other party in writing of its intention not to renew this agreement no later than 90 days prior to the expiration of the term. This agreement may only be terminated by the Company upon a vote of a majority of the directors. In the event that this agreement is terminated by the Company, the effective date of the termination will be six months following the expiration of the initial term or a renewal term, as the case may be. During each of the quarters ending March 31, 2026 and March 31, 2025, the Company paid $0.5 million of consulting fees under this contract
No dividends on the Series A Preferred Stock have been declared during the three months ended March 31, 2026.
23

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following is a discussion of the results of operations of: (i) TIC Solutions, Inc. and its subsidiaries (collectively, the “Company,” “we,” “our,” “us,” or “TIC Solutions”) (formerly Acuren Corporation) for the three months ended March 31, 2026, compared to the results of operations for the three months ended March 31, 2025. This discussion should be read in conjunction with the information contained in the unaudited TIC Solutions, Inc. condensed consolidated financial statements and the notes related thereto included elsewhere in this Quarterly Report and the audited financial statements for the year ended December 31, 2025, included in our Annual Report on Form 10-K. The tables below are presented in thousands except for percentages and share and per share amounts.
CAUTIONARY NOTE REGARDING FORWARD LOOKING STATEMENTS
This Quarterly Report contains “forward-looking statements”. These forward-looking statements are based on beliefs and assumptions as of the date such statements are made. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. In some cases, you can identify forward-looking statements by terms including “expect,” “anticipate,” “project,” “will,” “should,” “believe,” “intend,” “plan,” “estimate,” “potential,” “target,” “would,” and similar expressions, although not all forward-looking statements contain these identifying terms. These forward-looking statements are based on our current expectations and assumptions and on information currently available to management and include, among others, statements concerning our expectations regarding, as of the date such statements are made: (i) economic, industry and market conditions, including as a result of inflation, and trade and geopolitical conflicts, (ii) the sufficiency of our current sources of liquidity to fund our future liquidity requirements, our expectations regarding the types of future liquidity requirements and our expectations regarding the availability of future sources of liquidity, (iii) the cost of compliance with laws and regulations, (iv) the impact of legal claims and related contingencies, (v) estimates and liabilities regarding accounting and tax matters, and (vi) the Company’s acquisitions, including the NV5 Acquisition and the goodwill, synergies and benefits of such acquisition.
These forward-looking statements are subject to a number of known and unknown risks, uncertainties and assumptions, including, among others, (i) economic conditions affecting the industries we serve, including the construction industry and the energy sector, as well as general economic conditions; (ii) adverse developments in the credit markets that could adversely affect funding of construction projects; (iii) the ability and willingness of customers to invest in infrastructure projects; (iv) a decline in demand for our services or for the products and services of our customers; (v) the fact that our revenues are derived primarily from contracts with durations of less than six months and the risk that customers will not renew or enter into new contracts; (vi) our ability to successfully acquire other businesses, successfully integrate acquired businesses into our operations and manage the risks and potential liabilities associated with those acquisitions; (vii) our ability to compete successfully in the industries and markets we serve; (viii) our ability to properly manage and accurately estimate costs associated with specific customer projects, in particular for arrangements with fixed price terms; (ix) increases in the cost, or reductions in the supply, of the materials we use in our business and for which we bear the risk of such increases; (x) the inherently dangerous nature of the services we provide and the risks of potential liability; (xi) the seasonality of our business and the impact of weather conditions; (xii) our ability to remediate any material weaknesses; (xiii) the impact of health, safety and environmental laws and regulations, and the costs associated with compliance with such laws and regulations; (xiv) our substantial level of indebtedness and the effect of restrictions on our operations set forth in the documents that govern such indebtedness; (xv) a prolonged government shutdown, and (xvi) our compliance with certain financial maintenance covenants in the documents governing our indebtedness and the effect on our liquidity of any failure to comply with such covenants.
Please see the section entitled “Risk Factors” located in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2025, and Part II, Item 1A of this Quarterly Report for a further discussion of these and other risks and uncertainties which could affect our future results. You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance or achievements. We undertake no obligation to revise any forward-looking statements to reflect events or circumstances after the date of those statements or to reflect the occurrence of anticipated or unanticipated events, except to the extent we are legally required to disclose certain matters in our SEC filings or otherwise.
24

Overview
We are a leading provider of tech-enabled Testing, Inspection, Certification and Compliance (TICC), engineering and consulting, and geospatial services. We provide mission-critical services that are essential to the safety, reliability, and efficiency of industrial assets, buildings and public infrastructure. Our services are often non-discretionary and are driven by regulatory requirements, customer risk management policies, and the need to extend the useful life of critical assets.
We operate primarily in North America and serve both private and public-sector clients. Our private-sector clients span industrial, infrastructure, construction, and commercial real estate end markets. Our public-sector clients include federal, state, and municipal agencies, public utilities, transportation authorities, and environmental regulators. Within industrial markets, our services address energy processing and refining, pipeline and midstream infrastructure, chemicals and industrial processing, manufacturing and industrial services, power generation and utilities, and companies in aerospace, automotive, renewable energy, pulp and paper, and mining.
On October 10, 2025, we changed our name from Acuren Corporation to TIC Solutions, Inc.
Recent Developments
Employee Stock Purchase Plan
Our Employee Stock Purchase Plan (“ESPP”) allows qualified employees to purchase designated shares of the our common stock at a price equal to 85% of the lesser of the fair market value of common stock at the beginning or end of each semi-annual stock purchase period. We did not issue any shares of common stock pursuant to the ESPP during the three months ended March 31, 2026.
Share Repurchase
On March 10, 2026, our Board of Directors approved a share repurchase program of up to $200 million of our common stock. As of March 31, 2026, we have not repurchased any common stock under the share repurchase program. Our share repurchase program does not obligate us to purchase any shares.
NV5 Acquisition
On August 4, 2025 (the “NV5 Closing Date”), we completed the NV5 Acquisition. NV5 is a global provider of infrastructure engineering, building systems, environmental consulting and geospatial analytics to private and public-sector clients in the infrastructure, utility services, construction, real estate, environmental and geospatial markets. Pursuant to the terms of the merger agreement, the aggregate purchase price was approximately $1.7 billion, including the full repayment of NV5’s outstanding debt. The Company paid total consideration consisting of $870.9 million in cash and the issuance of approximately 73.2 million shares of Company common stock.
Certain Factors and Trends Affecting Results of Operations
Summary of Acquisitions
The Company completed other immaterial acquisitions during the periods presented that also affect the comparability of its results of operations.
Economic, Industry and Market Factors
We may experience increased costs associated with the recent developments around tariffs between the United States, Canada, and other international jurisdictions and will continue to monitor market conditions and respond accordingly. We also have observed some impact from inflationary pressures during 2025 and into 2026. Although we look to mitigate the impact of these pressures with a combination of cost management and price initiatives, there can be no guarantee that these initiatives will be successful. There has been no direct effect on our business from the Russian-Ukrainian or the Middle Eastern conflicts, although these conflicts may have an impact on certain end markets, results of operations or liquidity or in other ways which we cannot yet determine.
The Organization for Economic Co-operation and Development (“OECD”) has a framework to implement a global minimum corporate tax of 15% for companies with global revenues and profits above certain thresholds (referred to as "Pillar 2"), with certain aspects of Pillar 2 effective January 1, 2024, and other aspects effective January 1, 2025. The U.S. and other countries continue to discuss how Pillar 2 will apply to U.S. companies. We are continuing to evaluate and monitor the impact of Pillar 2 and the evolving legislative landscape. To date, Pillar 2 has not had a material impact on our effective tax rate or condensed consolidated financial statements.
25

Description of Key Financial Statement Line Items
Revenue
Revenue is recognized to depict the transfer of goods or services to a customer at an amount that reflects the consideration we expect to receive in exchange for those goods or services. Our performance obligations are satisfied as work progresses or at a point in time. Revenue is recognized over time based on time and material incurred to date which best portrays the transfer of control to the customer. For our cost-reimbursable contracts, revenue is recognized over time using direct costs incurred or direct costs incurred to date as compared to the estimated total direct costs for performance obligations because it depicts the transfer of control to the customer. Contract costs include labor, sub-consultant services, and other direct costs. Revenue from services transferred to customers at a point in time is recognized when control of the promised deliverable transfers to the customer, which is generally upon completion, delivery, or customer acceptance of reports or analyses.
Cost of revenue
Cost of revenue consists primarily of direct labor, sub-consultant services, and other direct costs. Other direct costs include materials and costs, such as supplies, tools, facility costs, and depreciation of equipment related to our services as well as travel, per diem, and lodging costs. Labor costs are recognized as labor hours are incurred in delivering services.
Selling, general and administrative expenses
Selling, general and administrative expenses consist primarily of certain indirect costs of providing our services, employee compensation, information systems and technology costs, share-based compensation, depreciation, amortization of intangibles, and facility related expenses.
Results of Operations
The comparability of our operating results for the three months ended March 31, 2026 and March 31, 2025 was impacted by the NV5 Acquisition. In the discussion of our results of operations for these periods, we may quantitatively disclose the impacts of the NV5 Acquisition to the extent they remain ascertainable.
The following table summarizes our results of operations for the periods indicated:
Three Months Ended
 March 31, 2026March 31, 2025
Revenue$488,029 $234,215 
Cost of revenue326,728 190,546 
Gross profit161,301 43,669 
Selling, general and administrative expenses150,328 39,872 
Depreciation and amortization40,036 13,237 
Loss from operations
(29,063)(9,440)
Interest expense, net29,021 16,007 
Other income, net
(77)(1,119)
Loss before income tax benefit
(58,007)(24,328)
Income tax provision (benefit)
(16,458)1,465 
Net loss
$(41,549)$(25,793)

Comparison of the three months ended March 31, 2026 to the three months ended March 31, 2025
Revenues
Revenues were $488.0 million for the three months ended March 31, 2026, an increase of $253.8 million, or 108%, compared to $234.2 million during the three months ended March 31, 2025. The increase in revenues was primarily driven by incremental revenues of $253.2 million resulting from the NV5 Acquisition. Excluding the NV5 Acquisition, revenues increased by $0.6 million due to increased call-out and outage work, which was partially offset by lower run-and-maintain and capital project activity.
26

Cost of revenues
Cost of revenues were $326.7 million for the three months ended March 31, 2026, an increase of $136.2 million, or 71%, compared to $190.5 million during the three months ended March 31, 2025. The increase was primarily driven by incremental cost of revenues of $132.7 million resulting from the NV5 Acquisition. Excluding the NV5 Acquisition, cost of revenues increased $3.5 million which was primarily driven by a decline in higher-margin capital project work and an associated shift in revenue mix toward callout and lower-margin run-and-maintain activity.
Gross profit
The following table presents gross profit and gross profit margin, defined as gross profit as a percentage of revenue, for the three months ended March 31, 2026 and March 31, 2025:
Three Months Ended
 March 31, 2026March 31, 2025
Revenue$488,029 $234,215 
Gross profit$161,301 $43,669 
Gross profit margin33 %19 %
Gross profit was $161.3 million for the three months ended March 31, 2026, an increase of $117.6 million, or 269%, compared to $43.7 million during the three months ended March 31, 2025. Gross profit margin was 33.1% for the three months ended March 31, 2026 compared to 18.6% during the three months ended March 31, 2025. The increase in gross profit and gross profit margin was primarily driven by the NV5 Acquisition. The NV5 Acquisition contributed $120.5 million of gross profit and 48% gross profit margin. NV5’s consulting engineering and geospatial services have higher gross profit than the TIC Solutions legacy services. Excluding the NV5 Acquisition, gross profit decreased $2.9 million. The decrease was primarily due to a decline in higher-margin capital project work and an associated shift in revenue mix toward callout and lower-margin run-and-maintain activity relative to the prior-year period.
Selling, general and administrative expenses
The following table presents selling, general and administrative expenses (“SG&A expenses”) and SG&A expenses as a percentage of revenue for the three months ended March 31, 2026 and March 31, 2025:
Three Months Ended
 March 31, 2026March 31, 2025
SG&A expenses$150,328 $39,872 
SG&A expenses as a percentage of revenue (%)31 %17 %
SG&A expenses were $150.3 million for the three months ended March 31, 2026, an increase of $110.5 million, or 277%, compared to $39.9 million during the three months ended March 31, 2025. The increase in SG&A expense was primarily driven by incremental expenses of $95.3 million resulting from the NV5 Acquisition. Excluding the NV5 Acquisition, SG&A expenses increased $15.2 million. The increase was primarily driven by an increase in share-based compensation and acquisition-related expenses.
Depreciation and amortization expense
Total depreciation expense for property and equipment and amortization expense for intangibles were recognized as follows:
Three Months Ended
March 31, 2026March 31, 2025
Depreciation expense included in cost of revenue
$18,843 $15,362 
Depreciation and amortization expense
40,036 13,237 
Total depreciation and amortization expense
$58,880 $28,599 
This increase in depreciation and amortization expense of $30.3 million, or 106%, was primarily driven by incremental amortization expense of $23.0 million and depreciation expense of $5.2 million resulting from the NV5 Acquisition.
27

Interest expense, net
Interest expense, net was $29.0 million for the three months ended March 31, 2026, an increase of $13.0 million, or 81%, compared to $16.0 million during the three months ended March 31, 2025. The increase in interest expense was primarily driven by an increase in our indebtedness as a result of the NV5 Acquisition.
Income taxes
The Company recorded an income tax benefit of $16.5 million for the three months ended March 31, 2026 compared to an income tax expense of $1.5 million during the three months ended March 31, 2025. The income tax benefit for the three months ended March 31, 2026 was primarily driven by the loss recognized in the period and the reversal of an uncertain tax liability from a prior acquisition. See “Note 13. Income Taxes” for further discussion.
Operating Segment Results
The following tables set forth summarized financial information about our reportable segments for the periods indicated.
Comparison of the three months ended March 31, 2026 to the three months ended March 31, 2025
Revenue
Three Months Ended
 March 31, 2026March 31, 2025
Inspection and Mitigation
$234,827 $234,215 
Consulting Engineering
187,341 — 
Geospatial
65,861 — 
Total$488,029 $234,215 
Cost of revenue
Three Months Ended
 March 31, 2026March 31, 2025
Inspection and Mitigation
$194,066 $190,546 
Consulting Engineering
98,191 — 
Geospatial
34,471 — 
Total$326,728 $190,546 
Gross profit
Three Months Ended
 March 31, 2026March 31, 2025
Inspection and Mitigation
$40,761 $43,669 
Consulting Engineering
89,150 — 
Geospatial
31,390 — 
Total$161,301 $43,669 
Inspection and Mitigation
Inspection and Mitigation revenues were $234.8 million for the three months ended March 31, 2026, an increase of $0.6 million, or 0.3%, compared to $234.2 million during the three months ended March 31, 2025. The increase primarily reflects higher call-out and outage activity, which was partially offset by a decline in capital project and construction work, as well as continued softness in the chemicals end market.
Segment gross profit was $40.8 million for the three months ended March 31, 2026, a decrease of $2.9 million, or 6.7%, compared to $43.7 million during the three months ended March 31, 2025. The decrease was primarily driven by a decline in higher-margin capital project work and an associated shift in revenue mix toward callout and lower-margin run-and-maintain activity, as well as increased depreciation expense.
28

Consulting Engineering
Consulting Engineering revenue was $187.3 million for the three months ended March 31, 2026 due to the NV5 Acquisition. During the period, the Consulting Engineering segment experienced growth primarily attributable to data center, buildings, and infrastructure activity, with data center growth concentrated in APAC and growth in infrastructure work concentrated in the eastern United States. Segment gross profit was $89.2 million for the three months ended March 31, 2026.
Geospatial
Geospatial revenue was $65.9 million for the three months ended March 31, 2026 due to the NV5 Acquisition. During the period, the Geospatial segment experienced normal course growth in government work primarily related to projects with federal agencies. Segment gross profit was $31.4 million for the three months ended March 31, 2026.
Liquidity and Capital Resources
Overview
Overall, we believe that available cash and cash equivalents, cash flows generated from future operations, access to capital markets, and availability under the revolving credit facility are sufficient to fund our operations, service our indebtedness, and maintain compliance with our debt covenants over the next 12 months. Our uses of available cash, borrowing capacity, cash flows from operations and financing arrangements are used to invest in capital expenditures to support our growth, repay debt maturities as they become due, and complete integration activities. Our principal liquidity requirements are for working capital and general corporate purposes, including capital expenditures and debt service, as well as to execute and integrate strategic acquisitions. In addition, we will use available cash, borrowing capacity, and cash flows from operations to fund our operating leases, finance leases, debt repayments, and various other obligations as they arise.
Financing
We have a $775.0 million senior secured 2024 Term Loan and an $875.0 million senior secured 2025 Term Loan under the Term Loan Facility, as well as a $125.0 million five-year senior secured revolving credit facility, of which up to $20.0 million can be used for the issuance of letters of credit. As of March 31, 2026, we had $1.6 billion of indebtedness outstanding under the Term Loans and no amounts outstanding under the Revolving Credit Facility. For discussion of the First Amendment to our Credit Agreement, and the Second Amendment, see “Note 11. Long-Term Debt” of the notes to our unaudited condensed consolidated financial statements.
For discussion of the covenants contained in the Credit Agreement governing our Revolving Credit Facility, see “Note 11. Long-Term Debt” of the notes to our unaudited condensed consolidated financial statements. As of March 31, 2026, we were in compliance with these covenants.
Cash Flows
The following table summarizes net cash flows with respect to our operating, investing and financing activities for the periods indicated:
 Three Months Ended
Cash flows provided by (used in):
March 31, 2026March 31, 2025
Operating activities
$9,925 $32,792 
Investing activities
(8,294)(12,213)
Financing activities
(12,907)(5,605)
Effect of exchange rate on cash
(1,696)1,631 
Net change in cash and cash equivalents
$(12,972)$16,605 
29

Operating activities
Net cash provided by operating activities for the three months ended March 31, 2026 was $9.9 million, a decrease of $22.9 million compared to cash provided by operating activities of $32.8 million during the three months ended March 31, 2025. The decrease was a result of changes in our working capital, partially offset by increases in our net income adjusted for noncash items primarily driven by increased revenues. The changes in our working capital that contributed to decreased cash flows from operations were primarily a result of increases in accounts receivable of $18.2 million and increases in contract assets of $19.5 million due to timing of project billing cycles, partially offset by increases in accrued expenses and other current liabilities of $13.1 million and increases in contract liabilities of $4.4 million.
Investing activities
For the three months ended March 31, 2026, net cash used in investing activities was $8.3 million, a decrease of $3.9 million compared to net cash used in investing activities of $12.2 million during three months ended March 31, 2025. The decrease in cash used in investing activities was primarily a result of decreased cash paid for acquisitions of $4.1 million.
Financing activities
For the three months ended March 31, 2026, net cash used in financing activities was $12.9 million, an increase of $7.3 million compared to net cash used in financing activities of $5.6 million during the three months ended March 31, 2025. The increase in cash used in financing activities was primarily a result of an increase in payments on finance lease obligations and other long-term debt of $6.3 million and an increase in payments on long-term borrowings of $2.2 million, partially offset by a decrease in payments of debt issuance costs of $1.2 million.
Effect of exchange rate changes
For the three months ended March 31, 2026 and March 31, 2025, the effect of foreign exchange rate changes on cash was $(1.7) million and $1.6 million, respectively. The impact of exchange rates on cash and cash equivalents is primarily attributable to fluctuations in the U.S. Dollar exchange rate against the Canadian Dollar.
Off-Balance Sheet Arrangements
During the three months ended March 31, 2026 and March 31, 2025, we did not have any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes.
Recently Issued Accounting Pronouncements
See “Note 1. Basis of Presentation and Significant Accounting Policies” of the notes to our unaudited condensed consolidated financial statements for disclosures regarding recently issued accounting pronouncements and the critical accounting policies related to our business.
Critical Accounting Estimates
There have been no significant changes to our critical accounting policies and estimates from the information provided in Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” included in the 2025 Annual Report, except for the changes discussed in Note 1. Basis of Presentation and Significant Accounting Policies of the Notes to the Consolidated Financial Statements.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
There have been no significant changes to our quantitative and qualitative disclosures about market risk as discussed in Part II, Item 7A “Quantitative and Qualitative Disclosures About Market Risk,” included in the 2025 Annual Report.
ITEM 4. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
Management maintains and assesses the effectiveness of our disclosure controls and procedures as defined under Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These disclosure controls and procedures provide reasonable assurance that the information we are required to disclose in the
30

reports that we file or submit under the Exchange Act is accumulated and communicated to management, including our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), to allow timely decisions regarding required disclosure. These disclosure controls and procedures are also designed to provide reasonable assurance that such information is recorded, processed, summarized and reported within the time periods specified by SEC rules and forms.
Based on this assessment, our CEO and CFO concluded that, as of March 31, 2026, our disclosure controls and procedures were not effective at a reasonable assurance level due to the material weaknesses previously disclosed in our 2025 Annual Report.
Material Weaknesses in Internal Control Over Financial Reporting
A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis.
As indicated above, we identified material weaknesses in our internal control over financial reporting as:
We did not design and maintain an effective control environment commensurate with our financial reporting requirements. Specifically, we lacked a sufficient complement of resources with (i) an appropriate level of accounting knowledge, training, and experience to appropriately analyze, record and disclose accounting matters timely and accurately, and (ii) an appropriate level of knowledge and experience to establish effective processes and controls. This material weakness contributed to the following additional material weaknesses.
We did not design and maintain effective controls related to the period-end financial reporting process, including designing and maintaining formal accounting policies, procedures and controls to achieve complete, accurate and timely financial accounting, reporting and disclosures; further, we did not design and maintain effective controls over the preparation and review of account reconciliations and journal entries, including maintaining appropriate segregation of duties.
These material weaknesses resulted in the misstatement of our income tax provision (benefit) and deferred tax liabilities and related financial statement disclosures which resulted in the restatement of our financial statements for the predecessor period January 1 through July 29, 2024. These material weaknesses also resulted in immaterial audit adjustments to our previously issued annual and interim consolidated financial statements in the following financial statement line items: accounts receivable; prepaid expenses and other current assets; accounts payable; accrued expenses and other current liabilities; deferred tax liabilities; current portion of lease obligations; non-current lease obligations; revenue; cost of revenue; selling, general and administrative expenses; and interest expense. Additionally, these material weaknesses could result in a misstatement of all of the Company’s accounts or disclosures that would result in a material misstatement to the annual or interim consolidated financial statements that would not be prevented or detected.
We did not design and maintain effective information technology (“IT”) general controls for information systems that are relevant to the preparation of our consolidated financial statements. Specifically, we did not design and maintain:
User access controls to ensure appropriate segregation of duties and to adequately restrict user and privileged access to appropriate personnel;
Program change management controls to ensure that information technology program and data changes are identified, tested, authorized, and implemented appropriately;
Computer operations controls to ensure that processing and transfer of data, and data backups and recovery are monitored; and
Program development controls to ensure that new software development is tested, authorized and implemented appropriately.
These IT deficiencies did not result in a material misstatement to the consolidated financial statements, however, the deficiencies, when aggregated, could impact maintaining effective segregation of duties, as well as the effectiveness of IT-dependent controls (such as automated controls that address the risk of material misstatement to one or more assertions, along with the IT controls and underlying data that support the effectiveness of system-generated data and reports) that could result in misstatements potentially impacting all financial statement accounts and disclosures that would not be prevented or detected. Accordingly, management has determined these deficiencies in the aggregate constitute a material weakness.
31

Management’s Plans to Remediate the Material Weaknesses
Management is in the process of developing a remediation plan for the material weaknesses that have been identified. The material weaknesses will not be considered remediated until management designs and implements effective controls that operate for a sufficient period of time and management has concluded, through testing, that these controls are effective. The Company is implementing enhancements to its internal controls to remediate the identified material weaknesses in its internal control over financial reporting. We are committed to maintaining an effective control environment and will continue to monitor the effectiveness of these efforts, adjusting as necessary.
Specifically, the Company has:
Engaged a third-party advisor to support the design and implementation of internal control over financial reporting in accordance with the Sarbanes-Oxley Act (“SOX”);
Hired skilled professionals with a strong background in developing and improving control environments to strengthen the finance organization;
Delivered targeted training across the Company on SOX requirements, internal control over financial reporting, segregation of duties and other critical control environment topics;
Completed a financial statement risk assessment and documented business processes and internal controls deemed critical to financial reporting;
Developed and begun implementing enhanced policies and procedures for journal entries, account reconciliations, and other core accounting processes;
Began assessing the design and operating effectiveness of internal control over financial reporting;
Initiated remediation of segregation of duties conflicts and improvements to user access protocols; and
Implemented monitoring controls over key information systems and applications relevant to financial reporting.
In addition, the Company plans to continue hiring qualified accounting, finance and IT personnel with the necessary skills and expertise to support ongoing remediation and sustain an effective control environment.
While these remediation efforts are expected to significantly improve our internal control over financial reporting, they require time to be fully implemented and validated. Additional controls may also be required over time as the Company evolves. The Company will not be able to conclude that the material weaknesses have been remediated until the new and enhanced controls have been in place for a sufficient period of time and have been tested for both design and operating effectiveness.
Changes in Internal Control Over Financial Reporting
Other than the changes described above, there have not been any changes to our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the three months ended March 31, 2026 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. As of the filing of this report, we continue to implement the changes and remediation plans described above.
32

PART II – OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
For information on legal proceedings, see “Note 15. Commitments and Contingencies” included in this Quarterly Report.
ITEM 1A. RISK FACTORS
Our operations and financial results are subject to various risks and uncertainties. There have been no material changes in our risk factors from those previously disclosed in Part 1, Item 1A, “Risk Factors” in our 2025 Annual Report on Form 10-K.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
None.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
None.
ITEM 4. MINE SAFETY DISCLOSURES
Not applicable.
ITEM 5. OTHER INFORMATION
(b) 10b5-1 Trading Plans
During the three months ended March 31, 2026, none of our officers (as defined in Rule 16a-1(f) of the Exchange Act) or directors adopted or terminated a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement," as each term is defined in Item 408(d) of Regulation S-K.
33

ITEM 6. EXHIBITS
Exhibit No.
Description
101.INS*
Inline XBRL Instance Document.
101.SCH*
Inline XBRL Taxonomy Extension Schema Document.
101.DEF*
Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.CAL*
Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.LAB*
Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE*
Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104*
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).
*Filed herewith.
**Furnished herewith
Management contract or compensatory plan or arrangement
#Certain schedules to these agreements have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The Company agrees to furnish a copy of any schedule omitted from the agreements to the SEC upon request.
34

SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
TIC Solutions, Inc.
May 6, 2026/s/ Benjamin Heraud
Benjamin Heraud
Chief Executive Officer and Director
(duly authorized officer)
May 6, 2026/s/ Kristin Schultes
Kristin Schultes
Chief Financial Officer
(principal financial officer)
35
EX-31.1 2 q126-ex311xceo302certifica.htm EX-31.1 Document

Exhibit 31.1
CERTIFICATION PURSUANT TO
RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Benjamin Heraud, certify that:
1.I have reviewed this quarterly report on Form 10-Q of TIC Solutions, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 6, 2026
By:/s/ Benjamin Heraud
 Benjamin Heraud
 Chief Executive Officer
 (Principal Executive Officer)


EX-31.2 3 q126-ex312xcfo302certifica.htm EX-31.2 Document

Exhibit 31.2
CERTIFICATION PURSUANT TO
RULES 13a-14(a) AND 15d-14(a)UNDER THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Kristin Schultes, certify that:
1.I have reviewed this quarterly report on Form 10-Q of TIC Solutions, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 6, 2026
By:/s/ Kristin Schultes
 Kristin Schultes
 Chief Financial Officer
 (Principal Financial Officer)


EX-32.1 4 q126-ex321xceo906certifica.htm EX-32.1 Document

Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of TIC Solutions, Inc. (the “Company”) for the quarterly period ended March 31, 2026, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 6, 2026
By:/s/ Benjamin Heraud
 Benjamin Heraud
 Chief Executive Officer
 (Principal Executive Officer)


EX-32.2 5 q126-ex322xcfo906certifica.htm EX-32.2 Document

Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of TIC Solutions, Inc. (the “Company”) for the quarterly period ended March 31, 2026, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 6, 2026
By:/s/ Kristin Schultes
 Kristin Schultes
 Chief Financial Officer
 (Principal Financial Officer)


EX-101.SCH 6 tic-20260331.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover page link:presentationLink link:calculationLink link:definitionLink 9952151 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 9952152 - Statement - Condensed Consolidated Balance Sheets (Parentheticals) link:presentationLink link:calculationLink link:definitionLink 9952153 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss link:presentationLink link:calculationLink link:definitionLink 9952154 - Statement - Condensed Consolidated Statements of Stockholders’ Equity link:presentationLink link:calculationLink link:definitionLink 9952155 - Statement - Condensed Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 9952156 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 9952157 - Disclosure - BUSINESS COMBINATIONS link:presentationLink link:calculationLink link:definitionLink 9952158 - Disclosure - STOCKHOLDERS’ EQUITY link:presentationLink link:calculationLink link:definitionLink 9952159 - Disclosure - EARNINGS PER SHARE link:presentationLink link:calculationLink link:definitionLink 9952160 - Disclosure - ACCOUNTS RECEIVABLE AND CONTRACT ASSETS link:presentationLink link:calculationLink link:definitionLink 9952161 - Disclosure - PROPERTY AND EQUIPMENT link:presentationLink link:calculationLink link:definitionLink 9952162 - Disclosure - GOODWILL link:presentationLink link:calculationLink link:definitionLink 9952163 - Disclosure - INTANGIBLE ASSETS link:presentationLink link:calculationLink link:definitionLink 9952164 - Disclosure - ACCRUED EXPENSES AND OTHER LIABILITIES link:presentationLink link:calculationLink link:definitionLink 9952165 - Disclosure - FAIR VALUE MEASUREMENTS link:presentationLink link:calculationLink link:definitionLink 9952166 - Disclosure - LONG-TERM DEBT link:presentationLink link:calculationLink link:definitionLink 9952167 - Disclosure - FINANCIAL INSTRUMENTS link:presentationLink link:calculationLink link:definitionLink 9952168 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 9952169 - Disclosure - STOCK-BASED COMPENSATION link:presentationLink link:calculationLink link:definitionLink 9952170 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 9952171 - Disclosure - SEGMENT REPORTING link:presentationLink link:calculationLink link:definitionLink 9952172 - Disclosure - RELATED PARTIES link:presentationLink link:calculationLink link:definitionLink 9955511 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 9955512 - Disclosure - BUSINESS COMBINATIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 9955513 - Disclosure - EARNINGS PER SHARE (Tables) link:presentationLink link:calculationLink link:definitionLink 9955514 - Disclosure - ACCOUNTS RECEIVABLE AND CONTRACT ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 9955515 - Disclosure - PROPERTY AND EQUIPMENT (Tables) link:presentationLink link:calculationLink link:definitionLink 9955516 - Disclosure - GOODWILL (Tables) link:presentationLink link:calculationLink link:definitionLink 9955517 - Disclosure - INTANGIBLE ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 9955518 - Disclosure - ACCRUED EXPENSES AND OTHER LIABILITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 9955519 - Disclosure - LONG-TERM DEBT (Tables) link:presentationLink link:calculationLink link:definitionLink 9955520 - Disclosure - STOCK-BASED COMPENSATION (Tables) link:presentationLink link:calculationLink link:definitionLink 9955521 - Disclosure - SEGMENT REPORTING (Tables) link:presentationLink link:calculationLink link:definitionLink 9955522 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Details) link:presentationLink link:calculationLink link:definitionLink 9955522 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Details) link:presentationLink link:calculationLink link:definitionLink 9955523 - Disclosure - BUSINESS COMBINATIONS - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9955524 - Disclosure - BUSINESS COMBINATIONS - Summary of Fair Value of Consideration Transferred (Details) link:presentationLink link:calculationLink link:definitionLink 9955525 - Disclosure - BUSINESS COMBINATIONS - Summary of Preliminary Fair Value of the Identifiable Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 9955526 - Disclosure - BUSINESS COMBINATIONS - Summary of Pro Forma Consolidated Financial Information (Details) link:presentationLink link:calculationLink link:definitionLink 9955527 - Disclosure - STOCKHOLDERS’ EQUITY - Preferred Stock Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9955528 - Disclosure - STOCKHOLDERS’ EQUITY - Warrants Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9955529 - Disclosure - EARNINGS PER SHARE - Summary of Basic and Diluted Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 9955530 - Disclosure - EARNINGS PER SHARE - Summary of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 9955531 - Disclosure - ACCOUNTS RECEIVABLE AND CONTRACT ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 9955532 - Disclosure - PROPERTY AND EQUIPMENT - Summary of Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 9955533 - Disclosure - PROPERTY AND EQUIPMENT - Depreciation (Details) link:presentationLink link:calculationLink link:definitionLink 9955534 - Disclosure - GOODWILL (Details) link:presentationLink link:calculationLink link:definitionLink 9955535 - Disclosure - INTANGIBLE ASSETS - Summary of Intangible Assets and Amortization Expense (Details) link:presentationLink link:calculationLink link:definitionLink 9955536 - Disclosure - INTANGIBLE ASSETS - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9955537 - Disclosure - ACCRUED EXPENSES AND OTHER LIABILITIES - Summary of Accrued Expenses and Other Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9955538 - Disclosure - ACCRUED EXPENSES AND OTHER LIABILITIES - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9955539 - Disclosure - LONG-TERM DEBT - Summary of Long-Term Debt (Details) link:presentationLink link:calculationLink link:definitionLink 9955540 - Disclosure - LONG-TERM DEBT - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9955541 - Disclosure - INCOME TAXES (Details) link:presentationLink link:calculationLink link:definitionLink 9955542 - Disclosure - STOCK-BASED COMPENSATION - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9955543 - Disclosure - STOCK-BASED COMPENSATION - Summary of Activities of RSUs (Details) link:presentationLink link:calculationLink link:definitionLink 9955544 - Disclosure - STOCK-BASED COMPENSATION - Summary of Activities of Restricted Stock Awards (Details) link:presentationLink link:calculationLink link:definitionLink 9955545 - Disclosure - SEGMENT REPORTING - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9955546 - Disclosure - SEGMENT REPORTING - Summary of Financial Information For each of the Company’s Reportable Segments (Details) link:presentationLink link:calculationLink link:definitionLink 9955547 - Disclosure - SEGMENT REPORTING - Summary of Service Revenues Classifications by Major Geographic Areas (Details) link:presentationLink link:calculationLink link:definitionLink 9955548 - Disclosure - RELATED PARTIES (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 tic-20260331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 8 tic-20260331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 9 tic-20260331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Accumulated 
Amortization Finite-Lived Intangible Assets, Accumulated Amortization Statistical Measurement [Domain] Statistical Measurement [Domain] Plant and equipment Business Combination, Recognized Asset Acquired, Property, Plant, and Equipment Business Combination, Separately Recognized Transaction [Table] Business Combination, Separately Recognized Transaction [Table] Award Timing Predetermined Award Timing Predetermined [Flag] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Indefinite-Lived Intangible Assets [Axis] Indefinite-Lived Intangible Assets [Axis] Goodwill expected to be tax deductible Business Combination, Goodwill, Expected Tax Deductible, Amount Entity File Number Entity File Number Additional 
Paid-In 
Capital Additional Paid-in Capital [Member] Tabular List, Table Tabular List [Table Text Block] Number of shares issued (in shares) Business Combination, Consideration Transferred, Equity Interest, Share Issued, Number of Shares Recent Accounting Pronouncements Not Yet Adopted New Accounting Pronouncements, Policy [Policy Text Block] Contract assets Business Combination, Recognized Asset Acquired, Contract with Customer, Asset Business Combination, Recognized Asset Acquired, Contract with Customer, Asset Accounts payable Increase (Decrease) in Accounts Payable Secured Overnight Financing Rate (SOFR) Secured Overnight Financing Rate (SOFR) [Member] Contract assets, net Contract with Customer, Asset, after Allowance for Credit Loss, Current Contingent consideration liability incurred Business Combination, Consideration Transferred, Liabilities Incurred Goodwill [Line Items] Goodwill [Line Items] Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Vested warrants outstanding (in shares) Class of Warrant or Right, Outstanding Basic loss per common stock and Series A Preferred Stock (in dollars per share) Earnings Per Share, Basic Adjustment to Compensation: Adjustment to Compensation [Axis] RELATED PARTIES Related Party Transactions Disclosure [Text Block] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Employee Stock Purchase Plan Employee Stock Purchase Plan [Member] Employee Stock Purchase Plan Contract assets Unbilled Receivables, Current Summary of Segment Reporting Information, by Segment Schedule of Segment Reporting Information, by Segment [Table Text Block] Short-term debt Short-Term Debt Remaining performance obligation, amount Revenue, Remaining Performance Obligation, Amount Adjustment to Compensation, Amount Adjustment to Compensation Amount Less: Unamortized deferred financing costs Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net Share-based compensation expense Share-Based Payment Arrangement, Noncash Expense Stock Option Share-Based Payment Arrangement, Option [Member] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Schedule of Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Aggregate intrinsic value, vested Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested Total stockholders' equity Balance at the beginning of the period Balance at the end of the period Equity, Attributable to Parent Insider Trading Policies and Procedures [Line Items] Share-based compensation expense Share-Based Payment Arrangement, Expense Common stock, shares authorized (in shares) Common Stock, Shares Authorized Summary of Property and Equipment Property, Plant and Equipment [Table Text Block] Surety Bond Surety Bond [Member] Goodwill and Intangible Assets Disclosure [Abstract] Current assets Assets, Current [Abstract] Total liabilities and stockholders' equity Liabilities and Equity Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Liabilities and Stockholders' Equity Liabilities and Equity [Abstract] Cover [Abstract] Maximum Maximum [Member] Weighted average 
remaining 
life (in years) Finite-Lived Intangible Asset, Useful Life Prior to expiration of term (in days) Consulting Services Agreement, Prior to Expiration of Term Consulting Services Agreement, Prior to Expiration of Term Net Carrying Amount Finite-Lived Intangible Assets, Net Restricted stock awards Contingently issuable RSUs Restricted Stock [Member] Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Debt Instrument [Line Items] Debt Instrument [Line Items] Promissory notes Uncollateralized Promissory Note [Member] Uncollateralized Promissory Note Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Summary of the Activity of Restricted Stock Awards Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block] Fair value of restricted shares vested Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Pay vs Performance Disclosure [Line Items] Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Foreign currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Business Combinations Business Combination [Text Block] Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Accrued operating expenses Accrued Operating Expenses Accrued Operating Expenses Depreciation and amortization Depreciation, Depletion and Amortization, Nonproduction Loss before income tax benefit Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Entity Shell Company Entity Shell Company Restricted Stock, Convertible, Conversion Ratio Restricted Stock, Convertible, Conversion Ratio Restricted Stock, Convertible, Conversion Ratio Other non-current liabilities Other Liabilities, Noncurrent Schedule of Long-Term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Proceeds from sale of property and equipment Proceeds from Sale of Property, Plant, and Equipment Accrued indirect taxes Accrual for Taxes Other than Income Taxes, Current Geospatial Geospatial Segment [Member] Geospatial Segment Statement of Stockholders' Equity [Abstract] Operating Segments Operating Segments [Member] Statement of Cash Flows [Abstract] Current portion of long-term debt Long-Term Debt, Current Maturities Long-Term Debt, Current Maturities Company Selected Measure Amount Company Selected Measure Amount Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Interest expense, net Interest Expense, Operating Debt issuance costs Debt Issuance Costs, Gross Replacement of share-based awards Business Combination, Consideration Transferred, Fair Value of Exchanged Acquiree Equity Awards Business Combination, Consideration Transferred, Fair Value of Exchanged Acquiree Equity Awards Total other comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Name Measure Name Letter of Credit Letter of Credit [Member] Term Loans Secured Debt [Member] Current portion of lease obligations Operating Lease, Liability, Current Deferred tax liabilities Deferred Income Tax Liabilities, Net Document Fiscal Period Focus Document Fiscal Period Focus Buildings and leasehold improvements Building and Leasehold Improvements [Member] Building and Leasehold Improvements [Member] Award Timing Method Award Timing Method [Text Block] Issuance of common shares in conjunction with the Series A Preferred Stock Dividend (in shares) Stock Issued During Period, Shares, In Conjunction With Preferred Stock Dividend Stock Issued During Period, Shares, In Conjunction With Preferred Stock Dividend Award Type Award Type [Axis] Total debt, net Long-Term Debt Summary of Pro Forma Consolidated Financial Information Reflects the Results of Operations Business Combination, Pro Forma Information [Table Text Block] Total assets Assets Consulting Engineering Consulting Engineering Segment [Member] Consulting Engineering Segment Trading Symbol Trading Symbol Units Vested, Weighted average grant date fair value (in dollars per share) Vested (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Geographical [Domain] Geographical [Domain] Entity Address, City or Town Entity Address, City or Town Cash flows from operating activities: Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Weighted Average 
Remaining 
Life (Years) Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life INTANGIBLE ASSETS Intangible Assets Disclosure [Text Block] Net effect of exchange rate fluctuations on cash and cash equivalents Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Statement of Income Location, Balance [Domain] Statement of Income Location, Balance [Domain] Restricted stock units Restricted Stock Units (RSUs) [Member] Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Total consideration Total consideration Business Combination, Consideration Transferred Numerator: Undistributed Earnings, Diluted [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Warrants Warrant [Member] Common stock, dividends, per share, declared Common Stock, Dividends, Per Share, Declared Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Changes in operating assets and liabilities, net of effects of acquisitions: Increase (Decrease) in Operating Assets [Abstract] Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Debt issuance costs Debt Issuance Costs, Net Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Business Combination [Domain] Business Combination [Domain] Pre-Funded Warrants Pre-Funded Warrants [Member] Pre-Funded Warrants Balance at the beginning of the period (in shares) (Successor) Balance at the beginning of the period (in shares) Balance at the end of the period (in shares) Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Intangible Asset, Acquired, Indefinite-Lived [Line Items] Intangible Asset, Acquired, Indefinite-Lived [Line Items] Number Of Authorized Shares Not Disclosed Number Of Authorized Shares Not Disclosed Number Of Authorized Shares Not Disclosed Plan Name [Axis] Plan Name [Axis] PEO PEO [Member] ACCOUNTS RECEIVABLE AND CONTRACT ASSETS Loans, Notes, Trade and Other Receivables Disclosure [Text Block] Mariposa Capital, LLC Mariposa Capital, LLC [Member] Mariposa Capital, LLC United States UNITED STATES Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Derivative Instruments and Hedging Activities Disclosure [Abstract] Accumulated 
Deficit Retained Earnings [Member] Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Number of Unvested Restricted Stock Awards Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Restatement Determination Date Restatement Determination Date Share-Based Payment Arrangement [Abstract] Beginning of period End of period Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Series A Preferred Stock (in shares) Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock Income Statement [Abstract] Income tax provision (benefit) Income Tax Expense (Benefit) Basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate Sale of Stock [Domain] Sale of Stock [Domain] Preferred stock, shares issued (in shares) Number of securities issued (in shares) Preferred Stock, Shares Issued Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Total property and equipment Property, Plant and Equipment, Gross Other foreign Other Foreign Countries [Member] Other Foreign Countries Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Covenant compliance, undrawn letter of credit threshold, percent (greater than) Debt Instrument, Covenant, Undrawn Letter of Credit Threshold, Percent Debt Instrument, Covenant, Undrawn Letter of Credit Threshold, Percent Organization, Consolidation and Presentation of Financial Statements [Abstract] Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Acquisitions Goodwill, Acquired During Period City Area Code City Area Code Business acquisitions, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] All Trading Arrangements All Trading Arrangements [Member] Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Restricted Stock Share Issuances And Restricted Stock Unit Vesting, Net Restricted Stock Share Issuances And Restricted Stock Unit Vesting, Net Restricted Stock Share Issuances And Restricted Stock Unit Vesting, Net Unvested beginning balance (in shares) Unvested ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Commitments and Contingencies Disclosure [Abstract] Class of Warrant or Right [Line Items] Class of Warrant or Right [Line Items] Share price baseline for calculating annual dividends (in dollars per share) Common Stock, Share Price Base For Calculating Annual Dividend Amount Common Stock, Share Price Base For Calculating Annual Dividend Amount Cash flows from investing activities: Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Net cash provided by operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Debt instrument, term (in years) Debt Instrument, Term Related Party Transactions [Abstract] Useful Life (Years) Property, Plant and Equipment, Useful Life Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Selling, general and administrative expenses Selling, General and Administrative Expenses [Member] Cost of revenue Cost of Sales [Member] Goodwill Balance at December 31, 2025 Balance at March 31, 2026 Goodwill Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] PEO Total Compensation Amount PEO Total Compensation Amount Total depreciation expense Depreciation Long-Term Debt, Type [Axis] Long-Term Debt, Type [Axis] New Term Loans New Term Loans [Member] New Term Loans Basic shares: Weighted Average Number of Shares Outstanding, Basic [Abstract] Numerator: Net Income (Loss) Available to Common Stockholders, Diluted [Abstract] Share price threshold for Preferred stock dividends consecutive trading days Common Stock, Share Price Threshold, Preferred Stock Dividend, Threshold Consecutive Trading Days Common Stock, Share Price Threshold, Preferred Stock Dividend, Threshold Consecutive Trading Days Replacement of unvested Business Combination, Consideration Transferred, Fair Value of Exchanged Acquiree, Share Based Awards, Unvested Business Combination, Consideration Transferred, Fair Value of Exchanged Acquiree, Share Based Awards, Unvested Equity Components [Axis] Equity Components [Axis] Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Standby Letters of Credit Standby Letters of Credit [Member] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Contract with Customer, Basis of Pricing [Axis] Contract with Customer, Basis of Pricing [Axis] Number of reportable segments Number of Reportable Segments Total estimated fair value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Share-Based Liabilities Paid Notes payable and other obligations issued for acquisitions Noncash or Part Noncash Acquisition, Payables Assumed Supplemental disclosure of cash flow information Supplemental Cash Flow Information [Abstract] Accounts receivables Business Combination, Recognized Asset Acquired, Receivable, Current Other Performance Measure, Amount Other Performance Measure, Amount Inspection and Mitigation Inspection and Mitigation Segment [Member] Inspection and Mitigation Segment Payments of debt issuance costs Payments of Debt Issuance Costs Entity Address, State or Province Entity Address, State or Province Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Security, Excluded EPS Calculation [Table] Dividends, common stock (in dollars per share) Dividends, Common Stock Total current liabilities Liabilities, Current Individual: Individual [Axis] Vesting [Axis] Vesting [Axis] Accrued expenses and other current liabilities Total accrued expenses and other current liabilities Accounts Payable And Accrued Liabilities Excluding Trade Payables, Current Accounts Payable And Accrued Liabilities Excluding Trade Payables, Current Net cash used in investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Revenue, remaining performance obligation, expected timing of satisfaction, period Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Private sector Private Sector [Member] Private Sector Interest paid Interest Paid, Excluding Capitalized Interest, Operating Activity Document Fiscal Year Focus Document Fiscal Year Focus Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Operating lease right-of-use assets, net Operating Lease, Right-of-Use Asset Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Payments on long-term borrowings Repayments of Long-Term Debt Effective income tax rate, percent Effective Income Tax Rate Reconciliation, Percent Entity Interactive Data Current Entity Interactive Data Current Plan Name [Domain] Plan Name [Domain] Acquisition-related cost, expense Business Combination, Acquisition-Related Cost, Expense Weighted average period (in shares) Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Valuation allowance Deferred Tax Assets, Valuation Allowance Equity [Abstract] Preferred stock dividends, shares amount Preferred Stock Dividends, Shares Revenue Recognition Revenue from Contract with Customer [Policy Text Block] Automatic renews for successive terms (in years) Consulting Services Agreement, Automatic Renews for Successive Terms Consulting Services Agreement, Automatic Renews for Successive Terms SEGMENT REPORTING Segment Reporting Disclosure [Text Block] Principal payment Debt Instrument, Periodic Payment, Principal Goodwill [Table] Goodwill [Table] Covenant compliance, first lien net leverage ratio Debt Instrument, Covenant, First Lien Net Leverage Ratio Debt Instrument, Covenant, First Lien Net Leverage Ratio Property, Plant and Equipment, Type [Axis] Long-Lived Tangible Asset [Axis] Class of Warrant or Right [Table] Class of Warrant or Right [Table] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Other liabilities Business Combination, Recognized Liability Assumed, Other Liability, Noncurrent Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Contingent consideration Business Combination, Contingent Consideration, Liability Amortization of intangible assets Amortization of Intangible Assets Selling, general and administrative expenses Selling, General and Administrative Expense Number of types of RSUs Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Types of Restricted Stock Units Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Types of Restricted Stock Units Deferred tax assets Deferred Income Tax Assets, Net Depreciation and amortization Depreciation, Depletion and Amortization Other assets Other Assets, Noncurrent Customer [Domain] Customer [Domain] Entity Central Index Key Entity Central Index Key PEO Name PEO Name Gross proceeds Sale of Stock, Consideration Received on Transaction Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Revolving Credit Facility Revolving Credit Facility [Member] Common Stock And Series A Preferred Stock Common Stock And Series A Preferred Stock [Member] Common Stock And Series A Preferred Stock Arrangement Duration Trading Arrangement Duration Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Contract liabilities Contract with Customer, Liability, Current Exercise price of warrants (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Segments [Axis] Segments [Axis] Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Exercise Price Award Exercise Price Entity Filer Category Entity Filer Category Class of Stock [Domain] Class of Stock [Domain] Local Phone Number Local Phone Number Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Unrecognized compensation expense Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Accounts receivables Accounts Receivable, before Allowance for Credit Loss, Current STOCK-BASED COMPENSATION Share-Based Payment Arrangement [Text Block] Current portion of contingent consideration Business Combination, Contingent Consideration, Liability, Current Intangible assets Business Combination, Recognized Asset Acquired, Identifiable Intangible Asset, Excluding Goodwill Cash and cash equivalents Business Combination, Recognized Asset Acquired, Cash and Cash Equivalent Assets Assets [Abstract] Long-term debt, net of current portion Long-Term Debt, Excluding Current Maturities Business Combination, Intangible Asset, Acquired, Indefinite-Lived [Table] Business Combination, Intangible Asset, Acquired, Indefinite-Lived [Table] Credit Facility [Axis] Credit Facility [Axis] Noncash lease expense Noncash Lease Expense Noncash Lease Expense Underlying Security Market Price Change Underlying Security Market Price Change, Percent Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Vesting [Domain] Vesting [Domain] Debt Instrument [Axis] Debt Instrument [Axis] Forfeited, Weighted average grant date fair value (dollar per share) Forfeited (dollar per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value FAIR VALUE MEASUREMENTS Fair Value Disclosures [Text Block] Gross Carrying Amount Finite-Lived Intangible Assets, Gross Credit Facility [Domain] Credit Facility [Domain] Equity, Attributable to Parent [Abstract] Equity, Attributable to Parent [Abstract] Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Accrued expenses and other current liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Expenses And Other Current Liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Expenses And Other Current Liabilities Accumulated 
Other 
Comprehensive 
Income (Loss) AOCI Attributable to Parent [Member] Allowance for credit losses Accounts Receivable, Allowance for Credit Loss, Current Accrued expenses and other current liabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities Non-current lease obligations Operating Lease, Liability, Noncurrent Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract] FINANCIAL INSTRUMENTS Derivative Instruments and Hedging Activities Disclosure [Text Block] Fair Value as of Grant Date Award Grant Date Fair Value Property, Plant and Equipment [Abstract] Entity Registrant Name Entity Registrant Name Undistributed loss allocated to Series A Preferred Stock Undistributed loss allocated to Series A Preferred Stock Undistributed Earnings, Basic Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Customer backlog Customer Lists [Member] Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Title of Individual [Domain] Title and Position [Domain] Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Related Party Transaction [Line Items] Related Party Transaction [Line Items] Document Quarterly Report Document Quarterly Report Deferred taxes Deferred Income Taxes and Tax Credits Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Time Vesting Units Time Vesting Units [Member] Time Vesting Units Counterparty Name [Domain] Counterparty Name [Domain] Advisory fees Consulting Services Agreement, Advisory Fees Consulting Services Agreement, Advisory Fees Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Summary of Long-Term Debt Schedule of Debt [Table Text Block] Summary of Accounts Payable and Accrued Liabilities Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Machinery and equipment Machinery and Equipment [Member] Granted, Weighted average grant date fair value (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Increase in existing senior secured revolving credit facility Line of Credit Facility, Increase (Decrease), Net Title Trading Arrangement, Individual Title Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Restricted stock unit vestings (in shares) Restricted Stock Issuances And Restricted Stock Unit Vesting, Net Restricted Stock Issuances And Restricted Stock Unit Vesting, Net Summary of Finite-Lived Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Restatement Determination Date: Restatement Determination Date [Axis] Cash paid to acquire business Cash consideration Payments to Acquire Businesses, Gross Non-PEO NEO Non-PEO NEO [Member] Fixed-unit price contracts Fixed-Unit Price Contracts [Member] Fixed-Unit Price Contracts Initial Public Stock Offering Initial Public Stock Offering [Member] Initial Public Stock Offering [Member] Dividend rate, percent of appreciation of market price Preferred Stock, Dividend Rate, Percentage Sale of Stock [Axis] Sale of Stock [Axis] Land Land [Member] Name Trading Arrangement, Individual Name All Award Types Award Type [Domain] Contract with Customer, Basis of Pricing [Domain] Contract with Customer, Basis of Pricing [Domain] GOODWILL Goodwill Disclosure [Text Block] Equity Awards Adjustments Equity Awards Adjustments [Member] Other Other Noncash Income (Expense) Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block] Lease liabilities Business Combination, Recognized Liability Assumed, Lease Obligation Canada CANADA Compensation Amount Outstanding Recovery Compensation Amount Debt instrument face amount Debt Instrument, Face Amount Total undistributed loss Undistributed Earnings, Diluted Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Equity consideration Business Combination, Consideration Transferred, Equity Interest Series A Preferred Stock Preferred Stock Preferred Stock [Member] MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Name Awards Close in Time to MNPI Disclosures, Individual Name Unvested, Weighted average grant date fair value at beginning balance (in dollars per share) Unvested, Weighted average grant date fair value at Ending balance (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Notice period Class Of Warrant Or Right, Exercise, Change in Beneficial Ownership Percentage, Notice Period Class Of Warrant Or Right, Exercise, Change in Beneficial Ownership Percentage, Notice Period Contingent consideration, change in contingent consideration, liability, increase (decrease) Business Combination, Contingent Consideration, Change in Contingent Consideration, Liability, Increase (Decrease) Denominator: Weighted Average Number of Shares Outstanding Reconciliation [Abstract] Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Operating lease right-of-use assets Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Operating Lease Right Of Use Assets Business combination recognized identifiable assets acquired and liabilities assumed operating lease right of use assets. Employee Stock Employee Stock [Member] Share-based compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Accumulated other comprehensive income (loss) Accumulated Other Comprehensive Income (Loss), Net of Tax Segments [Domain] Segments [Domain] Statement of Income Location, Balance [Axis] Statement of Income Location, Balance [Axis] Liability Based Awards Liability Based Awards [Member] Liability Based Awards Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Developed technology Developed Technology Rights [Member] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] 2025 Business Acquisitions 2025 Business Acquisitions [Member] 2025 Business Acquisitions Warrant conversion shares ratio (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Minimum Minimum [Member] NV5 Global, Inc. NV5 Global, Inc. [Member] NV5 Global, Inc. Accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Measurement period adjustments Goodwill, Measurement Period Adjustment Company Selected Measure Name Company Selected Measure Name Net Loss Business Combination, Pro Forma Information, Pro Forma Income (Loss), after Tax 2026 Business Acquisitions 2026 Business Acquisitions [Member] 2026 Business Acquisitions LONG-TERM DEBT Debt Disclosure [Text Block] Series A Preferred Stock, $0.0001 par value, 1,000,000 shares issued and outstanding Preferred Stock, Value, Issued Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Accounts payable Accounts Payable, Current Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] All Executive Categories All Executive Categories [Member] Common stock, $0.0001 par value, 221,039,674 and 220,485,045 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively Common Stock, Value, Issued Goodwill [Roll Forward] Goodwill [Roll Forward] Prepaid expenses and other current assets Business Combination, Recognized Asset Acquired, Prepaid Expense and Other Asset, Current COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] Title of Individual [Axis] Title and Position [Axis] Weighted average common stock stock and Series A Preferred Stock outstanding, diluted (in shares) Weighted average common stock and Series A Preferred Stock outstanding – diluted Weighted Average Number of Shares Outstanding, Diluted Commitments and contingencies (Note 15) Commitments and Contingencies Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Business Combination [Axis] Business Combination [Axis] Entity Small Business Entity Small Business Summary of Revenue from External Customers by Geographic Areas Revenue from External Customers by Geographic Areas [Table Text Block] Income Tax Disclosure [Abstract] Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Document Transition Report Document Transition Report Other assets Business Combination, Recognized Asset Acquired, Other Asset, Noncurrent Underlying Securities Award Underlying Securities Amount Equity Component [Domain] Equity Component [Domain] Document Period End Date Document Period End Date PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount INCOME TAXES Income Tax Disclosure [Text Block] Add: dilutive securities Earnings Per Share, Diluted [Abstract] Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Deferred tax liabilities Business Combination, Recognized Liability Assumed, Deferred Tax Liability Operating lease obligations Increase (Decrease) in Operating Lease Liability Amortization expense related to debt issuance costs Amortization of Debt Discount (Premium) Document Type Document Type EARNINGS PER SHARE Earnings Per Share [Text Block] Name Outstanding Recovery, Individual Name Loss Contingencies [Table] Loss Contingencies [Table] Additional paid-in capital Additional Paid in Capital Cost-reimbursable contracts Cost-Reimbursable Contracts [Member] Cost-Reimbursable Contracts Revenue Revenue from Contract with Customer, Excluding Assessed Tax Service period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period All Individuals All Individuals [Member] Long-Term Debt, Type [Domain] Long-Term Debt, Type [Domain] Fair Value Disclosures [Abstract] Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Name Forgone Recovery, Individual Name Total current assets Assets, Current Statistical Measurement [Axis] Statistical Measurement [Axis] Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Contingent consideration liability payment Business Combination, Contingent Consideration, Liability, Payment Business Combination, Contingent Consideration, Liability, Payment Unused capacity, commitment fee percentage Line of Credit Facility, Unused Capacity, Commitment Fee Percentage Share repurchase program, authorized, amount Share Repurchase Program, Authorized, Amount Weighted average interest rate (as a percent) Debt, Weighted Average Interest Rate Minimum beneficial ownership percentage Class Of Warrant Or Right, Exercise, Beneficial Ownership Percentage Class Of Warrant Or Right, Exercise, Beneficial Ownership Percentage Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Purchase price of common stock, percent Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent Currency adjustments Goodwill, Foreign Currency Translation, Gain (Loss) Private Placement Private Placement [Member] Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Net loss allocated to common stockholders Net loss available to holders of common stock Net Income (Loss) Available to Common Stockholders, Basic Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Intangible Asset, Finite-Lived [Table] Intangible Asset, Finite-Lived [Table] Other comprehensive income (loss) Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Current liabilities Liabilities, Current [Abstract] Geographical [Axis] Geographical [Axis] Quarterly installments Debt Instrument, Periodic Payment Other assets and liabilities Increase (Decrease) in Other Operating Assets and Liabilities, Net Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Net Revenue Business Combination, Pro Forma Information, Pro Forma Revenue Accounts payable Business Combination, Recognized Liability Assumed, Accounts Payable, Current Related Party Transaction [Table] Related Party Transaction [Table] Diluted loss per common stock and Series A Preferred Stock (in dollars per share) Earnings Per Share, Diluted Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Accounts receivable, net Accounts Receivable, after Allowance for Credit Loss, Current Title of 12(b) Security Title of 12(b) Security Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] Number of shares (in shares) Sale of Stock, Number of Shares Issued in Transaction Basic and diluted loss per share: Earnings Per Share [Abstract] Consolidation Items [Domain] Consolidation Items [Domain] BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES Business Description and Basis of Presentation [Text Block] 2024 Credit Agreement 2024 Credit Agreement [Member] 2024 Credit Agreement Gross profit Gross Profit Term Loan 2024 Term Loan 2024 [Member] Term Loan 2024 Summary of Antidilutive Securities Excluded from Computation of Earnings Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Contract liabilities Increase (Decrease) in Contract with Customer, Liability Accrued Expenses and Other Liabilities Accounts Payable and Accrued Liabilities Disclosure [Text Block] Income taxes paid Income Taxes Paid, Net Award Timing Disclosures [Line Items] Long-term debt Long-Term Debt, Gross Weighted average exercise price (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Accrued salaries, wages and related employee benefits Employee-related Liabilities, Current Property and Equipment Property, Plant and Equipment Disclosure [Text Block] Market Vesting Units Market Vesting Units [Member] Market Vesting Units Contract liabilities Business Combination, Recognized Asset Acquired, Contract with Customer, Liability Business Combination, Recognized Asset Acquired, Contract with Customer, Liability STOCKHOLDERS’ EQUITY Equity [Text Block] Trade name Trade Names [Member] Net loss Net loss Net loss Net Income (Loss) Attributable to Parent Public and quasi-public sector Public and Quasi-Public Sector [Member] Public and Quasi-Public Sector Expiration Date Trading Arrangement Expiration Date Construction in progress Construction in Progress [Member] Other accrued expenses Other Accrued Liabilities, Current Award vesting period (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Property and equipment, net Property and equipment, net Property, Plant and Equipment, Net Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Adoption Date Trading Arrangement Adoption Date Base Rate Base Rate [Member] Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Accounts receivable Increase (Decrease) in Accounts Receivable Series A Preferred Stock Shares issuable pursuant to the Series A Preferred Stock dividend Series A Preferred Stock [Member] Entity Current Reporting Status Entity Current Reporting Status Vehicles, aircrafts and vessels Vehicles, Aircraft and Vessels [Member] Vehicles, Aircraft and Vessels Corporate and Eliminations Consolidation, Eliminations [Member] Receivables [Abstract] Customer [Axis] Customer [Axis] Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Customer relationships Customer Relationships [Member] Loss from operations Operating Income (Loss) Consolidated Entities [Domain] Consolidated Entities [Domain] Accrued sales discounts Accrued Sales Discounts, Current Accrued Sales Discounts, Current Line of Credit Line of Credit [Member] Accumulated deficit Retained Earnings (Accumulated Deficit) Statement of Financial Position [Abstract] Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Executive Category: Executive Category [Axis] Other income, net Other Operating Income (Expense), Net Class of Stock [Axis] Class of Stock [Axis] Current Fiscal Year End Date Current Fiscal Year End Date Number of securities called by each warrant (in shares) Class of Warrant or Right, Number of Securities Called by Each Warrant or Right Developed technology Technology-Based Intangible Assets [Member] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Consecutive trading day Share-based Compensation Arrangement by Share-based Payment Award, Consecutive Trading Days Used To Calculate Weighted Average Price Share-based Compensation Arrangement by Share-based Payment Award, Consecutive Trading Days Used To Calculate Weighted Average Price Summary of Accounts Receivable and Contract Assets Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block] Payables and Accruals [Abstract] Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Statement [Table] Statement [Table] Summary of Business Acquisitions, by Acquisition Business Combination [Table Text Block] Adjustments to reconcile net loss to cash flows from operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table] Earnings Per Share, Basic, by Common Class, Including Two-Class Method [Table] Cash flows from financing activities: Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Total accounts receivables, net Receivables, Net, Current Variable Rate [Domain] Variable Rate [Domain] Common stock dividends, (in shares) Common Stock Dividends, Shares Total identifiable net assets acquired Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less) Mandatorily redeemable, stock trigger price (in dollars per share) Warrant, Mandatorily Redeemable, Stock Trigger Price Warrant, Mandatorily Redeemable, Stock Trigger Price Securities excluded from computation of diluted loss per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Weighted-average shares outstanding: Dilutive shares: Weighted Average Number of Shares Outstanding, Diluted [Abstract] All Adjustments to Compensation All Adjustments to Compensation [Member] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Amendment Flag Amendment Flag Sale price per share (in dollars per share) Sale of Stock, Price Per Share Termination Date Trading Arrangement Termination Date Net cash used in financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Contract assets Increase (Decrease) in Contract with Customer, Asset Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Measure: Measure [Axis] Computer, software, and office equipment Computer, Software, And Office Equipment [Member] Computer, Software, And Office Equipment Property, Plant and Equipment, Type [Domain] Long-Lived Tangible Asset [Domain] Weighted average common stock stock and Series A Preferred Stock outstanding – basic (in shares) Weighted Average Number of Shares Outstanding, Basic Summary of Basic and Diluted Earnings Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Non Founder Director Director [Member] Number of businesses acquired Business Combination, Number of Businesses Acquired Segment Reporting [Abstract] Cost of revenue Cost of Revenue Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Debt Disclosure [Abstract] Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Amortization of deferred financing costs Amortization of Debt Issuance Costs Entity Tax Identification Number Entity Tax Identification Number Summary of Fair Value of the Identifiable Intangible Assets Business Combination, Intangible Asset, Acquired, Indefinite-Lived [Table Text Block] Accrued trade payables Accounts Payable, Trade, Current Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Consolidated Entities [Axis] Consolidated Entities [Axis] Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Common stock, shares issued (in shares) Common Stock, Shares, Issued Payments on finance lease obligations and other long-term debt Finance Lease, Principal Payments And Other Finance Lease, Principal Payments And Other Line of credit facility outstanding Line of Credit Facility, Fair Value of Amount Outstanding Summary of Goodwill Schedule of Goodwill [Table Text Block] Trading Arrangement: Trading Arrangement [Axis] Total Shareholder Return Amount Total Shareholder Return Amount Loss Contingencies [Line Items] Loss Contingencies [Line Items] Performance Vesting Performance-based RSU’s [Member] Performance-based RSU’s Insider Trading Arrangements [Line Items] Security Exchange Name Security Exchange Name Covenant compliance, debt default, threshold amount Debt Instrument, Covenant Compliance, Events Of Default, Threshold Amount Debt Instrument, Covenant Compliance, Events Of Default, Threshold Amount Total liabilities Liabilities Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Business Combination, Separately Recognized Transaction [Line Items] Business Combination, Separately Recognized Transaction [Line Items] Purchases of property and equipment accrued and not yet paid Capital Expenditures Incurred but Not yet Paid Line of credit facility, maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Recognized amounts of identifiable assets acquired and liabilities assumed: Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less), and Goodwill [Abstract] Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Indefinite-Lived Intangible Assets, Major Class Name [Domain] Indefinite-Lived Intangible Assets, Major Class Name [Domain] Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Long-term debt Business Combination, Recognized Liability Assumed, Long-Term Debt, Noncurrent Statement [Line Items] Statement [Line Items] Consolidation Items [Axis] Consolidation Items [Axis] Variable Rate [Axis] Variable Rate [Axis] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Cash and cash equivalents Cash and Cash Equivalent Counterparty Name [Axis] Counterparty Name [Axis] Summary of Activities of RSUs Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block] Common Stock Common Stock [Member] Units vested (in shares) Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Average share price threshold for annual dividends (in dollars per share) Preferred Stock, Dividend Rate, Average Price Per Share, Threshold Preferred Stock, Dividend Rate, Average Price Per Share, Threshold Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Non-NEOs Non-NEOs [Member] Net change in cash and cash equivalents Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation EX-101.PRE 10 tic-20260331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 12 R1.htm IDEA: XBRL DOCUMENT v3.26.1
Cover page - shares
3 Months Ended
Mar. 31, 2026
May 01, 2026
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Mar. 31, 2026  
Document Transition Report false  
Entity File Number 001-42524  
Entity Registrant Name TIC Solutions, Inc.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 66-1076867  
Entity Address, Address Line One 200 South Park Road  
Entity Address, Address Line Two Suite 350  
Entity Address, City or Town Hollywood  
Entity Address, State or Province FL  
Entity Address, Postal Zip Code 33021  
City Area Code 954  
Local Phone Number 495-2112  
Title of 12(b) Security Common stock, par value $0.0001 per share  
Trading Symbol TIC  
Security Exchange Name NYSE  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   221,042,604
Entity Central Index Key 0002032966  
Current Fiscal Year End Date --12-31  
Document Fiscal Period Focus Q1  
Amendment Flag false  
Document Fiscal Year Focus 2026  
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Current assets    
Cash and cash equivalents $ 426,564 $ 439,536
Accounts receivable, net 344,243 366,293
Contract assets, net 182,732 154,439
Prepaid expenses and other current assets 66,821 60,768
Total current assets 1,020,360 1,021,036
Property and equipment, net 245,601 255,625
Operating lease right-of-use assets, net 54,919 60,209
Goodwill 1,647,534 1,649,595
Intangible assets, net 1,351,980 1,391,382
Deferred tax assets 1,423 1,438
Other assets 10,319 17,024
Total assets 4,332,136 4,396,309
Current liabilities    
Accounts payable 57,505 60,426
Accrued expenses and other current liabilities 168,237 151,626
Contract liabilities 52,000 47,846
Current portion of long-term debt 23,460 25,511
Current portion of lease obligations 32,215 33,584
Total current liabilities 333,417 318,993
Long-term debt, net of current portion 1,585,424 1,587,686
Non-current lease obligations 61,401 66,049
Deferred tax liabilities 205,155 222,955
Other non-current liabilities 12,880 20,710
Total liabilities 2,198,277 2,216,393
Commitments and contingencies (Note 15)
Equity, Attributable to Parent [Abstract]    
Series A Preferred Stock, $0.0001 par value, 1,000,000 shares issued and outstanding $ 0 0
Number Of Authorized Shares Not Disclosed true  
Common stock, $0.0001 par value, 221,039,674 and 220,485,045 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively $ 21 21
Additional paid-in capital 2,371,142 2,362,943
Accumulated deficit (235,654) (194,105)
Accumulated other comprehensive income (loss) (1,650) 11,057
Total stockholders' equity 2,133,859 2,179,916
Total liabilities and stockholders' equity $ 4,332,136 $ 4,396,309
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Balance Sheets (Parentheticals) - $ / shares
Mar. 31, 2026
Dec. 31, 2025
Dec. 16, 2024
Statement of Financial Position [Abstract]      
Preferred stock, par value (in dollars per share) $ 0.1000 $ 0.1000 $ 0.0001
Preferred stock, shares issued (in shares) 1,000,000 1,000,000  
Preferred stock, shares outstanding (in shares) 1,000,000 1,000,000  
Common stock, par value (in dollars per share) $ 0.1000 $ 0.1000 $ 0.0001
Common stock, shares issued (in shares) 221,039,674 220,485,045  
Balance at the beginning of the period (in shares) (Successor) 221,039,674 220,485,045  
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Revenue $ 488,029 $ 234,215
Cost of revenue 326,728 190,546
Gross profit 161,301 43,669
Selling, general and administrative expenses 150,328 39,872
Depreciation and amortization 40,036 13,237
Loss from operations (29,063) (9,440)
Interest expense, net 29,021 16,007
Other income, net (77) (1,119)
Loss before income tax benefit (58,007) (24,328)
Income tax provision (benefit) (16,458) 1,465
Net loss (41,549) (25,793)
Undistributed loss allocated to Series A Preferred Stock 190 211
Net loss allocated to common stockholders (41,359) (25,582)
Foreign currency translation adjustment (12,707) 2,561
Total other comprehensive loss $ (54,256) $ (23,232)
Weighted-average shares outstanding:    
Series A Preferred Stock (in shares) 1,000,000 1,000,000
Common Stock    
Basic and diluted loss per share:    
Basic loss per common stock and Series A Preferred Stock (in dollars per share) $ (0.19) $ (0.21)
Diluted loss per common stock and Series A Preferred Stock (in dollars per share) $ (0.19) $ (0.21)
Weighted-average shares outstanding:    
Weighted average common stock stock and Series A Preferred Stock outstanding – basic (in shares) 217,251,178 121,476,215
Weighted average common stock stock and Series A Preferred Stock outstanding, diluted (in shares) 218,251,178 122,476,215
Series A Preferred Stock    
Undistributed loss allocated to Series A Preferred Stock $ 190 $ 211
Basic and diluted loss per share:    
Basic loss per common stock and Series A Preferred Stock (in dollars per share) $ (0.19) $ (0.21)
Diluted loss per common stock and Series A Preferred Stock (in dollars per share) $ (0.19) $ (0.21)
Weighted-average shares outstanding:    
Weighted average common stock stock and Series A Preferred Stock outstanding – basic (in shares) 1,000,000 1,000,000
Weighted average common stock stock and Series A Preferred Stock outstanding, diluted (in shares) 1,000,000 1,000,000
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Series A Preferred Stock
Additional 
Paid-In 
Capital
Accumulated 
Deficit
Accumulated 
Other 
Comprehensive 
Income (Loss)
Balance at the beginning of the period (in shares) at Dec. 31, 2024   121,476,215 1,000,000,000      
Balance at the beginning of the period at Dec. 31, 2024 $ 1,151,172 $ 12 $ 0 $ 1,293,638 $ (106,989) $ (35,489)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (25,793)       (25,793)  
Share-based compensation expense 1,107     1,107    
Other comprehensive income (loss) 2,561         2,561
Balance at the end of the period (in shares) at Mar. 31, 2025   121,476,215 1,000,000,000      
Balance at the end of the period at Mar. 31, 2025 $ 1,129,047 $ 12 $ 0 1,294,745 (132,782) (32,928)
Balance at the beginning of the period (in shares) at Dec. 31, 2025 220,485,045 220,485,045 1,000,000      
Balance at the beginning of the period at Dec. 31, 2025 $ 2,179,916 $ 21 $ 0 2,362,943 (194,105) 11,057
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (41,549)       (41,549)  
Share-based compensation expense 8,728     8,728    
Restricted Stock Share Issuances And Restricted Stock Unit Vesting, Net   (113,718)        
Restricted stock unit vestings (in shares) (529)     (529)    
Issuance of common shares in conjunction with the Series A Preferred Stock Dividend (in shares)   668,347        
Other comprehensive income (loss) $ (12,707)         (12,707)
Balance at the end of the period (in shares) at Mar. 31, 2026 221,039,674 221,039,674 1,000,000      
Balance at the end of the period at Mar. 31, 2026 $ 2,133,859 $ 21 $ 0 $ 2,371,142 $ (235,654) $ (1,650)
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net loss $ (41,549) $ (25,793)
Adjustments to reconcile net loss to cash flows from operating activities:    
Depreciation and amortization 58,880 28,599
Noncash lease expense 6,035 2,491
Share-based compensation expense 12,912 1,107
Amortization of deferred financing costs 1,883 828
Deferred taxes (17,334) (4,320)
Other 1,189 (899)
Changes in operating assets and liabilities, net of effects of acquisitions:    
Accounts receivable 22,092 40,254
Contract assets (27,886) (8,395)
Prepaid expenses and other current assets (5,635) 4,306
Accounts payable (7,402) 3,433
Accrued expenses and other current liabilities 7,391 (5,708)
Operating lease obligations (5,801) (2,352)
Contract liabilities 4,161 (213)
Other assets and liabilities 989 (546)
Net cash provided by operating activities 9,925 32,792
Cash flows from investing activities:    
Business acquisitions, net of cash acquired (3,884) (8,030)
Purchases of property and equipment (5,697) (4,476)
Proceeds from sale of property and equipment 1,287 293
Net cash used in investing activities (8,294) (12,213)
Cash flows from financing activities:    
Payments on long-term borrowings (4,131) (1,932)
Payments of debt issuance costs 0 (1,165)
Payments on finance lease obligations and other long-term debt (8,776) (2,508)
Net cash used in financing activities (12,907) (5,605)
Net effect of exchange rate fluctuations on cash and cash equivalents (1,696) 1,631
Net change in cash and cash equivalents (12,972) 16,605
Beginning of period 439,536 139,134
End of period 426,564 155,739
Supplemental disclosure of cash flow information    
Interest paid 26,673 14,332
Income taxes paid 4,022 6,172
Purchases of property and equipment accrued and not yet paid 4,472 3,461
Notes payable and other obligations issued for acquisitions $ 3,000 $ 0
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.26.1
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES
3 Months Ended
Mar. 31, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES
Description of Business
TIC Solutions, Inc. (formerly Acuren Corporation and hereinafter referred to as “we,” “our,” “us,” “TIC Solutions,” or the “Company”) is a leading provider of tech-enabled Testing, Inspection, Certification and Compliance (“TICC”), engineering and consulting, and geospatial services. On August 4, 2025 (the “NV5 Closing Date”), the Company completed its acquisition of NV5 Global, Inc. (“NV5” and such acquisition, the “NV5 Acquisition”), an engineering and consulting services company. The Company operates primarily in North America and serves both private and public-sector clients. On October 10, 2025, the Company changed its name from Acuren Corporation to TIC Solutions, Inc.
The Company’s private-sector clients span industrial, infrastructure, construction, and commercial real estate end markets and its public-sector clients include federal, state, and municipal agencies, public utilities, transportation authorities, and environmental regulators. Within industrial markets, the Company’s services address energy processing and refining, pipeline and midstream infrastructure, chemicals and industrial processing, manufacturing and industrial services, power generation and utilities, and companies in aerospace, automotive, renewable energy, pulp and paper, and mining. The Company provides mission-critical services that are essential to the safety, reliability, and efficiency of industrial assets, buildings and public infrastructure. The Company’s services are often non-discretionary and are driven by regulatory requirements, customer risk management policies, and the need to extend the useful life of critical assets.
Basis of Presentation
The accompanying interim unaudited condensed consolidated financial statements (the “interim statements”) have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) and the rules and regulations of the Securities and Exchange Commission (the “SEC”) and do not include all of the information and footnotes required by U.S. GAAP for complete financial statements as certain information has been condensed or omitted. All intercompany accounts and transactions have been eliminated in consolidation. Certain amounts in prior periods have been reclassified to conform to the current period presentation. Such reclassifications did not have a material effect on the Company's financial condition or results of operations as previously reported. The results of operations of companies acquired are included from the date of acquisition. In the opinion of management, these interim statements include all adjustments, which are of a normal recurring nature, necessary for a fair statement of the results for the interim periods presented. The results of operations for any interim period are not necessarily indicative of results for the full year. These interim statements should be read in conjunction with the audited consolidated financial statements and notes contained in the Company’s Annual Report on Form 10-K for the period ended December 31, 2025, as filed with the SEC (the “2025 Annual Report”).
Significant Accounting Policies
The Company’s significant accounting policies are disclosed in “Note 2. Summary of Significant Accounting Policies” in our 2025 Annual Report and are supplemented by the notes included in this Quarterly Report on Form 10-Q (the “Quarterly Report”).
Revenue Recognition
The Company recognizes revenue in accordance with ASC Topic 606, Revenue from Contracts with Customers, by following the five-step model: the Company identifies a contract with a customer, identifies the performance obligation(s) in the contract, determines the transaction price, allocates the transaction price to each performance obligation in the contract and recognizes revenues as the Company satisfies the performance obligation(s).
Nature of Services and Performance Obligations
The Company provides TICC, engineering, geospatial and other services to customers under a variety of contract types. Contracts are evaluated to determine whether they should be combined and whether they contain one or multiple performance obligations. Most contracts contain a single performance obligation, as the promise to transfer individual services is not separately identifiable from other promises in the contract and, therefore, is not distinct. For contracts with multiple performance obligations, the Company allocates the contract’s transaction price to each performance obligation utilizing several different pricing scenarios and is able to discretely price out each individual component based on its nature and relation to the overall performance obligation.
Performance obligations are generally satisfied over time as work progresses or services are rendered, because the customer simultaneously receives and consumes the benefits of the Company’s performance. Revenue may be recognized over time based on time and material incurred to date, which best portrays the transfer of control to the customer, or based on progress measured using an input method by comparing direct costs incurred to date to the estimated total direct costs for the completion of the services. Contract costs include labor, sub-consultant services and other direct costs. For contracts that meet the required conditions, the Company applies the as-invoiced practical expedient and recognizes revenue based on its right to invoice for services performed.
Performance obligations in certain contracts are satisfied at a point in time. Revenue for these services is recognized when control of the promised deliverable transfers to the customer, which is generally upon completion, delivery or customer acceptance of reports or analyses.
The Company enters into contracts with its clients that contain two principal types of pricing provisions: cost-reimbursable and fixed-unit price. Cost-reimbursable contracts consist of the following:
time and material contracts, which are common for professional and technical consulting and certification services projects. Under these types of contracts, there is no predetermined fee. Instead, the Company negotiates hourly billing rates and charges the clients based upon actual hours expended on a project. In addition, any direct project expenditures are passed through to the client and are typically reimbursed. These contracts may have an initial not-to-exceed or guaranteed maximum price provision.
cost-plus contracts are the predominant contracting method used by the Company to charge clients for its costs, including both direct and indirect costs, plus a negotiated fee. The total estimated cost plus the negotiated fee represents the total contract value.
lump-sum contracts typically require the performance of all of the work under the contract for a specified lump-sum fee, subject to price adjustments if the scope of the project changes or unforeseen conditions arise. Many of the Company’s lump-sum contracts are negotiated and arise in the design of projects with a specified scope and project deliverables. In most cases, we can bill additional fees if the construction schedule is modified and lengthened.
Fixed-unit price contracts typically require the performance of an estimated number of units of work at an agreed price per unit, with the total payment under the contract determined by the actual number of units performed.
As of March 31, 2026, the Company had $1.1 billion of remaining performance obligations, of which $860.2 million is expected to be recognized over the next 12 months. Performance obligations include only those amounts that have been funded and authorized and does not reflect the full amounts the Company may receive over the term of such contracts. In the case of non-government contracts and project awards, performance obligations include future revenue at contract or customary rates, excluding contract renewals or extensions that are at the discretion of the client. For contracts with a not-to-exceed maximum amount, the Company includes revenue from such contracts in performance obligations to the extent of the remaining estimated amount.
Contract estimates are based on various assumptions to project the outcome of future events. These assumptions are dependent upon the accuracy of a variety of estimates, including engineering progress, achievement of milestones, labor productivity and cost estimates. Due to uncertainties inherent in the estimation process, it is possible that actual completion costs may vary from estimates. If estimated total costs on contracts indicate a loss or reduction to the percentage of total contract revenues recognized to date, these losses or reductions are recognized in the period in which the revisions are known. The effect of revisions to revenues and estimated costs to complete contracts, including penalties, incentive awards, change orders, claims and anticipated losses, are recorded on a cumulative catch-up basis in the period in which the revisions are identified and the loss can be reasonably estimated. Such revisions could occur in any reporting period and the effects on the results of operations for that reporting period may be material depending on the size of the project or the adjustment.
Contract Balances
The timing of revenue recognition, billings and cash collections results in, and are reflected within, “Accounts receivable, net,” “Contract assets, net,” and “Contract liabilities” on the condensed consolidated balance sheets.
“Accounts receivable, net” represents amounts billed to clients that remain uncollected as of the balance sheet date. The amounts are stated at their estimated realizable value. The Company maintains an allowance for credit losses to provide for the estimated amount of receivables that will not be collected. See further discussion in “Note 5. Accounts Receivable and Contract Assets.”
“Contract assets, net” represent recognized amounts pending billing pursuant to contract terms or accounts billed after period end and are expected to be billed and collected within the next 12 months. Generally, billing occurs subsequent to revenue recognition, resulting in contract assets that are classified as current.
In certain circumstances, the contract may allow for billing terms that result in cumulative amounts billed in excess of revenues recognized. “Contract liabilities” represent billings in excess of revenues recognized on these contracts as of the reporting date that are generally classified as current. During the three months ended March 31, 2026, revenue recognized related to the Company’s contract liabilities that existed as of December 31, 2025 was not material.
Contract Modifications
Contract modifications may occur in the normal course of business and typically result from changes in scope, specifications or performance period. In most cases, such modifications are not distinct and are accounted for as part of the existing contract. If a modification adds distinct goods or services at a price that reflects their standalone selling prices, it is accounted for as a separate contract.
Federal Acquisition Regulations
Federal Acquisition Regulations (“FAR”), which are applicable to the Company’s federal government contracts and may be incorporated in local and state agency contracts, limit the recovery of certain specified indirect costs on contracts. Cost-plus contracts covered by FAR or certain state and local agencies also may require an audit of actual costs and provide for upward or downward adjustments if actual recoverable costs differ from billed recoverable costs.
Recent Accounting Pronouncements Not Yet Adopted
The Company has not adopted any new accounting pronouncements since the audited consolidated financial statements for the year ended December 31, 2025. See the 2025 Annual Report for information pertaining to the effects of recently adopted and other recent accounting pronouncements.
In September 2025, the FASB issued ASU 2025-06, Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-40), Targeted Improvements to the Accounting for Internal-Use Software, to modernize the accounting for software costs that are accounted for under Subtopic 350-40. The amendments in this update remove all references to prescriptive and sequential software development stages. Under this ASU, capitalization of internal-use software begins when management authorizes and commits to funding the project and it is probable that the project will be completed. ASU 2025-06 is effective for annual periods beginning after December 15, 2027, and interim reporting periods within those annual reporting periods; however early adoption is permitted either prospectively or retrospectively. The Company is currently evaluating the impact the adoption of this guidance will have on its financial statements and related disclosures.
In November 2024, the FASB issued ASU 2024-03, Income Statement — Reporting Comprehensive Income — Expense Disaggregation Disclosures (Subtopic 220-40), requiring disclosure in the notes to the financial statements for specified information about certain costs and expenses. The ASU is effective for annual periods beginning after December 15, 2026, and interim periods beginning after December 15, 2027; however early adoption is permitted and can be applied either prospectively or retrospectively. The Company is currently evaluating the impact the adoption of this guidance will have on its financial statements and related disclosures.
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.26.1
BUSINESS COMBINATIONS
3 Months Ended
Mar. 31, 2026
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]  
Business Combinations BUSINESS COMBINATIONS
2026 Acquisitions
During the three months ended March 31, 2026, the Company completed one business combination, which was not significant to the consolidated financial statements. Total consideration for the acquisition was approximately $5.0 million. The Company recorded approximately $2.0 million of goodwill related to the acquisition. The final determination of the fair value of assets and liabilities will be completed within the one-year measurement period as required by ASC 805.
2025 Acquisitions
NV5 Acquisition
On August 4, 2025, the Company completed its acquisition of NV5 pursuant to the Agreement and Plan of Merger dated May 14, 2025.
In conjunction with the NV5 Acquisition, in 2025 the Company completed a reorganization of the Company’s reportable segments to align with the service offerings of the combined entity. Accordingly, the post-acquisition results of NV5 are reported within the Company’s Consulting Engineering and Geospatial reportable segments, and the Company’s historical United States and Canada reportable segments have been combined into the Inspection and Mitigation reportable segment. “See Note 16. Segment Reporting” for further discussion regarding the Company’s reorganization and revised reportable segments.
The aggregate purchase consideration paid to the stockholders of NV5 totaled $1.7 billion, including: (i) a cash payment at the NV5 Closing Date of $870.9 million, (ii) the issuance of 73.2 million shares of common stock to NV5 stockholders with an estimated fair value of $768.3 million, and, (iii) the replacement of $76.5 million of unvested NV5 share-based awards, of which $29.7 million was attributable to pre-combination services. The Company funded the cash portion of the purchase price with a new term loan in an aggregate principal amount of $875.0 million and cash on hand. In conjunction with the debt financing, the Company incurred $21.9 million in debt issuance costs that were capitalized and will be amortized using the effective interest method over the remaining term of the Term Loans (as defined in “Note 11. Long-Term Debt”). The Company also increased the amount of its existing senior secured revolving credit facility to $125.0 million (the “Revolving Credit Facility”) and incurred debt issuance costs of $1.3 million related to the Revolving Credit Facility which will be amortized on a straight-line basis over the remaining term of the Revolving Credit Facility.
The NV5 Acquisition was accounted for under the acquisition method of accounting. The purchase price has been preliminarily allocated to the tangible assets and identifiable intangible assets acquired and liabilities assumed based upon their estimated fair values. In order to determine the fair values of tangible and intangible assets acquired and liabilities assumed, the Company engaged an independent third-party valuation specialist to assist in the determination of the fair values. The final determination of the fair values of assets and liabilities will be completed within the one-year measurement period as required by ASC 805. The NV5 Acquisition will necessitate the use of this measurement period to adequately analyze and assess the factors used in establishing the asset and liability fair values as of the relevant acquisition date, including intangible assets, contract assets and liabilities, certain lease-related assets and liabilities, indemnification assets, and deferred tax assets and liabilities.
The excess of the purchase price over the preliminary fair value of the tangible and intangible net assets acquired and liabilities assumed has been recorded as goodwill. The goodwill balance is primarily attributed to the assembled workforce, expansion of service offerings, market opportunities and synergies expected to be achieved from the combined operations of the Company and NV5. The Company has preliminarily assigned goodwill amounts of approximately $15.4 million, $515.3 million, and $233.1 million to the Inspection and Mitigation, Consulting Engineering and Geospatial segments, respectively. Goodwill of $76.1 million is expected to be deductible for income tax purposes.
The following table summarizes the preliminary estimated fair value of consideration transferred and the preliminary estimated fair values of the assets acquired and liabilities assumed at the date of the NV5 Acquisition:
Total
Cash consideration$870,911 
Equity consideration768,304 
Replacement of share-based awards29,744 
Total consideration
$1,668,959 
Recognized amounts of identifiable assets acquired and liabilities assumed:
Cash and cash equivalents$58,958 
Accounts receivables186,228 
Contract assets123,428 
Prepaid expenses and other current assets33,536 
Plant and equipment80,557 
Other assets4,560 
Operating lease right-of-use assets33,464 
Intangible assets720,000 
Accounts payable(40,350)
Accrued expenses and other current liabilities(99,123)
Contract liabilities(47,694)
Other liabilities(10,569)
Deferred tax liabilities
(97,935)
Lease liabilities(39,908)
Total identifiable net assets acquired
$905,152 
Goodwill$763,807 
Measurement period adjustments made during the three months ended March 31, 2026 were immaterial.
As part of the purchase price allocation, the Company determined the identifiable intangible assets included customer relationships, customer backlog, trade name, and developed technology. Management used the multi-period excess earnings method to estimate the fair value of the customer relationships, which utilized the following significant assumptions and inputs: revenue growth rates, EBITDA margins, attrition rates, probability of renewal, contributory asset charges, income tax rates, depreciation and discount rates.
The following table summarizes the preliminary fair value of the identifiable intangible assets:
Fair Value as of March 31, 2026
Customer relationships$590,000 
Customer backlog88,000 
Trade name39,000 
Developed technology3,000 
Total intangible assets
$720,000 
The weighted useful lives over which the intangible assets will be amortized are estimated as follows: 15 years for customer relationships, 2 years for customer backlog, 10 years for the trade name, and 3 years for developed technology.
In conjunction with the NV5 Acquisition, the Company incurred transaction costs of $24.7 million, which were expensed and included in “Selling, general and administrative expenses” in the condensed consolidated statements of operations.
Pro Forma Consolidated Financial Information
The following pro forma consolidated financial information reflects the results of operations of the Company for the three months ended March 31, 2025 as if the NV5 Acquisition and related financing had occurred as of January 1, 2024, after giving effect to certain purchase accounting and financing adjustments. These amounts are based on financial information of the NV5 business and are not necessarily indicative of what the Company’s operating results would have been had the NV5 Acquisition and related financing taken place on January 1, 2024.
Three Months Ended
March 31, 2025
Net Revenue$468,260 
Net Loss$(43,109)
Pro forma financial information is presented as if the operations of NV5 had been included in the consolidated results of the Company since January 1, 2024, and gives effect to transactions that are directly attributable to the NV5 Acquisition and related financing. Adjustments, net of related tax impacts, include: additional depreciation and amortization expense related to the fair value of acquired property and equipment and intangible assets as if such assets were acquired on January 1, 2024; movement of transaction costs between reporting periods; interest expense under the Company’s Term Loans (defined in “Note 11. Long-Term Debt”) as if the amount borrowed to partially finance the purchase price was borrowed on January 1, 2024.
Other 2025 Acquisition Activity
During the year ended December 31, 2025, the Company completed seven other business combinations, which were not significant to the consolidated financial statements, either individually or in the aggregate. Total aggregate consideration was $45.8 million. The Company recorded a total $17.9 million of goodwill related to these acquisitions, of which $9.8 million was assigned to the Inspection and Mitigation reportable segment, $1.9 million was assigned to the Consulting Engineering reportable segment, and $6.2 million was assigned to the Geospatial reportable segment. The final determination of the fair values of assets and liabilities will be completed within the one-year measurement period as required by ASC 805. The measurement period adjustments were not material.
XML 20 R9.htm IDEA: XBRL DOCUMENT v3.26.1
STOCKHOLDERS’ EQUITY
3 Months Ended
Mar. 31, 2026
Equity [Abstract]  
STOCKHOLDERS’ EQUITY STOCKHOLDERS’ EQUITY
The Company has authorized shares consisting of two classes: 500,000,000 shares of common stock, $0.0001 par value per share, and 5,000,000 shares of preferred stock, $0.0001 par value per share, of which 1,000,000 shares are designated as “Series A Preferred Stock” (the “Series A Preferred Stock”). As of March 31, 2026, the Company had 221,039,674 shares of common stock and 1,000,000 shares of Series A Preferred Stock issued and outstanding.
Series A Preferred Stock
The Company has 1,000,000 shares of Series A Preferred Stock issued and outstanding as of March 31, 2026. Shares of the Series A Preferred Stock are not mandatorily redeemable and do not embody an unconditional obligation to settle in a variable number of equity shares and are not unconditionally redeemable or conditionally puttable by the holder for cash. As such, shares of Series A Preferred Stock are classified as permanent equity in the accompanying condensed consolidated balance sheets.
The holder of the Series A Preferred Stock are entitled to receive an annual dividend in the form of shares of common stock once the Average Price (as defined in our certificate of incorporation) of the common stock is at least $11.50 per share for any 10 consecutive trading days (the “Annual Dividend Amount”), with such condition having been satisfied during the year ended December 31, 2025.
The Annual Dividend Amount for the first Dividend Period (the year ended December 31, 2025) was equal to 20 percent of the increase in the volume-weighted average market price per share of the Company’s common stock for the last 10 trading days of the calendar year (the “Dividend Price”) over $10.00 per share multiplied by 121,476,215 shares. In subsequent years, the Annual Dividend Amount will be calculated based on the appreciated Dividend Price compared to the highest Dividend Price previously used in calculating the Annual Dividend Amount.
As of December 31, 2025, the Dividend Price was $10.28. The annual dividend was declared as of December 31, 2025, and the Company issued 668,347 shares of our common stock to the holder of the Series A Preferred Stock in January 2026.
Upon the liquidation of the Company, an Annual Dividend Amount shall be payable for the shortened Dividend Period and the holder of the Series A Preferred Stock shall have the right to a pro rata share (together with holders of the common stock) in the distribution of the surplus assets of the Company. In the event of a Change of Control, the holder of the Series A Preferred Stock will be entitled to receive, in the aggregate, a one-time dividend equal to the Change of Control Dividend Amount (as defined in our certificate of incorporation).
Holder of the Series A Preferred Stock will participate in any dividends on the common stock on an as converted basis. Specifically, if the Company pays a dividend on its common stock, the holder of the Series A Preferred Stock will also receive an amount equal to 20 percent of the dividend which would be distributable on 121,476,215 shares of common stock as of March 31, 2026. All such dividends on the Series A Preferred Stock will be paid at the same time as the dividends on the common stock.
Shares of Series A Preferred Stock will be automatically converted into shares of common stock on a one-for-one basis on December 31, 2034 (the “Conversion”). At the option of the holder, each share of Series A Preferred Stock is convertible into one share of common stock until the Conversion. The holder of the Series A Preferred Stock is entitled to one vote per share on all matters submitted to a vote of stockholders of the Company, voting together with the holders of common stock as a single class.
The Company followed ASC 718, Compensation — Stock Compensation, to account for the issuance of the Series A Preferred Stock. See “Note 17. Share-Based Compensation” in the 2025 Annual Report for further discussion.
Warrants
Pre-Funded Warrant
On October 5, 2025, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with the investor named therein (the “Investor”), for the private placement (the “Private Placement”), of (i) 17,708,333 shares of the Company’s common stock, par value $0.0001 per share, at $12.00 per share and (ii) a pre-funded warrant (the “Pre-Funded Warrant”) to purchase 3,125,000 shares of common stock, at $11.9999 per share. The aggregate gross proceeds of the Private Placement were approximately $250.0 million, before deducting placement agent fees and other expenses. The Private Placement closed on October 7, 2025.
The Pre-Funded Warrant has an exercise price of $0.0001 per share of common stock, is immediately exercisable and will remain exercisable until exercised in full. The Pre-Funded Warrant is exercisable in cash or by means of a cashless exercise. The Investor may not exercise the Pre-Funded Warrant if the Investor, together with its affiliates, would beneficially own more than 9.99% of the number of shares of common stock outstanding immediately after giving effect to such exercise; provided, however, that a holder may increase or decrease such percentage by giving 61 days’ notice to the Company, but not to any percentage in excess of 19.99%.
The Pre-Funded Warrant was classified as a component of permanent stockholders’ equity within additional paid-in capital and was recorded at the issuance date using a relative fair value allocation method.
The Pre-Funded Warrant is equity classified because it (i) is a freestanding financial instrument that is legally detachable and separately exercisable from the equity instrument, (ii) is immediately exercisable, (iii) does not embody an obligation for the Company to repurchase its shares, (iv) permits the holders to receive a fixed number of shares of common stock upon exercise, (v) is indexed to the Company’s common stock and (vi) meets the equity classification criteria. The Company valued the Pre-Funded Warrant at issuance, concluding that its sales price approximated its fair value, and allocated net proceeds from the Private Placement proportionately to the Company's common stock and Pre-Funded Warrant.
Public Warrants
In May 2023, in connection with the Company’s initial IPO, the Company issued 54,975,000 Public Warrants to the purchasers of both common shares and Series A Preferred Stock (including 25,000 Warrants that were issued to the then independent non-founder directors in connection with their fees). Each Public Warrant is exercisable until July 30, 2027. The Public Warrants are exercisable in multiples of four-for-one share of common stock at an exercise price of $11.50 per whole share of common stock.
The Public Warrants are mandatorily redeemable by the Company at a price of $0.01 should the average market price per share of the common stock exceed $18.00 for 10 consecutive trading days (subject to any prior adjustment in accordance with the terms of the Public Warrants). The Public Warrants expire worthless on July 30, 2027, if not exercised or redeemed. The Public Warrants were determined to be equity classified in accordance with ASC 815, Derivatives and Hedging, and ASC 480, Distinguishing Liabilities from Equity. During the three months ended March 31, 2026, no Public Warrants were exercised for shares of commons stock. As of March 31, 2026 and May 1, 2026, the Company had 14,952,860 Public Warrants outstanding for approximately 3,738,215 shares of common stock.
Share Repurchase Program
On March 10, 2026, the Company’s Board of Directors approved a share repurchase program of up to $200.0 million of the Company’s common stock through open market repurchases (including pursuant to Rule 10b-18 under the Securities Exchange Act of 1934) and/or in privately negotiated transactions, at management’s discretion and subject to market and business conditions, applicable legal requirements, and other factors. As of March 31, 2026, the Company has not repurchased any common stock under the share repurchase program. The Company’s share repurchase program does not obligate the Company to purchase any shares.
XML 21 R10.htm IDEA: XBRL DOCUMENT v3.26.1
EARNINGS PER SHARE
3 Months Ended
Mar. 31, 2026
Earnings Per Share [Abstract]  
EARNINGS PER SHARE EARNINGS PER SHARE
Net income is allocated between the Company’s common stock and other participating securities (excluding unvested restricted stock awards) based on their participation rights. The Company has determined that its Series A Preferred Stock represent participating securities and are a class of common stock. As such, the Company uses the two-class method of computing earnings per share. Under this method, net income (or loss) is allocated between the holders of common stock and the holders of the Series A Preferred Stock based on their respective participation rights.
Given that holders of Series A Preferred Stock participate in net losses on a 1:1 basis with holders of common stock, the allocation of net losses under the two-class method is equivalent to the allocation of net losses that would result under the if-converted method. Consequently, there is no difference between basic and diluted net loss per share of common stock, which also excludes all potential common stock equivalents as their impact on diluted net loss per share would be anti-dilutive.
The following table sets forth the computations of basic and diluted loss per share of common stock and Series A Preferred Stock using the two-class method and the if-converted method, respectively, for the three months ended March 31, 2026 and March 31, 2025.
Three Months Ended
March 31, 2026March 31, 2025
Basic shares:
 
Numerator: 
Net loss
$(41,549)$(25,793)
Undistributed loss allocated to Series A Preferred Stock
190 211 
Net loss available to holders of common stock
$(41,359)$(25,582)
Denominator: 
Weighted average common stock outstanding – basic
217,251,178 121,476,215 
Weighted average Series A Preferred Stock outstanding – basic
1,000,000 1,000,000 
Basic loss per common stock
$(0.19)$(0.21)
Basic loss per Series A Preferred Stock
$(0.19)$(0.21)
Dilutive shares:
 
Numerator: 
Undistributed loss allocated to common stock$(41,359)$(25,582)
Undistributed loss allocated to Series A Preferred Stock
(190)(211)
Total undistributed loss
$(41,549)$(25,793)
Denominator:
Weighted average common stock outstanding – basic
217,251,178 121,476,215 
Add: dilutive securities 
Series A Preferred Stock1,000,000 1,000,000 
Weighted average common stock outstanding – diluted
218,251,178 122,476,215 
Weighted average Series A Preferred Stock outstanding – diluted
1,000,000 1,000,000 
Diluted loss per common stock
$(0.19)$(0.21)
Diluted loss per Series A Preferred Stock
$(0.19)$(0.21)
For the three months ended March 31, 2026 and March 31, 2025, the Company excluded the following potentially dilutive shares from the computation of diluted loss per common stock as the impact would have been anti-dilutive:
Three Months Ended
Potentially dilutive securitiesMarch 31, 2026March 31, 2025
Stock options(1)
— 125,000 
Warrants(1)
— 212,901 
Restricted stock awards3,390,276 — 
Restricted stock units1,145,327 973,092 
Shares issuable pursuant to the Series A Preferred Stock dividend(2)
— 3,196,648 
(1) For the three months ended March 31, 2026, the stock options and warrants were out of the money.
(2) See discussion of the Annual Dividend Amount in “Note 3. Stockholders’ Equity.”
XML 22 R11.htm IDEA: XBRL DOCUMENT v3.26.1
ACCOUNTS RECEIVABLE AND CONTRACT ASSETS
3 Months Ended
Mar. 31, 2026
Receivables [Abstract]  
ACCOUNTS RECEIVABLE AND CONTRACT ASSETS ACCOUNTS RECEIVABLE AND CONTRACT ASSETS
Accounts receivable and contract assets are recorded net of allowances for credit losses. Accounts receivable represent invoiced and accrued revenue while contract assets represent accrued revenue that has yet to be invoiced to the customer. The Company’s accounts receivable, contract assets and allowance for credit losses consisted of the following as of the below dates:
March 31, 2026December 31, 2025
Accounts receivables$347,195 $369,669 
Contract assets182,802 154,510 
Allowance for credit losses(3,022)(3,447)
Total accounts receivables, net$526,975 $520,732 
The Company records an allowance for credit losses for accounts receivable based on management’s expected credit losses. Management’s estimate of expected credit losses is based on its assessment of the business environment, customers’ financial condition, historical collection experience, accounts receivable aging and customer disputes.
Changes to the allowance for credit losses are adjusted through credit loss expense, which is included within “Selling, general and administrative expenses” in the condensed consolidated statements of operations and comprehensive income (loss).
XML 23 R12.htm IDEA: XBRL DOCUMENT v3.26.1
PROPERTY AND EQUIPMENT
3 Months Ended
Mar. 31, 2026
Property, Plant and Equipment [Abstract]  
Property and Equipment PROPERTY AND EQUIPMENT
Property and equipment consists of the following:
 Useful Life (Years)March 31, 2026December 31, 2025
Land $6,117 $6,179 
Buildings and leasehold improvements2525,908 25,364 
Computer, software, and office equipment
3 – 5
24,560 23,279 
Machinery and equipment
3 – 10
186,145 181,437 
Vehicles, aircrafts and vessels
5 - 15
97,781 96,192 
Construction in progress 12,222 11,238 
Total property and equipment 352,733 343,689 
Accumulated depreciation (107,132)(88,064)
Property and equipment, net $245,601 $255,625 
Total depreciation expense for property and equipment was recognized as follows for the following periods:
Three Months Ended
March 31, 2026March 31, 2025
Cost of revenue
$18,843 $15,362 
Selling, general and administrative expenses
3,083 235 
Total depreciation expense
$21,926 $15,597 
XML 24 R13.htm IDEA: XBRL DOCUMENT v3.26.1
GOODWILL
3 Months Ended
Mar. 31, 2026
Goodwill and Intangible Assets Disclosure [Abstract]  
GOODWILL GOODWILL
The changes in the carrying amount of goodwill by reportable segment for the three months ended March 31, 2026 were as follows:
Inspection and MitigationConsulting EngineeringGeospatialTotal
Balance at December 31, 2025$895,533 $516,873 $237,189 1,649,595 
Acquisitions
— 2,069 — 2,069 
Measurement period adjustments102 292 2,147 2,541 
Currency adjustments(6,671)— — (6,671)
Balance at March 31, 2026$888,964 $519,234 $239,336 $1,647,534 
XML 25 R14.htm IDEA: XBRL DOCUMENT v3.26.1
INTANGIBLE ASSETS
3 Months Ended
Mar. 31, 2026
Goodwill and Intangible Assets Disclosure [Abstract]  
INTANGIBLE ASSETS INTANGIBLE ASSETS
The gross carrying amounts and accumulated amortization of intangible assets were as follows:
Weighted
Average
Remaining
Life (Years)
March 31, 2026December 31, 2025
Gross Carrying Amount
Accumulated
Amortization
Net Carrying AmountGross Carrying AmountAccumulated
Amortization
Net Carrying Amount
Customer relationships13.3$1,279,417 $(104,950)$1,174,467 $1,282,032 $(82,609)$1,199,423 
Customer backlog1.488,741 (42,215)46,526 88,466 (31,126)57,340 
Tradenames12.3138,946 (13,621)125,325 139,498 (11,059)128,439 
Technology2.97,993 (2,331)5,662 8,019 (1,839)6,180 
$1,515,097 $(163,117)$1,351,980 $1,518,015 $(126,633)$1,391,382 
Amortization expense recognized on intangible assets was $37.0 million and $13.0 million for the three months ended March 31, 2026 and March 31, 2025, respectively.
XML 26 R15.htm IDEA: XBRL DOCUMENT v3.26.1
ACCRUED EXPENSES AND OTHER LIABILITIES
3 Months Ended
Mar. 31, 2026
Payables and Accruals [Abstract]  
Accrued Expenses and Other Liabilities ACCRUED EXPENSES AND OTHER LIABILITIES
Accrued Expenses and Other Current Liabilities
The Company’s accrued expenses and other current liabilities consisted of the following as of the below dates:
March 31, 2026December 31, 2025
Accrued salaries, wages and related employee benefits$76,617 $58,655 
Accrued trade payables28,220 32,090 
Accrued operating expenses15,528 21,718 
Accrued indirect taxes4,334 4,676 
Accrued sales discounts1,986 3,094 
Current portion of contingent consideration12,670 8,608 
Other accrued expenses28,882 22,785 
Total accrued expenses and other current liabilities$168,237 $151,626 
Contingent Consideration
Contingent consideration arrangements are included as part of the purchase price of acquired companies on their respective acquisition dates. The Company estimates the fair value of contingent earn-out payments as part of the initial purchase price and records the estimated fair value of contingent consideration as a liability on the consolidated balance sheet. Changes in the estimated fair value of contingent consideration payments are included in “Selling, general and administrative expenses” in the consolidated statements of operations. During the three months ended March 31, 2026 the Company recorded contingent consideration of $1.0 million related to 2026 acquisitions and made payments of $1.3 million. Fair value re-measurements were $1.9 million during the three months ended March 31, 2026. Accordingly, as of March 31, 2026, the Company had $15.2 million of contingent consideration recorded on the condensed consolidated balance sheet, including $12.7 million reflected as current. As of December 31, 2025, the Company had $13.6 million of contingent consideration recorded on the consolidated balance sheet, including $8.6 million reflected as current
XML 27 R16.htm IDEA: XBRL DOCUMENT v3.26.1
FAIR VALUE MEASUREMENTS
3 Months Ended
Mar. 31, 2026
Fair Value Disclosures [Abstract]  
FAIR VALUE MEASUREMENTS FAIR VALUE MEASUREMENTS
The Company performs fair value measurements by determining the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. It also establishes a three-level hierarchy that prioritizes the inputs used to measure fair value. The three levels of the hierarchy are defined as follows:
Level 1Unadjusted quoted prices in active markets that are accessible at the measurement dates for identical, unrestricted assets or liabilities.
Level 2Quoted prices for markets that are not active, or inputs that are observable either directly or indirectly, for substantially the full term of the asset or liability.
Level 3Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e., supported with little or no market activity).
If the inputs used to measure the financial assets and liabilities fall within the different levels described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.
The carrying values of cash and cash equivalents, accounts receivable, prepaid expenses and other current assets, accounts payable, and accrued expenses and other current liabilities approximate their fair values because of their short maturity. The fair values of the Company’s revolving line of credit facilities and long-term debt approximate their carrying value as they are based on current lending rates for similar borrowings, assuming the debt is outstanding through maturity, and considering the collateral. The fair values of the Company’s finance lease obligations approximate their carrying amounts based on anticipated interest rates which management believes would currently be available to the Company for similar issuances of debt.
The Company reviews and re-assesses the estimated fair value of contingent consideration liabilities on a quarterly basis and the updated fair value could differ from the initial estimates. The Company measures contingent consideration recognized in connection with business combinations at fair value on a recurring basis using significant unobservable inputs classified as Level 3 inputs. The Company generally uses an option-based model or a probability-weighted approach to determine the fair value of earn-outs based on key inputs requiring significant judgments and estimates to be made by the Company, including projections of future earnings over the earn-out period. Significant increases or decreases to these inputs could result in a significantly higher or lower liability with a higher liability capped by the contractual maximum. Ultimately, the liability will be equivalent to the amount paid, and the difference between the fair value estimate as of the acquisition date and amount paid will be recorded in earnings.
The fair value of interest rate swap agreements are determined using standard pricing models and market-based assumptions for all significant inputs, such as yield curves and quoted spot and forward exchange rates. This fair value measurement is based on inputs that are observable either directly or indirectly and thus represents a Level 2 measurement within the fair value hierarchy. Refer to “Note 12. Financial Instruments” for further details on the accounting treatment of swap agreements.
XML 28 R17.htm IDEA: XBRL DOCUMENT v3.26.1
LONG-TERM DEBT
3 Months Ended
Mar. 31, 2026
Debt Disclosure [Abstract]  
LONG-TERM DEBT LONG-TERM DEBT
The Company’s long-term debt obligations consisted of the following:
Maturity DateMarch 31, 2026December 31, 2025
Term LoansJuly 30, 2031$1,631,804 $1,635,935 
Revolving credit facilityJuly 30, 2029— — 
Promissory notes13,389 15,273 
Less: Unamortized deferred financing costs(36,309)(38,011)
Total debt, net1,608,884 1,613,197 
Less:
Current portion of Term Loans(16,525)(16,525)
Current portion of promissory notes(6,935)(8,986)
Long-term debt, net of current portion$1,585,424 $1,587,686 
2024 Credit Agreement
The Company is party to a credit agreement by and among Acuren Delaware Holdco, Inc. (f/k/a AAL Delaware Holdco, Inc.), a wholly-owned subsidiary of the Company, as the initial borrower, Acuren Holdings, Inc. (f/k/a ASP Acuren Holdings, Inc.), a wholly-owned subsidiary of the Company, as a borrower, and any other subsidiaries of the Company from time to time party thereto as borrowers, (collectively, the “Borrowers”), the guarantors from time to time party thereto, the lenders from time to time party thereto, and Jefferies Finance LLC, as administrative agent and collateral agent (the “Credit Agreement”). The Credit Agreement provides for a $775.0 million seven-year senior secured term loan (the “2024 Term Loan”) under the senior secured term loan facility (the “Term Loan Facility”) and a $75.0 million five-year senior Revolving Credit Facility, of which up to $20.0 million can be used for the issuance of letters of credit (together with the Term Loan Facility, the “Credit Facility”).
The Credit Facility contains certain customary negative operating covenants (certain of which are not applicable depending on net leverage ratios), customary restrictive covenants and other customary provisions relating to events of default, including non-payment of principal, interest or fees, breach of covenants, misrepresentations, insolvency proceedings, cross default to other indebtedness of the Borrowers and its subsidiaries in excess of $40.0 million or judgments from creditors of such amount, change of control, and certain events relating to Employee Retirement Income Security Act plans. 
Solely with respect to the Revolving Credit Facility, the Credit Facility contains a financial covenant for the First Lien Net Leverage Ratio to be tested as of the last day of any such fiscal quarter only in the event that the total outstanding (excluding undrawn Letters of Credit) is greater than 35% of the total Revolving Credit Commitment, in which case the First Lien Net Leverage Ratio may exceed 5.85 to 1.00. As of March 31, 2026, the Company was in compliance with the covenants under the Credit Facility.
Obligations under the Credit Agreement are guaranteed on a senior secured basis, jointly and severally, by the Company and substantially all of its U.S. and Canadian subsidiaries. Amounts borrowed under the Credit Facility are secured on a first priority basis by a perfected security interest in substantially all of the present and future property (subject to certain exceptions) of the Borrower and each guarantor.
Repricing of Term Loan
On January 31, 2025, the Company entered into the First Amendment to the Credit Agreement, pursuant to which the interest rate margins for the Term Loan decreased from 2.50% to 1.75% for the base rate and from 3.50% to 2.75% for the secured overnight financing rate (“SOFR”), adjusted for statutory reserves. All other material terms of the Credit Agreement, including the aggregate principal amount, repayment terms, and interest rate applicable on the revolving credit facility available under the Credit Agreement (the “Revolving Credit Facility”) remained the same. The Company evaluated the change of terms under ASC 470-50, Debt–Modifications and Extinguishments, and concluded the change in terms did not result in significant and consequential changes to the economic substance of the debt and thus resulted in a modification of the debt and not an extinguishment of the debt. As such, the financing costs of $1.2 million were reflected as additional debt issuance costs and are amortized to interest expense over the term of the Term Loan.
Second Amendment to Credit Agreement
On August 4, 2025, in connection with the NV5 Acquisition, the Company entered into the Second Amendment to the Credit Agreement (the “Second Amendment”). The Second Amendment amended the Credit Agreement to: (i) include new term loans in an aggregate principal amount of $875.0 million (the “2025 Term Loans,” and together with the 2024 Term Loans, the “Term Loans”), and (ii) increase the aggregate amount of the Revolving Credit Facility from $75.0 million to $125.0 million. Principal payments on the Term Loans, commenced on September 30, 2025 and will be made in quarterly installments on the last day of each fiscal quarter in an amount equal to $4.1 million, subject to adjustments in accordance with the Credit Agreement. Accordingly, as of March 31, 2026, the Company has reflected $16.5 million of principal payments as current in the condensed consolidated balance sheet.
As of March 31, 2026, the Company had $1.6 billion of principal outstanding under the Term Loans. The interest rate applicable to the Term Loans is, at the Company’s option, either: (1) a base rate plus an applicable margin equal to 1.75% or (2) SOFR plus an applicable margin equal to 2.75%. For the three months ended March 31, 2026, the Company recorded $1.7 million of amortization expense related to debt issuance costs incurred in connection with the Term Loans. The Term Loans will mature on July 30, 2031.
Revolving Credit Facility 
The interest rate applicable to borrowings under the Revolving Credit Facility is, at the Company’s option, either: (1) a base rate plus an applicable margin equal to 2.50% or (2) SOFR (adjusted for statutory reserves) plus an applicable margin equal to 3.50%. The unused portion of the Revolving Credit Facility is subject to a commitment fee of 0.375% or 0.50% based on the Company’s first lien net leverage ratio. For the three months ended March 31, 2026, the amortization expense related to debt issuance costs incurred in connection with the Revolving Credit Facility was immaterial. As of March 31, 2026 and December 31, 2025, the Company had no amounts outstanding under its Revolving Credit Facility.
Letters of Credit and Surety Bonds  
As of March 31, 2026, the Company had $14.1 million in stand-by letters of credit issued (as a component of the Revolving Credit Facility), but did not withdraw any amount against the letters of credit. Additionally, the Company had $71.0 million in surety bonds outstanding, which are not a component of the Revolving Credit Facility.
Promissory Notes
The Company has outstanding uncollateralized promissory notes due to sellers issued in connection with prior acquisitions completed by NV5 prior to the NV5 Acquisition. As of March 31, 2026, the short-term and long-term outstanding balances of these promissory notes totaled $6.9 million and $6.5 million, respectively. As of March 31, 2026, the Company’s weighted average interest rate on promissory notes was 1.4%.
XML 29 R18.htm IDEA: XBRL DOCUMENT v3.26.1
FINANCIAL INSTRUMENTS
3 Months Ended
Mar. 31, 2026
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
FINANCIAL INSTRUMENTS FINANCIAL INSTRUMENTSThe Company’s risk management strategy from time to time utilizes interest rate swap agreements to mitigate interest rate exposure on its variable rate debt. The Company has not historically designated these derivatives as hedging instruments and reported these agreements at fair value with unrealized gains and losses recorded within “Interest expense, net” within the condensed consolidated statements of operations and comprehensive income (loss) in the reporting period in which the unrealized gains and losses occurred. During the three months ended March 31, 2026 and March 31, 2025, the Company had no interest rate swap agreements.
XML 30 R19.htm IDEA: XBRL DOCUMENT v3.26.1
INCOME TAXES
3 Months Ended
Mar. 31, 2026
Income Tax Disclosure [Abstract]  
INCOME TAXES INCOME TAXES
Income taxes are accounted for under the asset and liability method as required by ASC 740, Income Taxes. Deferred income tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred income tax assets and liabilities are measured at the enacted income tax rates expected to apply in the taxable year that the asset or liability is expected to be recovered or settled.
The Company recorded an income tax benefit of $16.5 million for the three months ended March 31, 2026 and an income tax provision of $1.5 million for the three months ended March 31, 2025. The effective tax rate, inclusive of discrete items, was 28.4% and (6.0)% for the three months ended March 31, 2026 and March 31, 2025, respectively, which was driven by a combination of the disparity between results of operations as well as the tax jurisdictions across the United States and Canada, permanent non-deductible expenses, and the valuation allowance discussed in further detail below.
The Company evaluated and considered all available evidence, both positive and negative, to determine whether, based on the weight of that evidence, a valuation allowance for its deferred tax assets was needed. The deferred tax assets are composed primarily of net operating loss carryforwards and 163(j) interest limitation carryforwards. The Company primarily relies on reversing taxable temporary differences to support the realization of its deferred tax assets. Based on available evidence and limitations on interest deductions under the tax law, the Company previously had a valuation allowance of $10.5 million as of March 31, 2025, primarily against the interest expense carryforward. However, the deferred tax liability recorded in connection with the NV5 Acquisition provided a source of future taxable income which supports the realizability of the interest expense carryforward asset and therefore the valuation allowance was reversed during the three months ended September 30, 2025. The deferred tax liability continues to support the realizability of the interest expense carryforward asset and no valuation allowance has been recorded during the three months ended March 31, 2026.
XML 31 R20.htm IDEA: XBRL DOCUMENT v3.26.1
STOCK-BASED COMPENSATION
3 Months Ended
Mar. 31, 2026
Share-Based Payment Arrangement [Abstract]  
STOCK-BASED COMPENSATION STOCK-BASED COMPENSATION
Restricted Stock Units
Awards of Restricted Stock Units (“RSUs”) are independent of stock option grants and are generally subject to forfeiture if employment terminates prior to vesting. Forfeitures are recognized as they occur. The Company’s RSU’s consist of three types: time-based units, market-based units and performance-based units, that are settled in shares of the Company’s common stock upon vesting.
The time-based awards issued to the Company’s employees vest either (i) in equal installments over a three-year service period from the grant date or (ii) cliff vest at the end of a one to three-year service period from the grant date. The time-based RSUs issued to the Company’s directors vest at the end of the anniversary date of their grant date. The market-based RSUs issued to the Company’s employees vest upon the later of the (i) first anniversary of the grant date and (ii) the calendar day following the 10 consecutive trading day period during which the VWAP of the Company’s common stock reaches $20.00 per share, which must be achieved before the fifth anniversary of the grant date. The performance-based RSUs issued to the Company’s employees vest based on the attainment of performance-based targets as outlined in the award grant notice over a three-year performance period.
The grant-date fair values of the time-based units and the performance-based units were determined based on the fair value of the underlying common stock on the grant date. The grant-date fair value of the market-based units was determined using a Monte Carlo simulation method which takes into consideration different stock price paths.
Below is a summary of RSU activity for the three months ended March 31, 2026:
Time Vesting UnitsMarket Vesting UnitsPerformance Vesting
Number of UnitsWeighted Average Grant Date Fair ValueNumber of UnitsWeighted Average Grant Date Fair ValueNumber of UnitsWeighted Average Grant Date Fair Value
Unvested as of December 31, 2025
944,202$9.76555,000$5.35984,321$9.38
Granted
3,577,1607.602,564,1797.60
Forfeited
(18,677)9.30(15,000)5.35(83,001)9.19
Units Vested
(146,667)9.60
Unvested as of March 31, 20264,356,018$8.40540,000$5.353,465,499$8.27
Share-based compensation expense is recorded in “Selling, general and administrative expenses” in the condensed consolidated statements of operations and comprehensive income (loss). Share-based compensation expense for the Company’s RSUs during the three months ended March 31, 2026 was $7.8 million, consisting of $6.6 million for time-based RSU’s, $0.3 million for market-based RSUs, and $0.9 million for performance-based RSU’s. Share-based compensation expense includes $4.2 million of expense related to the Company’s liability-classified awards during the three months ended March 31, 2026. The total estimated amount of the liability-classified awards is approximately $17.4 million.
As of March 31, 2026, the total unrecognized compensation expense for time-based RSUs was $43.5 million, which is expected to be recognized over a weighted average period of approximately 2.1 years. As of March 31, 2026, the total unrecognized compensation expense for market-based RSUs was $1.1 million, which is expected to be recognized over a weighted average period of approximately 1.0 years. As of March 31, 2026, the total unrecognized compensation expense for performance-based RSUs was $24.8 million, which is expected to be recognized over a weighted average period of approximately 2.7 years. The aggregate intrinsic value of RSUs vested during the three months ended March 31, 2026 was $1.0 million.
Restricted Stock Awards
NV5 historically granted Restricted Stock Awards (“RSAs”) to its employees. The RSAs generally provided for service-based cliff vesting two to four years following the grant date. In connection with the NV5 Acquisition, all outstanding unvested RSAs otherwise not accelerated upon the NV5 Closing Date were converted into RSAs of the Company with substantially similar terms and conditions of the previously existing awards, including future service requirements. The RSAs were replaced based on an exchange ratio of 2.0387, which was calculated in the same manner as the exchange ratio that was applicable to the NV5 common stock outstanding on the NV5 Closing Date and that received merger consideration on the NV5 Closing Date.
The following summarizes the activity of restricted stock awards during the three months ended March 31, 2026:
Number of Unvested Restricted Stock Awards    Weighted Average Grant Date Fair Value
Unvested as of December 31, 2025
6,958,429 $10.50 
Forfeited
(180,010)10.50 
Vested
(385,558)10.50 
Unvested as of March 31, 20266,392,861 $10.50 
Share-based compensation expense relating to RSAs during the three months ended March 31, 2026 was $5.1 million. As of March 31, 2026, the total unrecognized share-based compensation expense for RSAs was $29.8 million, which is expected to be recognized over a weighted average period of approximately 1.4 years. The aggregate intrinsic value of RSAs vested during the three months ended March 31, 2026 was $3.5 million.
Employee Stock Purchase Plan
The Company’s Employee Stock Purchase Plan (“ESPP”) allows qualified employees to purchase designated shares of the Company’s common stock at a price equal to 85% of the lesser of the fair market value of common stock at the beginning or end of each semi-annual stock purchase period. The Company did not issue any shares of common stock pursuant to the ESPP during the three months ended March 31, 2026. Share-based compensation expense for the Company’s ESPP during the three months ended March 31, 2026 was not material.
XML 32 R21.htm IDEA: XBRL DOCUMENT v3.26.1
COMMITMENTS AND CONTINGENCIES
3 Months Ended
Mar. 31, 2026
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES COMMITMENTS AND CONTINGENCIES
Legal Proceedings
The Company is involved in matters that involve various claims which have arisen in the normal course of business. The Company does not believe any liabilities that may arise as a result of such claims will have a material adverse effect, individually or in the aggregate, on its business, results of operations, cash flows or financial condition.
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.26.1
SEGMENT REPORTING
3 Months Ended
Mar. 31, 2026
Segment Reporting [Abstract]  
SEGMENT REPORTING SEGMENT REPORTING
The Company reports segment information in accordance with ASC Topic No. 280 “Segment Reporting” (“Topic No. 280”). The Company’s Chief Executive Officer is the Company’s chief operating decision-maker (“CODM”). The Company is organized into three reportable segments as follows:
Inspection and Mitigation, which includes the Company’s legacy testing, inspection, certification and compliance services in the United States, Canada, and United Kingdom;
Consulting Engineering, which includes the Company’s engineering, civil program management, utility services, conformity assessment, clean energy consulting, data center commissioning and consulting, buildings and program management, MEP & technology design, and environmental health science services; and
Geospatial, which includes the Company’s geospatial solution services.
The Company’s reportable segments are strategic business units that offer different products and services. The accounting policies of the reportable segments are the same as those described under “Note 1. Basis of Presentation and Significant Accounting Policies.” The CODM evaluates the performance of these reportable segments based on their respective gross profit. The CODM considers budget-to-actual and forecast-to-actual variances on a monthly basis when making decisions about allocating resources. The CODM does not regularly review capital expenditures by segment.
The following tables set forth certain financial information for each of the Company’s reportable segments for the periods indicated:
Three Months Ended March 31, 2026
Inspection and MitigationConsulting Engineering
Geospatial
Corporate and EliminationsTotal
Revenue$234,827 $187,341 $65,861 $— $488,029 
Cost of revenue$194,066 $98,191 $34,471 $— $326,728 
Gross profit$40,761 $89,150 $31,390 $— $161,301 
Depreciation and amortization$16,723 $1,686 $2,714 $37,757 $58,880 
Total assets$1,982,840 $1,160,672 $626,315 $562,309 $4,332,136 
Long-lived assets (1)
$163,822 $10,700 $44,481 $26,598 $245,601 
(1) Long-lived assets consist of property and equipment, net as identified in “Note 6. Property and equipment.”
Three Months Ended March 31, 2025
Inspection and MitigationConsulting Engineering
Geospatial
Corporate and EliminationsTotal
Revenue
$234,215 $— $— $— $234,215 
Cost of revenue$190,546 $— $— $— $190,546 
Gross profit$43,669 $— $— $— $43,669 
Depreciation and amortization$15,597 $— $— $13,002 $28,599 
Total assets$1,986,435 $— $— $193,845 $2,180,280 
Long-lived assets (1)
$183,473 $— $— $— $183,473 
(1) Long-lived assets consist of property and equipment, net as identified in “Note 6. Property and equipment.”
The Company disaggregates its revenues from contracts with customers by geographic location, customer type, and contract type for each of its reportable segments. Disaggregated revenues include inter-segment revenues which are ultimately eliminated within Corporate and Eliminations. The Company believes this best depicts how the nature, amount, timing and uncertainty of its revenues and cash flows are affected by economic factors.
Revenues, classified by the major geographic areas in which the Company's customers are located, were as follows:
Three Months Ended March 31, 2026
Inspection and MitigationConsulting Engineering
Geospatial
Total
United States$134,044 $156,286 $62,416 $352,746 
Canada98,013 — 228 98,241 
Other foreign2,770 31,055 3,217 37,042 
Total segment revenues$234,827 $187,341 $65,861 $488,029 
Three Months Ended March 31, 2025
Inspection and MitigationConsulting Engineering
Geospatial
Total
United States$145,321 $— $— $145,321 
Canada86,528 — — 86,528 
Other foreign2,366 — — 2,366 
Total segment revenues$234,215 $— $— $234,215 
Revenues by customer were as follows:
Three Months Ended March 31, 2026
Inspection and MitigationConsulting Engineering
Geospatial
Total
Public and quasi-public sector$6,876 $89,505 $55,394 $151,775 
Private sector227,951 97,836 10,467 336,254 
Total segment revenues$234,827 $187,341 $65,861 $488,029 
Three Months Ended March 31, 2025
Inspection and MitigationConsulting Engineering
Geospatial
Total
Public and quasi-public sector$5,903 $— $— $5,903 
Private sector228,312 — — 228,312 
Total segment revenues$234,215 $— $— $234,215 
Revenues by contract type were as follows:
Three Months Ended March 31, 2026
Inspection and MitigationConsulting Engineering
Geospatial
Total
Cost-reimbursable contracts$224,526 $170,311 $64,278 $459,115 
Fixed-unit price contracts10,301 17,030 1,583 28,914 
Total segment revenues$234,827 $187,341 $65,861 $488,029 
Three Months Ended March 31, 2025
Inspection and MitigationConsulting Engineering
Geospatial
Total
Cost-reimbursable contracts$220,772 $— $— $220,772 
Fixed-unit price contracts13,443 — — 13,443 
Total segment revenues$234,215 $— $— $234,215 
XML 34 R23.htm IDEA: XBRL DOCUMENT v3.26.1
RELATED PARTIES
3 Months Ended
Mar. 31, 2026
Related Party Transactions [Abstract]  
RELATED PARTIES RELATED PARTIES
On July 30, 2024, the Company entered into a Consulting Services Agreement with Mariposa Capital, LLC, an entity owned by the Co-Chairman of the Company’s board of directors. Under this agreement, Mariposa Capital, LLC agreed to provide certain services, including corporate development and consulting services, consulting services with respect to mergers and acquisitions, investor relations services, strategic planning consulting services, capital expenditure allocation consulting services, strategic treasury consulting services and such other services relating to the Company as may from time to time be mutually agreed. In connection with these services, Mariposa Capital, LLC is entitled to receive an annual fee equal to $2.0 million, payable in quarterly installments. The initial term of this agreement was for the one-year period ended July 30, 2025. The agreement was automatically renewed and automatically renews for successive one-year terms unless either party notifies the other party in writing of its intention not to renew this agreement no later than 90 days prior to the expiration of the term. This agreement may only be terminated by the Company upon a vote of a majority of the directors. In the event that this agreement is terminated by the Company, the effective date of the termination will be six months following the expiration of the initial term or a renewal term, as the case may be. During each of the quarters ending March 31, 2026 and March 31, 2025, the Company paid $0.5 million of consulting fees under this contract
No dividends on the Series A Preferred Stock have been declared during the three months ended March 31, 2026.
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.26.1
Insider Trading Arrangements
3 Months Ended
Mar. 31, 2026
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.26.1
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Policies)
3 Months Ended
Mar. 31, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation
Basis of Presentation
The accompanying interim unaudited condensed consolidated financial statements (the “interim statements”) have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) and the rules and regulations of the Securities and Exchange Commission (the “SEC”) and do not include all of the information and footnotes required by U.S. GAAP for complete financial statements as certain information has been condensed or omitted. All intercompany accounts and transactions have been eliminated in consolidation. Certain amounts in prior periods have been reclassified to conform to the current period presentation. Such reclassifications did not have a material effect on the Company's financial condition or results of operations as previously reported. The results of operations of companies acquired are included from the date of acquisition. In the opinion of management, these interim statements include all adjustments, which are of a normal recurring nature, necessary for a fair statement of the results for the interim periods presented. The results of operations for any interim period are not necessarily indicative of results for the full year. These interim statements should be read in conjunction with the audited consolidated financial statements and notes contained in the Company’s Annual Report on Form 10-K for the period ended December 31, 2025, as filed with the SEC (the “2025 Annual Report”).
Revenue Recognition
Revenue Recognition
The Company recognizes revenue in accordance with ASC Topic 606, Revenue from Contracts with Customers, by following the five-step model: the Company identifies a contract with a customer, identifies the performance obligation(s) in the contract, determines the transaction price, allocates the transaction price to each performance obligation in the contract and recognizes revenues as the Company satisfies the performance obligation(s).
Nature of Services and Performance Obligations
The Company provides TICC, engineering, geospatial and other services to customers under a variety of contract types. Contracts are evaluated to determine whether they should be combined and whether they contain one or multiple performance obligations. Most contracts contain a single performance obligation, as the promise to transfer individual services is not separately identifiable from other promises in the contract and, therefore, is not distinct. For contracts with multiple performance obligations, the Company allocates the contract’s transaction price to each performance obligation utilizing several different pricing scenarios and is able to discretely price out each individual component based on its nature and relation to the overall performance obligation.
Performance obligations are generally satisfied over time as work progresses or services are rendered, because the customer simultaneously receives and consumes the benefits of the Company’s performance. Revenue may be recognized over time based on time and material incurred to date, which best portrays the transfer of control to the customer, or based on progress measured using an input method by comparing direct costs incurred to date to the estimated total direct costs for the completion of the services. Contract costs include labor, sub-consultant services and other direct costs. For contracts that meet the required conditions, the Company applies the as-invoiced practical expedient and recognizes revenue based on its right to invoice for services performed.
Performance obligations in certain contracts are satisfied at a point in time. Revenue for these services is recognized when control of the promised deliverable transfers to the customer, which is generally upon completion, delivery or customer acceptance of reports or analyses.
The Company enters into contracts with its clients that contain two principal types of pricing provisions: cost-reimbursable and fixed-unit price. Cost-reimbursable contracts consist of the following:
time and material contracts, which are common for professional and technical consulting and certification services projects. Under these types of contracts, there is no predetermined fee. Instead, the Company negotiates hourly billing rates and charges the clients based upon actual hours expended on a project. In addition, any direct project expenditures are passed through to the client and are typically reimbursed. These contracts may have an initial not-to-exceed or guaranteed maximum price provision.
cost-plus contracts are the predominant contracting method used by the Company to charge clients for its costs, including both direct and indirect costs, plus a negotiated fee. The total estimated cost plus the negotiated fee represents the total contract value.
lump-sum contracts typically require the performance of all of the work under the contract for a specified lump-sum fee, subject to price adjustments if the scope of the project changes or unforeseen conditions arise. Many of the Company’s lump-sum contracts are negotiated and arise in the design of projects with a specified scope and project deliverables. In most cases, we can bill additional fees if the construction schedule is modified and lengthened.
Fixed-unit price contracts typically require the performance of an estimated number of units of work at an agreed price per unit, with the total payment under the contract determined by the actual number of units performed.
As of March 31, 2026, the Company had $1.1 billion of remaining performance obligations, of which $860.2 million is expected to be recognized over the next 12 months. Performance obligations include only those amounts that have been funded and authorized and does not reflect the full amounts the Company may receive over the term of such contracts. In the case of non-government contracts and project awards, performance obligations include future revenue at contract or customary rates, excluding contract renewals or extensions that are at the discretion of the client. For contracts with a not-to-exceed maximum amount, the Company includes revenue from such contracts in performance obligations to the extent of the remaining estimated amount.
Contract estimates are based on various assumptions to project the outcome of future events. These assumptions are dependent upon the accuracy of a variety of estimates, including engineering progress, achievement of milestones, labor productivity and cost estimates. Due to uncertainties inherent in the estimation process, it is possible that actual completion costs may vary from estimates. If estimated total costs on contracts indicate a loss or reduction to the percentage of total contract revenues recognized to date, these losses or reductions are recognized in the period in which the revisions are known. The effect of revisions to revenues and estimated costs to complete contracts, including penalties, incentive awards, change orders, claims and anticipated losses, are recorded on a cumulative catch-up basis in the period in which the revisions are identified and the loss can be reasonably estimated. Such revisions could occur in any reporting period and the effects on the results of operations for that reporting period may be material depending on the size of the project or the adjustment.
Contract Balances
The timing of revenue recognition, billings and cash collections results in, and are reflected within, “Accounts receivable, net,” “Contract assets, net,” and “Contract liabilities” on the condensed consolidated balance sheets.
“Accounts receivable, net” represents amounts billed to clients that remain uncollected as of the balance sheet date. The amounts are stated at their estimated realizable value. The Company maintains an allowance for credit losses to provide for the estimated amount of receivables that will not be collected. See further discussion in “Note 5. Accounts Receivable and Contract Assets.”
“Contract assets, net” represent recognized amounts pending billing pursuant to contract terms or accounts billed after period end and are expected to be billed and collected within the next 12 months. Generally, billing occurs subsequent to revenue recognition, resulting in contract assets that are classified as current.
In certain circumstances, the contract may allow for billing terms that result in cumulative amounts billed in excess of revenues recognized. “Contract liabilities” represent billings in excess of revenues recognized on these contracts as of the reporting date that are generally classified as current. During the three months ended March 31, 2026, revenue recognized related to the Company’s contract liabilities that existed as of December 31, 2025 was not material.
Contract Modifications
Contract modifications may occur in the normal course of business and typically result from changes in scope, specifications or performance period. In most cases, such modifications are not distinct and are accounted for as part of the existing contract. If a modification adds distinct goods or services at a price that reflects their standalone selling prices, it is accounted for as a separate contract.
Federal Acquisition Regulations
Federal Acquisition Regulations (“FAR”), which are applicable to the Company’s federal government contracts and may be incorporated in local and state agency contracts, limit the recovery of certain specified indirect costs on contracts. Cost-plus contracts covered by FAR or certain state and local agencies also may require an audit of actual costs and provide for upward or downward adjustments if actual recoverable costs differ from billed recoverable costs.
Recent Accounting Pronouncements Not Yet Adopted
Recent Accounting Pronouncements Not Yet Adopted
The Company has not adopted any new accounting pronouncements since the audited consolidated financial statements for the year ended December 31, 2025. See the 2025 Annual Report for information pertaining to the effects of recently adopted and other recent accounting pronouncements.
In September 2025, the FASB issued ASU 2025-06, Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-40), Targeted Improvements to the Accounting for Internal-Use Software, to modernize the accounting for software costs that are accounted for under Subtopic 350-40. The amendments in this update remove all references to prescriptive and sequential software development stages. Under this ASU, capitalization of internal-use software begins when management authorizes and commits to funding the project and it is probable that the project will be completed. ASU 2025-06 is effective for annual periods beginning after December 15, 2027, and interim reporting periods within those annual reporting periods; however early adoption is permitted either prospectively or retrospectively. The Company is currently evaluating the impact the adoption of this guidance will have on its financial statements and related disclosures.
In November 2024, the FASB issued ASU 2024-03, Income Statement — Reporting Comprehensive Income — Expense Disaggregation Disclosures (Subtopic 220-40), requiring disclosure in the notes to the financial statements for specified information about certain costs and expenses. The ASU is effective for annual periods beginning after December 15, 2026, and interim periods beginning after December 15, 2027; however early adoption is permitted and can be applied either prospectively or retrospectively. The Company is currently evaluating the impact the adoption of this guidance will have on its financial statements and related disclosures.
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.26.1
BUSINESS COMBINATIONS (Tables)
3 Months Ended
Mar. 31, 2026
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]  
Summary of Business Acquisitions, by Acquisition
The following table summarizes the preliminary estimated fair value of consideration transferred and the preliminary estimated fair values of the assets acquired and liabilities assumed at the date of the NV5 Acquisition:
Total
Cash consideration$870,911 
Equity consideration768,304 
Replacement of share-based awards29,744 
Total consideration
$1,668,959 
Recognized amounts of identifiable assets acquired and liabilities assumed:
Cash and cash equivalents$58,958 
Accounts receivables186,228 
Contract assets123,428 
Prepaid expenses and other current assets33,536 
Plant and equipment80,557 
Other assets4,560 
Operating lease right-of-use assets33,464 
Intangible assets720,000 
Accounts payable(40,350)
Accrued expenses and other current liabilities(99,123)
Contract liabilities(47,694)
Other liabilities(10,569)
Deferred tax liabilities
(97,935)
Lease liabilities(39,908)
Total identifiable net assets acquired
$905,152 
Goodwill$763,807 
Measurement period adjustments made during the three months ended March 31, 2026 were immaterial.
Summary of Fair Value of the Identifiable Intangible Assets
The following table summarizes the preliminary fair value of the identifiable intangible assets:
Fair Value as of March 31, 2026
Customer relationships$590,000 
Customer backlog88,000 
Trade name39,000 
Developed technology3,000 
Total intangible assets
$720,000 
Summary of Pro Forma Consolidated Financial Information Reflects the Results of Operations
The following pro forma consolidated financial information reflects the results of operations of the Company for the three months ended March 31, 2025 as if the NV5 Acquisition and related financing had occurred as of January 1, 2024, after giving effect to certain purchase accounting and financing adjustments. These amounts are based on financial information of the NV5 business and are not necessarily indicative of what the Company’s operating results would have been had the NV5 Acquisition and related financing taken place on January 1, 2024.
Three Months Ended
March 31, 2025
Net Revenue$468,260 
Net Loss$(43,109)
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.26.1
EARNINGS PER SHARE (Tables)
3 Months Ended
Mar. 31, 2026
Earnings Per Share [Abstract]  
Summary of Basic and Diluted Earnings Per Share
The following table sets forth the computations of basic and diluted loss per share of common stock and Series A Preferred Stock using the two-class method and the if-converted method, respectively, for the three months ended March 31, 2026 and March 31, 2025.
Three Months Ended
March 31, 2026March 31, 2025
Basic shares:
 
Numerator: 
Net loss
$(41,549)$(25,793)
Undistributed loss allocated to Series A Preferred Stock
190 211 
Net loss available to holders of common stock
$(41,359)$(25,582)
Denominator: 
Weighted average common stock outstanding – basic
217,251,178 121,476,215 
Weighted average Series A Preferred Stock outstanding – basic
1,000,000 1,000,000 
Basic loss per common stock
$(0.19)$(0.21)
Basic loss per Series A Preferred Stock
$(0.19)$(0.21)
Dilutive shares:
 
Numerator: 
Undistributed loss allocated to common stock$(41,359)$(25,582)
Undistributed loss allocated to Series A Preferred Stock
(190)(211)
Total undistributed loss
$(41,549)$(25,793)
Denominator:
Weighted average common stock outstanding – basic
217,251,178 121,476,215 
Add: dilutive securities 
Series A Preferred Stock1,000,000 1,000,000 
Weighted average common stock outstanding – diluted
218,251,178 122,476,215 
Weighted average Series A Preferred Stock outstanding – diluted
1,000,000 1,000,000 
Diluted loss per common stock
$(0.19)$(0.21)
Diluted loss per Series A Preferred Stock
$(0.19)$(0.21)
Summary of Antidilutive Securities Excluded from Computation of Earnings Per Share
For the three months ended March 31, 2026 and March 31, 2025, the Company excluded the following potentially dilutive shares from the computation of diluted loss per common stock as the impact would have been anti-dilutive:
Three Months Ended
Potentially dilutive securitiesMarch 31, 2026March 31, 2025
Stock options(1)
— 125,000 
Warrants(1)
— 212,901 
Restricted stock awards3,390,276 — 
Restricted stock units1,145,327 973,092 
Shares issuable pursuant to the Series A Preferred Stock dividend(2)
— 3,196,648 
(1) For the three months ended March 31, 2026, the stock options and warrants were out of the money.
(2) See discussion of the Annual Dividend Amount in “Note 3. Stockholders’ Equity.”
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.26.1
ACCOUNTS RECEIVABLE AND CONTRACT ASSETS (Tables)
3 Months Ended
Mar. 31, 2026
Receivables [Abstract]  
Summary of Accounts Receivable and Contract Assets
Accounts receivable and contract assets are recorded net of allowances for credit losses. Accounts receivable represent invoiced and accrued revenue while contract assets represent accrued revenue that has yet to be invoiced to the customer. The Company’s accounts receivable, contract assets and allowance for credit losses consisted of the following as of the below dates:
March 31, 2026December 31, 2025
Accounts receivables$347,195 $369,669 
Contract assets182,802 154,510 
Allowance for credit losses(3,022)(3,447)
Total accounts receivables, net$526,975 $520,732 
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.26.1
PROPERTY AND EQUIPMENT (Tables)
3 Months Ended
Mar. 31, 2026
Property, Plant and Equipment [Abstract]  
Summary of Property and Equipment
Property and equipment consists of the following:
 Useful Life (Years)March 31, 2026December 31, 2025
Land $6,117 $6,179 
Buildings and leasehold improvements2525,908 25,364 
Computer, software, and office equipment
3 – 5
24,560 23,279 
Machinery and equipment
3 – 10
186,145 181,437 
Vehicles, aircrafts and vessels
5 - 15
97,781 96,192 
Construction in progress 12,222 11,238 
Total property and equipment 352,733 343,689 
Accumulated depreciation (107,132)(88,064)
Property and equipment, net $245,601 $255,625 
Total depreciation expense for property and equipment was recognized as follows for the following periods:
Three Months Ended
March 31, 2026March 31, 2025
Cost of revenue
$18,843 $15,362 
Selling, general and administrative expenses
3,083 235 
Total depreciation expense
$21,926 $15,597 
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.26.1
GOODWILL (Tables)
3 Months Ended
Mar. 31, 2026
Goodwill and Intangible Assets Disclosure [Abstract]  
Summary of Goodwill
The changes in the carrying amount of goodwill by reportable segment for the three months ended March 31, 2026 were as follows:
Inspection and MitigationConsulting EngineeringGeospatialTotal
Balance at December 31, 2025$895,533 $516,873 $237,189 1,649,595 
Acquisitions
— 2,069 — 2,069 
Measurement period adjustments102 292 2,147 2,541 
Currency adjustments(6,671)— — (6,671)
Balance at March 31, 2026$888,964 $519,234 $239,336 $1,647,534 
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.26.1
INTANGIBLE ASSETS (Tables)
3 Months Ended
Mar. 31, 2026
Goodwill and Intangible Assets Disclosure [Abstract]  
Summary of Finite-Lived Intangible Assets
The gross carrying amounts and accumulated amortization of intangible assets were as follows:
Weighted
Average
Remaining
Life (Years)
March 31, 2026December 31, 2025
Gross Carrying Amount
Accumulated
Amortization
Net Carrying AmountGross Carrying AmountAccumulated
Amortization
Net Carrying Amount
Customer relationships13.3$1,279,417 $(104,950)$1,174,467 $1,282,032 $(82,609)$1,199,423 
Customer backlog1.488,741 (42,215)46,526 88,466 (31,126)57,340 
Tradenames12.3138,946 (13,621)125,325 139,498 (11,059)128,439 
Technology2.97,993 (2,331)5,662 8,019 (1,839)6,180 
$1,515,097 $(163,117)$1,351,980 $1,518,015 $(126,633)$1,391,382 
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.26.1
ACCRUED EXPENSES AND OTHER LIABILITIES (Tables)
3 Months Ended
Mar. 31, 2026
Payables and Accruals [Abstract]  
Summary of Accounts Payable and Accrued Liabilities
The Company’s accrued expenses and other current liabilities consisted of the following as of the below dates:
March 31, 2026December 31, 2025
Accrued salaries, wages and related employee benefits$76,617 $58,655 
Accrued trade payables28,220 32,090 
Accrued operating expenses15,528 21,718 
Accrued indirect taxes4,334 4,676 
Accrued sales discounts1,986 3,094 
Current portion of contingent consideration12,670 8,608 
Other accrued expenses28,882 22,785 
Total accrued expenses and other current liabilities$168,237 $151,626 
XML 44 R33.htm IDEA: XBRL DOCUMENT v3.26.1
LONG-TERM DEBT (Tables)
3 Months Ended
Mar. 31, 2026
Debt Disclosure [Abstract]  
Summary of Long-Term Debt
The Company’s long-term debt obligations consisted of the following:
Maturity DateMarch 31, 2026December 31, 2025
Term LoansJuly 30, 2031$1,631,804 $1,635,935 
Revolving credit facilityJuly 30, 2029— — 
Promissory notes13,389 15,273 
Less: Unamortized deferred financing costs(36,309)(38,011)
Total debt, net1,608,884 1,613,197 
Less:
Current portion of Term Loans(16,525)(16,525)
Current portion of promissory notes(6,935)(8,986)
Long-term debt, net of current portion$1,585,424 $1,587,686 
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.26.1
STOCK-BASED COMPENSATION (Tables)
3 Months Ended
Mar. 31, 2026
Share-Based Payment Arrangement [Abstract]  
Summary of Activities of RSUs
Below is a summary of RSU activity for the three months ended March 31, 2026:
Time Vesting UnitsMarket Vesting UnitsPerformance Vesting
Number of UnitsWeighted Average Grant Date Fair ValueNumber of UnitsWeighted Average Grant Date Fair ValueNumber of UnitsWeighted Average Grant Date Fair Value
Unvested as of December 31, 2025
944,202$9.76555,000$5.35984,321$9.38
Granted
3,577,1607.602,564,1797.60
Forfeited
(18,677)9.30(15,000)5.35(83,001)9.19
Units Vested
(146,667)9.60
Unvested as of March 31, 20264,356,018$8.40540,000$5.353,465,499$8.27
Summary of the Activity of Restricted Stock Awards
The following summarizes the activity of restricted stock awards during the three months ended March 31, 2026:
Number of Unvested Restricted Stock Awards    Weighted Average Grant Date Fair Value
Unvested as of December 31, 2025
6,958,429 $10.50 
Forfeited
(180,010)10.50 
Vested
(385,558)10.50 
Unvested as of March 31, 20266,392,861 $10.50 
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.26.1
SEGMENT REPORTING (Tables)
3 Months Ended
Mar. 31, 2026
Segment Reporting [Abstract]  
Summary of Segment Reporting Information, by Segment
The following tables set forth certain financial information for each of the Company’s reportable segments for the periods indicated:
Three Months Ended March 31, 2026
Inspection and MitigationConsulting Engineering
Geospatial
Corporate and EliminationsTotal
Revenue$234,827 $187,341 $65,861 $— $488,029 
Cost of revenue$194,066 $98,191 $34,471 $— $326,728 
Gross profit$40,761 $89,150 $31,390 $— $161,301 
Depreciation and amortization$16,723 $1,686 $2,714 $37,757 $58,880 
Total assets$1,982,840 $1,160,672 $626,315 $562,309 $4,332,136 
Long-lived assets (1)
$163,822 $10,700 $44,481 $26,598 $245,601 
(1) Long-lived assets consist of property and equipment, net as identified in “Note 6. Property and equipment.”
Three Months Ended March 31, 2025
Inspection and MitigationConsulting Engineering
Geospatial
Corporate and EliminationsTotal
Revenue
$234,215 $— $— $— $234,215 
Cost of revenue$190,546 $— $— $— $190,546 
Gross profit$43,669 $— $— $— $43,669 
Depreciation and amortization$15,597 $— $— $13,002 $28,599 
Total assets$1,986,435 $— $— $193,845 $2,180,280 
Long-lived assets (1)
$183,473 $— $— $— $183,473 
(1) Long-lived assets consist of property and equipment, net as identified in “Note 6. Property and equipment.”
Summary of Revenue from External Customers by Geographic Areas
Revenues, classified by the major geographic areas in which the Company's customers are located, were as follows:
Three Months Ended March 31, 2026
Inspection and MitigationConsulting Engineering
Geospatial
Total
United States$134,044 $156,286 $62,416 $352,746 
Canada98,013 — 228 98,241 
Other foreign2,770 31,055 3,217 37,042 
Total segment revenues$234,827 $187,341 $65,861 $488,029 
Three Months Ended March 31, 2025
Inspection and MitigationConsulting Engineering
Geospatial
Total
United States$145,321 $— $— $145,321 
Canada86,528 — — 86,528 
Other foreign2,366 — — 2,366 
Total segment revenues$234,215 $— $— $234,215 
Revenues by customer were as follows:
Three Months Ended March 31, 2026
Inspection and MitigationConsulting Engineering
Geospatial
Total
Public and quasi-public sector$6,876 $89,505 $55,394 $151,775 
Private sector227,951 97,836 10,467 336,254 
Total segment revenues$234,827 $187,341 $65,861 $488,029 
Three Months Ended March 31, 2025
Inspection and MitigationConsulting Engineering
Geospatial
Total
Public and quasi-public sector$5,903 $— $— $5,903 
Private sector228,312 — — 228,312 
Total segment revenues$234,215 $— $— $234,215 
Revenues by contract type were as follows:
Three Months Ended March 31, 2026
Inspection and MitigationConsulting Engineering
Geospatial
Total
Cost-reimbursable contracts$224,526 $170,311 $64,278 $459,115 
Fixed-unit price contracts10,301 17,030 1,583 28,914 
Total segment revenues$234,827 $187,341 $65,861 $488,029 
Three Months Ended March 31, 2025
Inspection and MitigationConsulting Engineering
Geospatial
Total
Cost-reimbursable contracts$220,772 $— $— $220,772 
Fixed-unit price contracts13,443 — — 13,443 
Total segment revenues$234,215 $— $— $234,215 
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.26.1
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Details)
$ in Millions
Mar. 31, 2026
USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Remaining performance obligation, amount $ 1,100.0
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-04-01  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Remaining performance obligation, amount $ 860.2
Revenue, remaining performance obligation, expected timing of satisfaction, period 12 months
XML 48 R37.htm IDEA: XBRL DOCUMENT v3.26.1
BUSINESS COMBINATIONS - Narrative (Details)
$ in Thousands, shares in Millions
3 Months Ended 12 Months Ended
May 14, 2025
USD ($)
shares
Mar. 31, 2026
USD ($)
Dec. 31, 2025
USD ($)
business
Business Combination, Separately Recognized Transaction [Line Items]      
Goodwill   $ 1,647,534 $ 1,649,595
Consulting Engineering      
Business Combination, Separately Recognized Transaction [Line Items]      
Goodwill   519,234 516,873
Inspection and Mitigation      
Business Combination, Separately Recognized Transaction [Line Items]      
Goodwill   888,964 895,533
Geospatial      
Business Combination, Separately Recognized Transaction [Line Items]      
Goodwill   239,336 237,189
2026 Business Acquisitions      
Business Combination, Separately Recognized Transaction [Line Items]      
Total consideration   5,000  
Goodwill   $ 2,000  
NV5 Global, Inc.      
Business Combination, Separately Recognized Transaction [Line Items]      
Total consideration $ 1,668,959    
Goodwill 763,807    
Cash paid to acquire business $ 870,911    
Number of shares issued (in shares) | shares 73.2    
Equity consideration $ 768,304    
Replacement of unvested 76,500    
Replacement of share-based awards 29,744    
Debt issuance costs 21,900    
Goodwill expected to be tax deductible 76,100    
Acquisition-related cost, expense 24,700    
NV5 Global, Inc. | Revolving Credit Facility      
Business Combination, Separately Recognized Transaction [Line Items]      
Debt issuance costs 1,300    
Increase in existing senior secured revolving credit facility 125,000    
NV5 Global, Inc. | Revolving Credit Facility | Line of Credit      
Business Combination, Separately Recognized Transaction [Line Items]      
Long-term debt 875,000    
NV5 Global, Inc. | Consulting Engineering      
Business Combination, Separately Recognized Transaction [Line Items]      
Goodwill 515,300    
NV5 Global, Inc. | Inspection and Mitigation      
Business Combination, Separately Recognized Transaction [Line Items]      
Goodwill 15,400    
NV5 Global, Inc. | Geospatial      
Business Combination, Separately Recognized Transaction [Line Items]      
Goodwill $ 233,100    
NV5 Global, Inc. | Customer relationships      
Business Combination, Separately Recognized Transaction [Line Items]      
Weighted average 
remaining 
life (in years) 15 years    
NV5 Global, Inc. | Customer backlog      
Business Combination, Separately Recognized Transaction [Line Items]      
Weighted average 
remaining 
life (in years) 2 years    
NV5 Global, Inc. | Trade name      
Business Combination, Separately Recognized Transaction [Line Items]      
Weighted average 
remaining 
life (in years) 10 years    
NV5 Global, Inc. | Developed technology      
Business Combination, Separately Recognized Transaction [Line Items]      
Weighted average 
remaining 
life (in years) 3 years    
2025 Business Acquisitions      
Business Combination, Separately Recognized Transaction [Line Items]      
Goodwill     17,900
Cash paid to acquire business     $ 45,800
Number of businesses acquired | business     7
2025 Business Acquisitions | Consulting Engineering      
Business Combination, Separately Recognized Transaction [Line Items]      
Goodwill     $ 1,900
2025 Business Acquisitions | Inspection and Mitigation      
Business Combination, Separately Recognized Transaction [Line Items]      
Goodwill     9,800
2025 Business Acquisitions | Geospatial      
Business Combination, Separately Recognized Transaction [Line Items]      
Goodwill     $ 6,200
XML 49 R38.htm IDEA: XBRL DOCUMENT v3.26.1
BUSINESS COMBINATIONS - Summary of Fair Value of Consideration Transferred (Details)
€ in Thousands, $ in Thousands
May 14, 2025
USD ($)
Mar. 31, 2026
USD ($)
Dec. 31, 2025
USD ($)
May 14, 2025
EUR (€)
Recognized amounts of identifiable assets acquired and liabilities assumed:        
Goodwill   $ 1,647,534 $ 1,649,595  
NV5 Global, Inc.        
Business Combination, Separately Recognized Transaction [Line Items]        
Cash consideration $ 870,911      
Equity consideration 768,304      
Replacement of share-based awards 29,744      
Total consideration 1,668,959      
Recognized amounts of identifiable assets acquired and liabilities assumed:        
Cash and cash equivalents 58,958      
Accounts receivables 186,228      
Contract assets 123,428      
Prepaid expenses and other current assets 33,536      
Plant and equipment 80,557      
Other assets 4,560      
Operating lease right-of-use assets 33,464      
Intangible assets 720,000 $ 720,000    
Accounts payable (40,350)      
Accrued expenses and other current liabilities (99,123)      
Contract liabilities (47,694)      
Other liabilities (10,569)      
Deferred tax liabilities | €       € (97,935)
Lease liabilities (39,908)      
Total identifiable net assets acquired 905,152      
Goodwill $ 763,807      
XML 50 R39.htm IDEA: XBRL DOCUMENT v3.26.1
BUSINESS COMBINATIONS - Summary of Preliminary Fair Value of the Identifiable Intangible Assets (Details) - NV5 Global, Inc. - USD ($)
$ in Thousands
Mar. 31, 2026
May 14, 2025
Intangible Asset, Acquired, Indefinite-Lived [Line Items]    
Intangible assets $ 720,000 $ 720,000
Customer relationships    
Intangible Asset, Acquired, Indefinite-Lived [Line Items]    
Intangible assets 590,000  
Customer backlog    
Intangible Asset, Acquired, Indefinite-Lived [Line Items]    
Intangible assets 88,000  
Trade name    
Intangible Asset, Acquired, Indefinite-Lived [Line Items]    
Intangible assets 39,000  
Developed technology    
Intangible Asset, Acquired, Indefinite-Lived [Line Items]    
Intangible assets $ 3,000  
XML 51 R40.htm IDEA: XBRL DOCUMENT v3.26.1
BUSINESS COMBINATIONS - Summary of Pro Forma Consolidated Financial Information (Details)
$ in Thousands
3 Months Ended
Mar. 31, 2026
USD ($)
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]  
Net Revenue $ 468,260
Net Loss $ (43,109)
XML 52 R41.htm IDEA: XBRL DOCUMENT v3.26.1
STOCKHOLDERS’ EQUITY - Preferred Stock Narrative (Details)
3 Months Ended 12 Months Ended
Mar. 31, 2026
$ / shares
shares
Dec. 31, 2025
USD ($)
d
$ / shares
shares
Dec. 16, 2024
$ / shares
shares
Class of Warrant or Right [Line Items]      
Common stock, shares authorized (in shares)     500,000,000
Common stock, par value (in dollars per share) | $ / shares $ 0.1000 $ 0.1000 $ 0.0001
Preferred stock, par value (in dollars per share) | $ / shares $ 0.1000 $ 0.1000 $ 0.0001
Common stock, shares issued (in shares) 221,039,674 220,485,045  
Common stock, shares outstanding (in shares) 221,039,674 220,485,045  
Number of securities issued (in shares) 1,000,000 1,000,000  
Preferred stock, shares outstanding (in shares) 1,000,000 1,000,000  
Average share price threshold for annual dividends (in dollars per share) | $ / shares   $ 11.50  
Share price threshold for Preferred stock dividends consecutive trading days | d   10  
Dividend rate, percent of appreciation of market price 20.00%    
Share price baseline for calculating annual dividends (in dollars per share) | $ / shares   $ 10.00  
Preferred stock dividends, shares amount 121,476,215 121,476,215  
Common stock, dividends, per share, declared | $ / shares   $ 10.28  
Preferred Stock      
Class of Warrant or Right [Line Items]      
Preferred stock, shares authorized (in shares)     5,000,000
Series A Preferred Stock      
Class of Warrant or Right [Line Items]      
Preferred stock, shares authorized (in shares)     1,000,000
Number of securities issued (in shares) 1,000,000    
Preferred stock, shares outstanding (in shares) 1,000,000    
Dividends, common stock (in dollars per share) | $   $ 668,347  
XML 53 R42.htm IDEA: XBRL DOCUMENT v3.26.1
STOCKHOLDERS’ EQUITY - Warrants Narrative (Details)
$ / shares in Units, $ in Millions
12 Months Ended
Oct. 05, 2025
USD ($)
$ / shares
shares
Dec. 31, 2025
d
$ / shares
Mar. 31, 2026
$ / shares
shares
Mar. 10, 2026
USD ($)
Dec. 16, 2024
$ / shares
May 31, 2023
$ / shares
shares
Class of Warrant or Right [Line Items]            
Common stock, par value (in dollars per share) | $ / shares   $ 0.1000 $ 0.1000   $ 0.0001  
Warrant conversion shares ratio (in shares) | shares     0      
Vested warrants outstanding (in shares) | shares     14,952,860      
Share price threshold for Preferred stock dividends consecutive trading days | d   10        
Number of securities called by each warrant (in shares) | shares     3,738,215      
Private Placement            
Class of Warrant or Right [Line Items]            
Gross proceeds | $ $ 250.0          
Private Placement | Pre-Funded Warrants            
Class of Warrant or Right [Line Items]            
Sale price per share (in dollars per share) | $ / shares $ 11.9999          
Warrant conversion shares ratio (in shares) | shares 3,125,000          
Exercise price of warrants (in dollars per share) | $ / shares $ 0.0001          
Notice period 61 days          
Private Placement | Pre-Funded Warrants | Minimum            
Class of Warrant or Right [Line Items]            
Minimum beneficial ownership percentage 9.99%          
Private Placement | Pre-Funded Warrants | Maximum            
Class of Warrant or Right [Line Items]            
Minimum beneficial ownership percentage 19.99%          
Initial Public Stock Offering | Common Stock And Series A Preferred Stock            
Class of Warrant or Right [Line Items]            
Warrant conversion shares ratio (in shares) | shares           4
Exercise price of warrants (in dollars per share) | $ / shares           $ 11.50
Vested warrants outstanding (in shares) | shares           54,975,000
Initial Public Stock Offering | Common Stock And Series A Preferred Stock | Non Founder Director            
Class of Warrant or Right [Line Items]            
Vested warrants outstanding (in shares) | shares           25,000
Initial Public Stock Offering | Common Stock And Series A Preferred Stock | Minimum            
Class of Warrant or Right [Line Items]            
Mandatorily redeemable, stock trigger price (in dollars per share) | $ / shares           $ 0.01
Initial Public Stock Offering | Common Stock And Series A Preferred Stock | Maximum            
Class of Warrant or Right [Line Items]            
Mandatorily redeemable, stock trigger price (in dollars per share) | $ / shares           $ 18.00
Common Stock            
Class of Warrant or Right [Line Items]            
Share repurchase program, authorized, amount | $       $ 200.0    
Common Stock | Private Placement            
Class of Warrant or Right [Line Items]            
Number of shares (in shares) | shares 17,708,333          
Common stock, par value (in dollars per share) | $ / shares $ 0.0001          
Sale price per share (in dollars per share) | $ / shares $ 12.00          
XML 54 R43.htm IDEA: XBRL DOCUMENT v3.26.1
EARNINGS PER SHARE - Summary of Basic and Diluted Earnings Per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Numerator:    
Net loss $ (41,549) $ (25,793)
Undistributed loss allocated to Series A Preferred Stock (190) (211)
Net loss available to holders of common stock (41,359) (25,582)
Numerator:    
Total undistributed loss $ (41,549) $ (25,793)
Add: dilutive securities    
Series A Preferred Stock (in shares) 1,000,000 1,000,000
Series A Preferred Stock    
Numerator:    
Undistributed loss allocated to Series A Preferred Stock $ (190) $ (211)
Denominator:    
Weighted average common stock stock and Series A Preferred Stock outstanding – basic (in shares) 1,000,000 1,000,000
Basic loss per common stock and Series A Preferred Stock (in dollars per share) $ (0.19) $ (0.21)
Numerator:    
Total undistributed loss $ (190) $ (211)
Add: dilutive securities    
Weighted average common stock and Series A Preferred Stock outstanding – diluted 1,000,000 1,000,000
Diluted loss per common stock and Series A Preferred Stock (in dollars per share) $ (0.19) $ (0.21)
Common Stock    
Denominator:    
Weighted average common stock stock and Series A Preferred Stock outstanding – basic (in shares) 217,251,178 121,476,215
Basic loss per common stock and Series A Preferred Stock (in dollars per share) $ (0.19) $ (0.21)
Numerator:    
Total undistributed loss $ (41,359) $ (25,582)
Add: dilutive securities    
Weighted average common stock and Series A Preferred Stock outstanding – diluted 218,251,178 122,476,215
Diluted loss per common stock and Series A Preferred Stock (in dollars per share) $ (0.19) $ (0.21)
XML 55 R44.htm IDEA: XBRL DOCUMENT v3.26.1
EARNINGS PER SHARE - Summary of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Stock Option    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Securities excluded from computation of diluted loss per share (in shares) 0 125,000
Warrants    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Securities excluded from computation of diluted loss per share (in shares) 0 212,901
Restricted stock awards    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Securities excluded from computation of diluted loss per share (in shares) 3,390,276 0
Restricted stock units    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Securities excluded from computation of diluted loss per share (in shares) 1,145,327 973,092
Shares issuable pursuant to the Series A Preferred Stock dividend    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Securities excluded from computation of diluted loss per share (in shares) 0 3,196,648
XML 56 R45.htm IDEA: XBRL DOCUMENT v3.26.1
ACCOUNTS RECEIVABLE AND CONTRACT ASSETS (Details) - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Receivables [Abstract]    
Accounts receivables $ 347,195 $ 369,669
Contract assets 182,802 154,510
Allowance for credit losses (3,022) (3,447)
Total accounts receivables, net $ 526,975 $ 520,732
XML 57 R46.htm IDEA: XBRL DOCUMENT v3.26.1
PROPERTY AND EQUIPMENT - Summary of Property and Equipment (Details) - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Mar. 31, 2025
Property, Plant and Equipment [Line Items]      
Total property and equipment $ 352,733 $ 343,689  
Accumulated depreciation (107,132) (88,064)  
Property and equipment, net 245,601 255,625 $ 183,473
Land      
Property, Plant and Equipment [Line Items]      
Total property and equipment $ 6,117 6,179  
Buildings and leasehold improvements      
Property, Plant and Equipment [Line Items]      
Useful Life (Years) 25 years    
Total property and equipment $ 25,908 25,364  
Computer, software, and office equipment      
Property, Plant and Equipment [Line Items]      
Total property and equipment $ 24,560 23,279  
Computer, software, and office equipment | Minimum      
Property, Plant and Equipment [Line Items]      
Useful Life (Years) 3 years    
Computer, software, and office equipment | Maximum      
Property, Plant and Equipment [Line Items]      
Useful Life (Years) 5 years    
Machinery and equipment      
Property, Plant and Equipment [Line Items]      
Total property and equipment $ 186,145 181,437  
Machinery and equipment | Minimum      
Property, Plant and Equipment [Line Items]      
Useful Life (Years) 3 years    
Machinery and equipment | Maximum      
Property, Plant and Equipment [Line Items]      
Useful Life (Years) 10 years    
Vehicles, aircrafts and vessels      
Property, Plant and Equipment [Line Items]      
Total property and equipment $ 97,781 96,192  
Vehicles, aircrafts and vessels | Minimum      
Property, Plant and Equipment [Line Items]      
Useful Life (Years) 5 years    
Vehicles, aircrafts and vessels | Maximum      
Property, Plant and Equipment [Line Items]      
Useful Life (Years) 15 years    
Construction in progress      
Property, Plant and Equipment [Line Items]      
Total property and equipment $ 12,222 $ 11,238  
XML 58 R47.htm IDEA: XBRL DOCUMENT v3.26.1
PROPERTY AND EQUIPMENT - Depreciation (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Property, Plant and Equipment [Line Items]    
Total depreciation expense $ 21,926 $ 15,597
Cost of revenue    
Property, Plant and Equipment [Line Items]    
Total depreciation expense 18,843 15,362
Selling, general and administrative expenses    
Property, Plant and Equipment [Line Items]    
Total depreciation expense $ 3,083 $ 235
XML 59 R48.htm IDEA: XBRL DOCUMENT v3.26.1
GOODWILL (Details)
$ in Thousands
3 Months Ended
Mar. 31, 2026
USD ($)
Goodwill [Roll Forward]  
Balance at December 31, 2025 $ 1,649,595
Acquisitions 2,069
Measurement period adjustments 2,541
Currency adjustments (6,671)
Balance at March 31, 2026 1,647,534
Inspection and Mitigation  
Goodwill [Roll Forward]  
Balance at December 31, 2025 895,533
Acquisitions 0
Measurement period adjustments 102
Currency adjustments (6,671)
Balance at March 31, 2026 888,964
Consulting Engineering  
Goodwill [Roll Forward]  
Balance at December 31, 2025 516,873
Acquisitions 2,069
Measurement period adjustments 292
Currency adjustments 0
Balance at March 31, 2026 519,234
Geospatial  
Goodwill [Roll Forward]  
Balance at December 31, 2025 237,189
Acquisitions 0
Measurement period adjustments 2,147
Currency adjustments 0
Balance at March 31, 2026 $ 239,336
XML 60 R49.htm IDEA: XBRL DOCUMENT v3.26.1
INTANGIBLE ASSETS - Summary of Intangible Assets and Amortization Expense (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Dec. 31, 2025
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount $ 1,515,097 $ 1,518,015
Accumulated 
Amortization (163,117) (126,633)
Net Carrying Amount $ 1,351,980 1,391,382
Customer relationships    
Finite-Lived Intangible Assets [Line Items]    
Weighted Average 
Remaining 
Life (Years) 13 years 3 months 18 days  
Gross Carrying Amount $ 1,279,417 1,282,032
Accumulated 
Amortization (104,950) (82,609)
Net Carrying Amount $ 1,174,467 1,199,423
Customer backlog    
Finite-Lived Intangible Assets [Line Items]    
Weighted Average 
Remaining 
Life (Years) 1 year 4 months 24 days  
Gross Carrying Amount $ 88,741 88,466
Accumulated 
Amortization (42,215) (31,126)
Net Carrying Amount $ 46,526 57,340
Trade name    
Finite-Lived Intangible Assets [Line Items]    
Weighted Average 
Remaining 
Life (Years) 12 years 3 months 18 days  
Gross Carrying Amount $ 138,946 139,498
Accumulated 
Amortization (13,621) (11,059)
Net Carrying Amount $ 125,325 128,439
Developed technology    
Finite-Lived Intangible Assets [Line Items]    
Weighted Average 
Remaining 
Life (Years) 2 years 10 months 24 days  
Gross Carrying Amount $ 7,993 8,019
Accumulated 
Amortization (2,331) (1,839)
Net Carrying Amount $ 5,662 $ 6,180
XML 61 R50.htm IDEA: XBRL DOCUMENT v3.26.1
INTANGIBLE ASSETS - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Goodwill and Intangible Assets Disclosure [Abstract]    
Amortization of intangible assets $ 37.0 $ 13.0
XML 62 R51.htm IDEA: XBRL DOCUMENT v3.26.1
ACCRUED EXPENSES AND OTHER LIABILITIES - Summary of Accrued Expenses and Other Liabilities (Details) - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Payables and Accruals [Abstract]    
Accrued salaries, wages and related employee benefits $ 76,617 $ 58,655
Accrued trade payables 28,220 32,090
Accrued operating expenses 15,528 21,718
Accrued indirect taxes 4,334 4,676
Accrued sales discounts 1,986 3,094
Current portion of contingent consideration 12,670 8,608
Other accrued expenses 28,882 22,785
Total accrued expenses and other current liabilities $ 168,237 $ 151,626
XML 63 R52.htm IDEA: XBRL DOCUMENT v3.26.1
ACCRUED EXPENSES AND OTHER LIABILITIES - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Dec. 31, 2025
Loss Contingencies [Line Items]    
Contingent consideration, change in contingent consideration, liability, increase (decrease) $ 1,900  
Current portion of contingent consideration 12,670 $ 8,608
2026 Business Acquisitions    
Loss Contingencies [Line Items]    
Contingent consideration liability incurred 1,000  
Contingent consideration liability payment (1,300)  
Contingent consideration $ 15,200  
NV5 Global, Inc.    
Loss Contingencies [Line Items]    
Contingent consideration   $ 13,600
XML 64 R53.htm IDEA: XBRL DOCUMENT v3.26.1
LONG-TERM DEBT - Summary of Long-Term Debt (Details) - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Debt Instrument [Line Items]    
Less: Unamortized deferred financing costs $ (36,309) $ (38,011)
Total debt, net 1,608,884 1,613,197
Long-Term Debt, Current Maturities (23,460) (25,511)
Long-term debt, net of current portion 1,585,424 1,587,686
Term Loans    
Debt Instrument [Line Items]    
Long-term debt 1,631,804 1,635,935
Long-Term Debt, Current Maturities (16,525) (16,525)
Revolving Credit Facility    
Debt Instrument [Line Items]    
Long-term debt 0 0
Promissory notes    
Debt Instrument [Line Items]    
Long-term debt 13,389 15,273
Long-Term Debt, Current Maturities $ (6,935) $ (8,986)
XML 65 R54.htm IDEA: XBRL DOCUMENT v3.26.1
LONG-TERM DEBT - Narrative (Details)
$ in Millions
3 Months Ended
Aug. 04, 2025
USD ($)
Jan. 31, 2025
USD ($)
Mar. 31, 2026
USD ($)
Dec. 31, 2025
USD ($)
Aug. 03, 2025
USD ($)
Term Loan 2024          
Debt Instrument [Line Items]          
Amortization expense related to debt issuance costs     $ 1.7    
Long-term debt     1,600.0    
New Term Loans | Line of Credit          
Debt Instrument [Line Items]          
Quarterly installments $ 4.1        
Principal payment     16.5    
Promissory notes          
Debt Instrument [Line Items]          
Short-term debt     6.9    
Long-term debt     $ 6.5    
Weighted average interest rate (as a percent)     1.40%    
Term Loans | 2024 Credit Agreement | Term Loan 2024          
Debt Instrument [Line Items]          
Debt instrument face amount     $ 775.0    
Debt instrument, term (in years)     7 years    
Debt issuance costs   $ 1.2      
Term Loans | 2024 Credit Agreement | Term Loan 2024 | Base Rate          
Debt Instrument [Line Items]          
Basis spread on variable rate   2.50% 1.75%    
Term Loans | 2024 Credit Agreement | Term Loan 2024 | Secured Overnight Financing Rate (SOFR)          
Debt Instrument [Line Items]          
Basis spread on variable rate   3.50% 2.75%    
Revolving Credit Facility | Line of Credit          
Debt Instrument [Line Items]          
Line of credit facility, maximum borrowing capacity 875.0        
Revolving Credit Facility | 2024 Credit Agreement          
Debt Instrument [Line Items]          
Covenant compliance, debt default, threshold amount     $ 40.0    
Covenant compliance, undrawn letter of credit threshold, percent (greater than)     0.35    
Covenant compliance, first lien net leverage ratio     0.0585    
Revolving Credit Facility | 2024 Credit Agreement | Term Loan 2024          
Debt Instrument [Line Items]          
Amortization expense related to debt issuance costs     $ 0.0    
Line of credit facility outstanding     $ 0.0 $ 0.0  
Revolving Credit Facility | 2024 Credit Agreement | Term Loan 2024 | Base Rate          
Debt Instrument [Line Items]          
Basis spread on variable rate     2.50%    
Revolving Credit Facility | 2024 Credit Agreement | Term Loan 2024 | Secured Overnight Financing Rate (SOFR)          
Debt Instrument [Line Items]          
Basis spread on variable rate     3.50%    
Revolving Credit Facility | 2024 Credit Agreement | Term Loan 2024 | Secured Overnight Financing Rate (SOFR) | Minimum          
Debt Instrument [Line Items]          
Unused capacity, commitment fee percentage     0.375%    
Revolving Credit Facility | 2024 Credit Agreement | Term Loan 2024 | Secured Overnight Financing Rate (SOFR) | Maximum          
Debt Instrument [Line Items]          
Unused capacity, commitment fee percentage     0.50%    
Revolving Credit Facility | 2024 Credit Agreement | Line of Credit          
Debt Instrument [Line Items]          
Debt instrument, term (in years)     5 years    
Line of credit facility, maximum borrowing capacity $ 125.0   $ 75.0   $ 75.0
Letter of Credit | 2024 Credit Agreement | Line of Credit          
Debt Instrument [Line Items]          
Line of credit facility, maximum borrowing capacity     20.0    
Standby Letters of Credit          
Debt Instrument [Line Items]          
Line of credit facility, maximum borrowing capacity     14.1    
Surety Bond | Line of Credit          
Debt Instrument [Line Items]          
Line of credit facility, maximum borrowing capacity     $ 71.0    
XML 66 R55.htm IDEA: XBRL DOCUMENT v3.26.1
INCOME TAXES (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Tax Disclosure [Abstract]    
Income tax provision (benefit) $ (16,458) $ 1,465
Effective income tax rate, percent 28.40% (6.00%)
Valuation allowance   $ 10,500
XML 67 R56.htm IDEA: XBRL DOCUMENT v3.26.1
STOCK-BASED COMPENSATION - Narrative (Details)
$ / shares in Units, $ in Millions
3 Months Ended 12 Months Ended
Mar. 31, 2026
USD ($)
rsu
$ / shares
Dec. 31, 2025
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Restricted Stock, Convertible, Conversion Ratio   2.0387
Restricted stock units    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of types of RSUs | rsu 3  
Share-based compensation expense $ 7.8  
Aggregate intrinsic value, vested $ 1.0  
Restricted stock units | Time Vesting Units    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Award vesting period (in years) 3 years  
Service period 3 years  
Consecutive trading day 10 days  
Weighted average exercise price (in dollars per share) | $ / shares $ 20.00  
Share-based compensation expense $ 6.6  
Unrecognized compensation expense $ 43.5  
Weighted average period (in shares) 2 years 1 month 6 days  
Restricted stock units | Performance Vesting    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Service period 3 years  
Share-based compensation expense $ 0.9  
Unrecognized compensation expense $ 24.8  
Weighted average period (in shares) 2 years 8 months 12 days  
Restricted stock units | Market Vesting Units    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Share-based compensation expense $ 0.3  
Unrecognized compensation expense $ 1.1  
Weighted average period (in shares) 1 year  
Contingently issuable RSUs    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Share-based compensation expense $ 5.1  
Unrecognized compensation expense $ 29.8  
Weighted average period (in shares) 1 year 4 months 24 days  
Fair value of restricted shares vested $ 3.5  
Total estimated fair value $ 17.4  
Contingently issuable RSUs | Minimum    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Award vesting period (in years) 2 years  
Contingently issuable RSUs | Maximum    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Award vesting period (in years) 4 years  
Liability Based Awards    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Share-based compensation expense $ 4.2  
Employee Stock | Employee Stock Purchase Plan    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Purchase price of common stock, percent 85.00%  
XML 68 R57.htm IDEA: XBRL DOCUMENT v3.26.1
STOCK-BASED COMPENSATION - Summary of Activities of RSUs (Details) - Restricted stock units
3 Months Ended
Mar. 31, 2026
$ / shares
shares
Time Vesting Units  
Number of Unvested Restricted Stock Awards  
Unvested beginning balance (in shares) | shares 944,202
Granted (in shares) | shares 3,577,160
Forfeited (in shares) | shares (18,677)
Units vested (in shares) | shares (146,667)
Unvested ending balance (in shares) | shares 4,356,018
Weighted Average Grant Date Fair Value  
Unvested, Weighted average grant date fair value at beginning balance (in dollars per share) | $ / shares $ 9.76
Granted, Weighted average grant date fair value (in dollars per share) | $ / shares 7.60
Forfeited, Weighted average grant date fair value (dollar per share) | $ / shares 9.30
Units Vested, Weighted average grant date fair value (in dollars per share) | $ / shares 9.60
Unvested, Weighted average grant date fair value at Ending balance (in dollars per share) | $ / shares $ 8.40
Market Vesting Units  
Number of Unvested Restricted Stock Awards  
Unvested beginning balance (in shares) | shares 555,000
Granted (in shares) | shares 0
Forfeited (in shares) | shares (15,000)
Units vested (in shares) | shares 0
Unvested ending balance (in shares) | shares 540,000
Weighted Average Grant Date Fair Value  
Unvested, Weighted average grant date fair value at beginning balance (in dollars per share) | $ / shares $ 5.35
Granted, Weighted average grant date fair value (in dollars per share) | $ / shares 0
Forfeited, Weighted average grant date fair value (dollar per share) | $ / shares 5.35
Units Vested, Weighted average grant date fair value (in dollars per share) | $ / shares 0
Unvested, Weighted average grant date fair value at Ending balance (in dollars per share) | $ / shares $ 5.35
Performance Vesting  
Number of Unvested Restricted Stock Awards  
Unvested beginning balance (in shares) | shares 984,321
Granted (in shares) | shares 2,564,179
Forfeited (in shares) | shares (83,001)
Units vested (in shares) | shares 0
Unvested ending balance (in shares) | shares 3,465,499
Weighted Average Grant Date Fair Value  
Unvested, Weighted average grant date fair value at beginning balance (in dollars per share) | $ / shares $ 9.38
Granted, Weighted average grant date fair value (in dollars per share) | $ / shares 7.60
Forfeited, Weighted average grant date fair value (dollar per share) | $ / shares 9.19
Units Vested, Weighted average grant date fair value (in dollars per share) | $ / shares 0
Unvested, Weighted average grant date fair value at Ending balance (in dollars per share) | $ / shares $ 8.27
XML 69 R58.htm IDEA: XBRL DOCUMENT v3.26.1
STOCK-BASED COMPENSATION - Summary of Activities of Restricted Stock Awards (Details) - Contingently issuable RSUs
3 Months Ended
Mar. 31, 2026
$ / shares
shares
Number of Unvested Restricted Stock Awards  
Unvested beginning balance (in shares) | shares 6,958,429
Forfeited (in shares) | shares (180,010)
Vested (in shares) | shares (385,558)
Unvested ending balance (in shares) | shares 6,392,861
Weighted Average Grant Date Fair Value  
Unvested, Weighted average grant date fair value at beginning balance (in dollars per share) | $ / shares $ 10.50
Forfeited (dollar per share) | $ / shares 10.50
Vested (in dollars per share) | $ / shares 10.50
Unvested, Weighted average grant date fair value at Ending balance (in dollars per share) | $ / shares $ 10.50
XML 70 R59.htm IDEA: XBRL DOCUMENT v3.26.1
SEGMENT REPORTING - Narrative (Details)
3 Months Ended
Mar. 31, 2026
segment
Segment Reporting [Abstract]  
Number of reportable segments 3
XML 71 R60.htm IDEA: XBRL DOCUMENT v3.26.1
SEGMENT REPORTING - Summary of Financial Information For each of the Company’s Reportable Segments (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Segment Reporting Information [Line Items]      
Revenue $ 488,029 $ 234,215  
Cost of revenue 326,728 190,546  
Gross profit 161,301 43,669  
Depreciation and amortization 58,880 28,599  
Total assets 4,332,136 2,180,280 $ 4,396,309
Property and equipment, net 245,601 183,473 $ 255,625
Operating Segments      
Segment Reporting Information [Line Items]      
Revenue 488,029 234,215  
Corporate and Eliminations      
Segment Reporting Information [Line Items]      
Revenue 0 0  
Cost of revenue 0 0  
Gross profit 0 0  
Depreciation and amortization (37,757) (13,002)  
Total assets (562,309) (193,845)  
Property and equipment, net (26,598) 0  
Inspection and Mitigation | Operating Segments      
Segment Reporting Information [Line Items]      
Revenue 234,827 234,215  
Cost of revenue 194,066 190,546  
Gross profit 40,761 43,669  
Depreciation and amortization 16,723 15,597  
Total assets 1,982,840 1,986,435  
Property and equipment, net 163,822 183,473  
Consulting Engineering | Operating Segments      
Segment Reporting Information [Line Items]      
Revenue 187,341 0  
Cost of revenue 98,191 0  
Gross profit 89,150 0  
Depreciation and amortization 1,686 0  
Total assets 1,160,672 0  
Property and equipment, net 10,700 0  
Geospatial | Operating Segments      
Segment Reporting Information [Line Items]      
Revenue 65,861 0  
Cost of revenue 34,471 0  
Gross profit 31,390 0  
Depreciation and amortization 2,714 0  
Total assets 626,315 0  
Property and equipment, net $ 44,481 $ 0  
XML 72 R61.htm IDEA: XBRL DOCUMENT v3.26.1
SEGMENT REPORTING - Summary of Service Revenues Classifications by Major Geographic Areas (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Segment Reporting Information [Line Items]    
Revenue $ 488,029 $ 234,215
Operating Segments    
Segment Reporting Information [Line Items]    
Revenue 488,029 234,215
Operating Segments | Cost-reimbursable contracts    
Segment Reporting Information [Line Items]    
Revenue 459,115 220,772
Operating Segments | Fixed-unit price contracts    
Segment Reporting Information [Line Items]    
Revenue 28,914 13,443
Operating Segments | Public and quasi-public sector    
Segment Reporting Information [Line Items]    
Revenue 151,775 5,903
Operating Segments | Private sector    
Segment Reporting Information [Line Items]    
Revenue 336,254 228,312
Operating Segments | Inspection and Mitigation    
Segment Reporting Information [Line Items]    
Revenue 234,827 234,215
Operating Segments | Inspection and Mitigation | Cost-reimbursable contracts    
Segment Reporting Information [Line Items]    
Revenue 224,526 220,772
Operating Segments | Inspection and Mitigation | Fixed-unit price contracts    
Segment Reporting Information [Line Items]    
Revenue 10,301 13,443
Operating Segments | Inspection and Mitigation | Public and quasi-public sector    
Segment Reporting Information [Line Items]    
Revenue 6,876 5,903
Operating Segments | Inspection and Mitigation | Private sector    
Segment Reporting Information [Line Items]    
Revenue 227,951 228,312
Operating Segments | Consulting Engineering    
Segment Reporting Information [Line Items]    
Revenue 187,341 0
Operating Segments | Consulting Engineering | Cost-reimbursable contracts    
Segment Reporting Information [Line Items]    
Revenue 170,311 0
Operating Segments | Consulting Engineering | Fixed-unit price contracts    
Segment Reporting Information [Line Items]    
Revenue 17,030 0
Operating Segments | Consulting Engineering | Public and quasi-public sector    
Segment Reporting Information [Line Items]    
Revenue 89,505 0
Operating Segments | Consulting Engineering | Private sector    
Segment Reporting Information [Line Items]    
Revenue 97,836 0
Operating Segments | Geospatial    
Segment Reporting Information [Line Items]    
Revenue 65,861 0
Operating Segments | Geospatial | Cost-reimbursable contracts    
Segment Reporting Information [Line Items]    
Revenue 64,278 0
Operating Segments | Geospatial | Fixed-unit price contracts    
Segment Reporting Information [Line Items]    
Revenue 1,583 0
Operating Segments | Geospatial | Public and quasi-public sector    
Segment Reporting Information [Line Items]    
Revenue 55,394 0
Operating Segments | Geospatial | Private sector    
Segment Reporting Information [Line Items]    
Revenue 10,467 0
Operating Segments | United States    
Segment Reporting Information [Line Items]    
Revenue 352,746 145,321
Operating Segments | United States | Inspection and Mitigation    
Segment Reporting Information [Line Items]    
Revenue 134,044 145,321
Operating Segments | United States | Consulting Engineering    
Segment Reporting Information [Line Items]    
Revenue 156,286 0
Operating Segments | United States | Geospatial    
Segment Reporting Information [Line Items]    
Revenue 62,416 0
Operating Segments | Canada    
Segment Reporting Information [Line Items]    
Revenue 98,241 86,528
Operating Segments | Canada | Inspection and Mitigation    
Segment Reporting Information [Line Items]    
Revenue 98,013 86,528
Operating Segments | Canada | Consulting Engineering    
Segment Reporting Information [Line Items]    
Revenue 0 0
Operating Segments | Canada | Geospatial    
Segment Reporting Information [Line Items]    
Revenue 228 0
Operating Segments | Other foreign    
Segment Reporting Information [Line Items]    
Revenue 37,042 2,366
Operating Segments | Other foreign | Inspection and Mitigation    
Segment Reporting Information [Line Items]    
Revenue 2,770 2,366
Operating Segments | Other foreign | Consulting Engineering    
Segment Reporting Information [Line Items]    
Revenue 31,055 0
Operating Segments | Other foreign | Geospatial    
Segment Reporting Information [Line Items]    
Revenue $ 3,217 $ 0
XML 73 R62.htm IDEA: XBRL DOCUMENT v3.26.1
RELATED PARTIES (Details) - USD ($)
$ in Millions
3 Months Ended
Jul. 30, 2025
Jul. 30, 2024
Mar. 31, 2026
Mar. 31, 2025
Related Party Transaction [Line Items]        
Automatic renews for successive terms (in years) 1 year      
Prior to expiration of term (in days) 90 days      
Series A Preferred Stock        
Related Party Transaction [Line Items]        
Common stock dividends, (in shares)     0  
Mariposa Capital, LLC        
Related Party Transaction [Line Items]        
Advisory fees   $ 2.0 $ 0.5 $ 0.5
XML 74 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ .report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } .report table.authRefData a { display: block; font-weight: bold; } .report table.authRefData p { margin-top: 0px; } .report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } .report table.authRefData .hide a:hover { background-color: #2F4497; } .report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } .report table.authRefData table{ font-size: 1em; } /* Report Styles */ .pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ .report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } .report hr { border: 1px solid #acf; } /* Top labels */ .report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } .report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } .report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } .report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } .report td.pl div.a { width: 200px; } .report td.pl a:hover { background-color: #ffc; } /* Header rows... */ .report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ .report .rc { background-color: #f0f0f0; } /* Even rows... */ .report .re, .report .reu { background-color: #def; } .report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ .report .ro, .report .rou { background-color: white; } .report .rou td { border-bottom: 1px solid black; } .report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ .report .fn { white-space: nowrap; } /* styles for numeric types */ .report .num, .report .nump { text-align: right; white-space: nowrap; } .report .nump { padding-left: 2em; } .report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ .report .text { text-align: left; white-space: normal; } .report .text .big { margin-bottom: 1em; width: 17em; } .report .text .more { display: none; } .report .text .note { font-style: italic; font-weight: bold; } .report .text .small { width: 10em; } .report sup { font-style: italic; } .report .outerFootnotes { font-size: 1em; } XML 75 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 77 FilingSummary.xml IDEA: XBRL DOCUMENT 3.26.1 html 265 289 1 false 79 0 false 9 false false R1.htm 0000001 - Document - Cover page Sheet http://www.acuren.com/role/Coverpage Cover page Cover 1 false false R2.htm 9952151 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.acuren.com/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 9952152 - Statement - Condensed Consolidated Balance Sheets (Parentheticals) Sheet http://www.acuren.com/role/CondensedConsolidatedBalanceSheetsParentheticals Condensed Consolidated Balance Sheets (Parentheticals) Statements 3 false false R4.htm 9952153 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss Sheet http://www.acuren.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss Condensed Consolidated Statements of Operations and Comprehensive Loss Statements 4 false false R5.htm 9952154 - Statement - Condensed Consolidated Statements of Stockholders??? Equity Sheet http://www.acuren.com/role/CondensedConsolidatedStatementsofStockholdersEquity Condensed Consolidated Statements of Stockholders??? Equity Statements 5 false false R6.htm 9952155 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.acuren.com/role/CondensedConsolidatedStatementsofCashFlows Condensed Consolidated Statements of Cash Flows Statements 6 false false R7.htm 9952156 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.acuren.com/role/BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIES BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES Notes 7 false false R8.htm 9952157 - Disclosure - BUSINESS COMBINATIONS Sheet http://www.acuren.com/role/BUSINESSCOMBINATIONS BUSINESS COMBINATIONS Notes 8 false false R9.htm 9952158 - Disclosure - STOCKHOLDERS??? EQUITY Sheet http://www.acuren.com/role/STOCKHOLDERSEQUITY STOCKHOLDERS??? EQUITY Notes 9 false false R10.htm 9952159 - Disclosure - EARNINGS PER SHARE Sheet http://www.acuren.com/role/EARNINGSPERSHARE EARNINGS PER SHARE Notes 10 false false R11.htm 9952160 - Disclosure - ACCOUNTS RECEIVABLE AND CONTRACT ASSETS Sheet http://www.acuren.com/role/ACCOUNTSRECEIVABLEANDCONTRACTASSETS ACCOUNTS RECEIVABLE AND CONTRACT ASSETS Notes 11 false false R12.htm 9952161 - Disclosure - PROPERTY AND EQUIPMENT Sheet http://www.acuren.com/role/PROPERTYANDEQUIPMENT PROPERTY AND EQUIPMENT Notes 12 false false R13.htm 9952162 - Disclosure - GOODWILL Sheet http://www.acuren.com/role/GOODWILL GOODWILL Notes 13 false false R14.htm 9952163 - Disclosure - INTANGIBLE ASSETS Sheet http://www.acuren.com/role/INTANGIBLEASSETS INTANGIBLE ASSETS Notes 14 false false R15.htm 9952164 - Disclosure - ACCRUED EXPENSES AND OTHER LIABILITIES Sheet http://www.acuren.com/role/ACCRUEDEXPENSESANDOTHERLIABILITIES ACCRUED EXPENSES AND OTHER LIABILITIES Notes 15 false false R16.htm 9952165 - Disclosure - FAIR VALUE MEASUREMENTS Sheet http://www.acuren.com/role/FAIRVALUEMEASUREMENTS FAIR VALUE MEASUREMENTS Notes 16 false false R17.htm 9952166 - Disclosure - LONG-TERM DEBT Sheet http://www.acuren.com/role/LONGTERMDEBT LONG-TERM DEBT Notes 17 false false R18.htm 9952167 - Disclosure - FINANCIAL INSTRUMENTS Sheet http://www.acuren.com/role/FINANCIALINSTRUMENTS FINANCIAL INSTRUMENTS Notes 18 false false R19.htm 9952168 - Disclosure - INCOME TAXES Sheet http://www.acuren.com/role/INCOMETAXES INCOME TAXES Notes 19 false false R20.htm 9952169 - Disclosure - STOCK-BASED COMPENSATION Sheet http://www.acuren.com/role/STOCKBASEDCOMPENSATION STOCK-BASED COMPENSATION Notes 20 false false R21.htm 9952170 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://www.acuren.com/role/COMMITMENTSANDCONTINGENCIES COMMITMENTS AND CONTINGENCIES Notes 21 false false R22.htm 9952171 - Disclosure - SEGMENT REPORTING Sheet http://www.acuren.com/role/SEGMENTREPORTING SEGMENT REPORTING Notes 22 false false R23.htm 9952172 - Disclosure - RELATED PARTIES Sheet http://www.acuren.com/role/RELATEDPARTIES RELATED PARTIES Notes 23 false false R24.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 24 false false R25.htm 9955511 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.acuren.com/role/BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 25 false false R26.htm 9955512 - Disclosure - BUSINESS COMBINATIONS (Tables) Sheet http://www.acuren.com/role/BUSINESSCOMBINATIONSTables BUSINESS COMBINATIONS (Tables) Tables http://www.acuren.com/role/BUSINESSCOMBINATIONS 26 false false R27.htm 9955513 - Disclosure - EARNINGS PER SHARE (Tables) Sheet http://www.acuren.com/role/EARNINGSPERSHARETables EARNINGS PER SHARE (Tables) Tables http://www.acuren.com/role/EARNINGSPERSHARE 27 false false R28.htm 9955514 - Disclosure - ACCOUNTS RECEIVABLE AND CONTRACT ASSETS (Tables) Sheet http://www.acuren.com/role/ACCOUNTSRECEIVABLEANDCONTRACTASSETSTables ACCOUNTS RECEIVABLE AND CONTRACT ASSETS (Tables) Tables http://www.acuren.com/role/ACCOUNTSRECEIVABLEANDCONTRACTASSETS 28 false false R29.htm 9955515 - Disclosure - PROPERTY AND EQUIPMENT (Tables) Sheet http://www.acuren.com/role/PROPERTYANDEQUIPMENTTables PROPERTY AND EQUIPMENT (Tables) Tables http://www.acuren.com/role/PROPERTYANDEQUIPMENT 29 false false R30.htm 9955516 - Disclosure - GOODWILL (Tables) Sheet http://www.acuren.com/role/GOODWILLTables GOODWILL (Tables) Tables http://www.acuren.com/role/GOODWILL 30 false false R31.htm 9955517 - Disclosure - INTANGIBLE ASSETS (Tables) Sheet http://www.acuren.com/role/INTANGIBLEASSETSTables INTANGIBLE ASSETS (Tables) Tables http://www.acuren.com/role/INTANGIBLEASSETS 31 false false R32.htm 9955518 - Disclosure - ACCRUED EXPENSES AND OTHER LIABILITIES (Tables) Sheet http://www.acuren.com/role/ACCRUEDEXPENSESANDOTHERLIABILITIESTables ACCRUED EXPENSES AND OTHER LIABILITIES (Tables) Tables http://www.acuren.com/role/ACCRUEDEXPENSESANDOTHERLIABILITIES 32 false false R33.htm 9955519 - Disclosure - LONG-TERM DEBT (Tables) Sheet http://www.acuren.com/role/LONGTERMDEBTTables LONG-TERM DEBT (Tables) Tables http://www.acuren.com/role/LONGTERMDEBT 33 false false R34.htm 9955520 - Disclosure - STOCK-BASED COMPENSATION (Tables) Sheet http://www.acuren.com/role/STOCKBASEDCOMPENSATIONTables STOCK-BASED COMPENSATION (Tables) Tables http://www.acuren.com/role/STOCKBASEDCOMPENSATION 34 false false R35.htm 9955521 - Disclosure - SEGMENT REPORTING (Tables) Sheet http://www.acuren.com/role/SEGMENTREPORTINGTables SEGMENT REPORTING (Tables) Tables http://www.acuren.com/role/SEGMENTREPORTING 35 false false R36.htm 9955522 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Details) Sheet http://www.acuren.com/role/BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESDetails BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Details) Details http://www.acuren.com/role/BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies 36 false false R37.htm 9955523 - Disclosure - BUSINESS COMBINATIONS - Narrative (Details) Sheet http://www.acuren.com/role/BUSINESSCOMBINATIONSNarrativeDetails BUSINESS COMBINATIONS - Narrative (Details) Details 37 false false R38.htm 9955524 - Disclosure - BUSINESS COMBINATIONS - Summary of Fair Value of Consideration Transferred (Details) Sheet http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofFairValueofConsiderationTransferredDetails BUSINESS COMBINATIONS - Summary of Fair Value of Consideration Transferred (Details) Details 38 false false R39.htm 9955525 - Disclosure - BUSINESS COMBINATIONS - Summary of Preliminary Fair Value of the Identifiable Intangible Assets (Details) Sheet http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofPreliminaryFairValueoftheIdentifiableIntangibleAssetsDetails BUSINESS COMBINATIONS - Summary of Preliminary Fair Value of the Identifiable Intangible Assets (Details) Details 39 false false R40.htm 9955526 - Disclosure - BUSINESS COMBINATIONS - Summary of Pro Forma Consolidated Financial Information (Details) Sheet http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofProFormaConsolidatedFinancialInformationDetails BUSINESS COMBINATIONS - Summary of Pro Forma Consolidated Financial Information (Details) Details 40 false false R41.htm 9955527 - Disclosure - STOCKHOLDERS??? EQUITY - Preferred Stock Narrative (Details) Sheet http://www.acuren.com/role/STOCKHOLDERSEQUITYPreferredStockNarrativeDetails STOCKHOLDERS??? EQUITY - Preferred Stock Narrative (Details) Details 41 false false R42.htm 9955528 - Disclosure - STOCKHOLDERS??? EQUITY - Warrants Narrative (Details) Sheet http://www.acuren.com/role/STOCKHOLDERSEQUITYWarrantsNarrativeDetails STOCKHOLDERS??? EQUITY - Warrants Narrative (Details) Details 42 false false R43.htm 9955529 - Disclosure - EARNINGS PER SHARE - Summary of Basic and Diluted Earnings Per Share (Details) Sheet http://www.acuren.com/role/EARNINGSPERSHARESummaryofBasicandDilutedEarningsPerShareDetails EARNINGS PER SHARE - Summary of Basic and Diluted Earnings Per Share (Details) Details 43 false false R44.htm 9955530 - Disclosure - EARNINGS PER SHARE - Summary of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) Sheet http://www.acuren.com/role/EARNINGSPERSHARESummaryofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails EARNINGS PER SHARE - Summary of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) Details 44 false false R45.htm 9955531 - Disclosure - ACCOUNTS RECEIVABLE AND CONTRACT ASSETS (Details) Sheet http://www.acuren.com/role/ACCOUNTSRECEIVABLEANDCONTRACTASSETSDetails ACCOUNTS RECEIVABLE AND CONTRACT ASSETS (Details) Details http://www.acuren.com/role/ACCOUNTSRECEIVABLEANDCONTRACTASSETSTables 45 false false R46.htm 9955532 - Disclosure - PROPERTY AND EQUIPMENT - Summary of Property and Equipment (Details) Sheet http://www.acuren.com/role/PROPERTYANDEQUIPMENTSummaryofPropertyandEquipmentDetails PROPERTY AND EQUIPMENT - Summary of Property and Equipment (Details) Details 46 false false R47.htm 9955533 - Disclosure - PROPERTY AND EQUIPMENT - Depreciation (Details) Sheet http://www.acuren.com/role/PROPERTYANDEQUIPMENTDepreciationDetails PROPERTY AND EQUIPMENT - Depreciation (Details) Details 47 false false R48.htm 9955534 - Disclosure - GOODWILL (Details) Sheet http://www.acuren.com/role/GOODWILLDetails GOODWILL (Details) Details http://www.acuren.com/role/GOODWILLTables 48 false false R49.htm 9955535 - Disclosure - INTANGIBLE ASSETS - Summary of Intangible Assets and Amortization Expense (Details) Sheet http://www.acuren.com/role/INTANGIBLEASSETSSummaryofIntangibleAssetsandAmortizationExpenseDetails INTANGIBLE ASSETS - Summary of Intangible Assets and Amortization Expense (Details) Details 49 false false R50.htm 9955536 - Disclosure - INTANGIBLE ASSETS - Narrative (Details) Sheet http://www.acuren.com/role/INTANGIBLEASSETSNarrativeDetails INTANGIBLE ASSETS - Narrative (Details) Details 50 false false R51.htm 9955537 - Disclosure - ACCRUED EXPENSES AND OTHER LIABILITIES - Summary of Accrued Expenses and Other Liabilities (Details) Sheet http://www.acuren.com/role/ACCRUEDEXPENSESANDOTHERLIABILITIESSummaryofAccruedExpensesandOtherLiabilitiesDetails ACCRUED EXPENSES AND OTHER LIABILITIES - Summary of Accrued Expenses and Other Liabilities (Details) Details 51 false false R52.htm 9955538 - Disclosure - ACCRUED EXPENSES AND OTHER LIABILITIES - Narrative (Details) Sheet http://www.acuren.com/role/ACCRUEDEXPENSESANDOTHERLIABILITIESNarrativeDetails ACCRUED EXPENSES AND OTHER LIABILITIES - Narrative (Details) Details 52 false false R53.htm 9955539 - Disclosure - LONG-TERM DEBT - Summary of Long-Term Debt (Details) Sheet http://www.acuren.com/role/LONGTERMDEBTSummaryofLongTermDebtDetails LONG-TERM DEBT - Summary of Long-Term Debt (Details) Details 53 false false R54.htm 9955540 - Disclosure - LONG-TERM DEBT - Narrative (Details) Sheet http://www.acuren.com/role/LONGTERMDEBTNarrativeDetails LONG-TERM DEBT - Narrative (Details) Details 54 false false R55.htm 9955541 - Disclosure - INCOME TAXES (Details) Sheet http://www.acuren.com/role/INCOMETAXESDetails INCOME TAXES (Details) Details http://www.acuren.com/role/INCOMETAXES 55 false false R56.htm 9955542 - Disclosure - STOCK-BASED COMPENSATION - Narrative (Details) Sheet http://www.acuren.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails STOCK-BASED COMPENSATION - Narrative (Details) Details 56 false false R57.htm 9955543 - Disclosure - STOCK-BASED COMPENSATION - Summary of Activities of RSUs (Details) Sheet http://www.acuren.com/role/STOCKBASEDCOMPENSATIONSummaryofActivitiesofRSUsDetails STOCK-BASED COMPENSATION - Summary of Activities of RSUs (Details) Details 57 false false R58.htm 9955544 - Disclosure - STOCK-BASED COMPENSATION - Summary of Activities of Restricted Stock Awards (Details) Sheet http://www.acuren.com/role/STOCKBASEDCOMPENSATIONSummaryofActivitiesofRestrictedStockAwardsDetails STOCK-BASED COMPENSATION - Summary of Activities of Restricted Stock Awards (Details) Details 58 false false R59.htm 9955545 - Disclosure - SEGMENT REPORTING - Narrative (Details) Sheet http://www.acuren.com/role/SEGMENTREPORTINGNarrativeDetails SEGMENT REPORTING - Narrative (Details) Details 59 false false R60.htm 9955546 - Disclosure - SEGMENT REPORTING - Summary of Financial Information For each of the Company???s Reportable Segments (Details) Sheet http://www.acuren.com/role/SEGMENTREPORTINGSummaryofFinancialInformationForeachoftheCompanysReportableSegmentsDetails SEGMENT REPORTING - Summary of Financial Information For each of the Company???s Reportable Segments (Details) Details 60 false false R61.htm 9955547 - Disclosure - SEGMENT REPORTING - Summary of Service Revenues Classifications by Major Geographic Areas (Details) Sheet http://www.acuren.com/role/SEGMENTREPORTINGSummaryofServiceRevenuesClassificationsbyMajorGeographicAreasDetails SEGMENT REPORTING - Summary of Service Revenues Classifications by Major Geographic Areas (Details) Details 61 false false R62.htm 9955548 - Disclosure - RELATED PARTIES (Details) Sheet http://www.acuren.com/role/RELATEDPARTIESDetails RELATED PARTIES (Details) Details http://www.acuren.com/role/RELATEDPARTIES 62 false false All Reports Book All Reports tic-20260331.htm tic-20260331.xsd tic-20260331_cal.xml tic-20260331_def.xml tic-20260331_lab.xml tic-20260331_pre.xml http://fasb.org/srt/2025 http://fasb.org/us-gaap/2025 http://xbrl.sec.gov/dei/2025 http://xbrl.sec.gov/ecd/2025 true true JSON 80 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "tic-20260331.htm": { "nsprefix": "tic", "nsuri": "http://www.acuren.com/20260331", "dts": { "inline": { "local": [ "tic-20260331.htm" ] }, "schema": { "local": [ "tic-20260331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/2023/calculation-1.1.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd", "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd", "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd", "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd", "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd", "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd", "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd", "https://xbrl.sec.gov/country/2025/country-2025.xsd", "https://xbrl.sec.gov/dei/2025/dei-2025.xsd", "https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd", "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd" ] }, "calculationLink": { "local": [ "tic-20260331_cal.xml" ] }, "definitionLink": { "local": [ "tic-20260331_def.xml" ] }, "labelLink": { "local": [ "tic-20260331_lab.xml" ] }, "presentationLink": { "local": [ "tic-20260331_pre.xml" ] } }, "keyStandard": 258, "keyCustom": 31, "axisStandard": 27, "axisCustom": 0, "memberStandard": 38, "memberCustom": 27, "hidden": { "total": 6, "http://fasb.org/us-gaap/2025": 1, "http://xbrl.sec.gov/dei/2025": 5 }, "contextCount": 265, "entityCount": 1, "segmentCount": 79, "elementCount": 580, "unitCount": 9, "baseTaxonomies": { "http://fasb.org/us-gaap/2025": 751, "http://xbrl.sec.gov/dei/2025": 30, "http://xbrl.sec.gov/ecd/2025": 4, "http://fasb.org/srt/2025": 1 }, "report": { "R1": { "role": "http://www.acuren.com/role/Coverpage", "longName": "0000001 - Document - Cover page", "shortName": "Cover page", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true } }, "R2": { "role": "http://www.acuren.com/role/CondensedConsolidatedBalanceSheets", "longName": "9952151 - Statement - Condensed Consolidated Balance Sheets", "shortName": "Condensed Consolidated Balance Sheets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true } }, "R3": { "role": "http://www.acuren.com/role/CondensedConsolidatedBalanceSheetsParentheticals", "longName": "9952152 - Statement - Condensed Consolidated Balance Sheets (Parentheticals)", "shortName": "Condensed Consolidated Balance Sheets (Parentheticals)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true }, "uniqueAnchor": null }, "R4": { "role": "http://www.acuren.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss", "longName": "9952153 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss", "shortName": "Condensed Consolidated Statements of Operations and Comprehensive Loss", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SellingGeneralAndAdministrativeExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "unique": true } }, "R5": { "role": "http://www.acuren.com/role/CondensedConsolidatedStatementsofStockholdersEquity", "longName": "9952154 - Statement - Condensed Consolidated Statements of Stockholders\u2019 Equity", "shortName": "Condensed Consolidated Statements of Stockholders\u2019 Equity", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "c-24", "name": "us-gaap:CommonStockSharesOutstanding", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-24", "name": "us-gaap:CommonStockSharesOutstanding", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true } }, "R6": { "role": "http://www.acuren.com/role/CondensedConsolidatedStatementsofCashFlows", "longName": "9952155 - Statement - Condensed Consolidated Statements of Cash Flows", "shortName": "Condensed Consolidated Statements of Cash Flows", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "tic:NoncashLeaseExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "unique": true } }, "R7": { "role": "http://www.acuren.com/role/BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIES", "longName": "9952156 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES", "shortName": "BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "7", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true } }, "R8": { "role": "http://www.acuren.com/role/BUSINESSCOMBINATIONS", "longName": "9952157 - Disclosure - BUSINESS COMBINATIONS", "shortName": "BUSINESS COMBINATIONS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true } }, "R9": { "role": "http://www.acuren.com/role/STOCKHOLDERSEQUITY", "longName": "9952158 - Disclosure - STOCKHOLDERS\u2019 EQUITY", "shortName": "STOCKHOLDERS\u2019 EQUITY", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true } }, "R10": { "role": "http://www.acuren.com/role/EARNINGSPERSHARE", "longName": "9952159 - Disclosure - EARNINGS PER SHARE", "shortName": "EARNINGS PER SHARE", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true } }, "R11": { "role": "http://www.acuren.com/role/ACCOUNTSRECEIVABLEANDCONTRACTASSETS", "longName": "9952160 - Disclosure - ACCOUNTS RECEIVABLE AND CONTRACT ASSETS", "shortName": "ACCOUNTS RECEIVABLE AND CONTRACT ASSETS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true } }, "R12": { "role": "http://www.acuren.com/role/PROPERTYANDEQUIPMENT", "longName": "9952161 - Disclosure - PROPERTY AND EQUIPMENT", "shortName": "PROPERTY AND EQUIPMENT", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true } }, "R13": { "role": "http://www.acuren.com/role/GOODWILL", "longName": "9952162 - Disclosure - GOODWILL", "shortName": "GOODWILL", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.acuren.com/role/INTANGIBLEASSETS", "longName": "9952163 - Disclosure - INTANGIBLE ASSETS", "shortName": "INTANGIBLE ASSETS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true } }, "R15": { "role": "http://www.acuren.com/role/ACCRUEDEXPENSESANDOTHERLIABILITIES", "longName": "9952164 - Disclosure - ACCRUED EXPENSES AND OTHER LIABILITIES", "shortName": "ACCRUED EXPENSES AND OTHER LIABILITIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true } }, "R16": { "role": "http://www.acuren.com/role/FAIRVALUEMEASUREMENTS", "longName": "9952165 - Disclosure - FAIR VALUE MEASUREMENTS", "shortName": "FAIR VALUE MEASUREMENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true } }, "R17": { "role": "http://www.acuren.com/role/LONGTERMDEBT", "longName": "9952166 - Disclosure - LONG-TERM DEBT", "shortName": "LONG-TERM DEBT", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true } }, "R18": { "role": "http://www.acuren.com/role/FINANCIALINSTRUMENTS", "longName": "9952167 - Disclosure - FINANCIAL INSTRUMENTS", "shortName": "FINANCIAL INSTRUMENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true } }, "R19": { "role": "http://www.acuren.com/role/INCOMETAXES", "longName": "9952168 - Disclosure - INCOME TAXES", "shortName": "INCOME TAXES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true } }, "R20": { "role": "http://www.acuren.com/role/STOCKBASEDCOMPENSATION", "longName": "9952169 - Disclosure - STOCK-BASED COMPENSATION", "shortName": "STOCK-BASED COMPENSATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true } }, "R21": { "role": "http://www.acuren.com/role/COMMITMENTSANDCONTINGENCIES", "longName": "9952170 - Disclosure - COMMITMENTS AND CONTINGENCIES", "shortName": "COMMITMENTS AND CONTINGENCIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true } }, "R22": { "role": "http://www.acuren.com/role/SEGMENTREPORTING", "longName": "9952171 - Disclosure - SEGMENT REPORTING", "shortName": "SEGMENT REPORTING", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true } }, "R23": { "role": "http://www.acuren.com/role/RELATEDPARTIES", "longName": "9952172 - Disclosure - RELATED PARTIES", "shortName": "RELATED PARTIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true } }, "R24": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "24", "firstAnchor": { "contextRef": "c-1", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true } }, "R25": { "role": "http://www.acuren.com/role/BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies", "longName": "9955511 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Policies)", "shortName": "BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "25", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true } }, "R26": { "role": "http://www.acuren.com/role/BUSINESSCOMBINATIONSTables", "longName": "9955512 - Disclosure - BUSINESS COMBINATIONS (Tables)", "shortName": "BUSINESS COMBINATIONS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "26", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true } }, "R27": { "role": "http://www.acuren.com/role/EARNINGSPERSHARETables", "longName": "9955513 - Disclosure - EARNINGS PER SHARE (Tables)", "shortName": "EARNINGS PER SHARE (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "27", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true } }, "R28": { "role": "http://www.acuren.com/role/ACCOUNTSRECEIVABLEANDCONTRACTASSETSTables", "longName": "9955514 - Disclosure - ACCOUNTS RECEIVABLE AND CONTRACT ASSETS (Tables)", "shortName": "ACCOUNTS RECEIVABLE AND CONTRACT ASSETS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "28", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true } }, "R29": { "role": "http://www.acuren.com/role/PROPERTYANDEQUIPMENTTables", "longName": "9955515 - Disclosure - PROPERTY AND EQUIPMENT (Tables)", "shortName": "PROPERTY AND EQUIPMENT (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "29", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true } }, "R30": { "role": "http://www.acuren.com/role/GOODWILLTables", "longName": "9955516 - Disclosure - GOODWILL (Tables)", "shortName": "GOODWILL (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "30", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true } }, "R31": { "role": "http://www.acuren.com/role/INTANGIBLEASSETSTables", "longName": "9955517 - Disclosure - INTANGIBLE ASSETS (Tables)", "shortName": "INTANGIBLE ASSETS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "31", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true } }, "R32": { "role": "http://www.acuren.com/role/ACCRUEDEXPENSESANDOTHERLIABILITIESTables", "longName": "9955518 - Disclosure - ACCRUED EXPENSES AND OTHER LIABILITIES (Tables)", "shortName": "ACCRUED EXPENSES AND OTHER LIABILITIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true } }, "R33": { "role": "http://www.acuren.com/role/LONGTERMDEBTTables", "longName": "9955519 - Disclosure - LONG-TERM DEBT (Tables)", "shortName": "LONG-TERM DEBT (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "33", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true } }, "R34": { "role": "http://www.acuren.com/role/STOCKBASEDCOMPENSATIONTables", "longName": "9955520 - Disclosure - STOCK-BASED COMPENSATION (Tables)", "shortName": "STOCK-BASED COMPENSATION (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "34", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true } }, "R35": { "role": "http://www.acuren.com/role/SEGMENTREPORTINGTables", "longName": "9955521 - Disclosure - SEGMENT REPORTING (Tables)", "shortName": "SEGMENT REPORTING (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "35", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true } }, "R36": { "role": "http://www.acuren.com/role/BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESDetails", "longName": "9955522 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Details)", "shortName": "BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "36", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:RevenueRemainingPerformanceObligation", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-8", "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:RevenueRemainingPerformanceObligation", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-8", "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true } }, "R37": { "role": "http://www.acuren.com/role/BUSINESSCOMBINATIONSNarrativeDetails", "longName": "9955523 - Disclosure - BUSINESS COMBINATIONS - Narrative (Details)", "shortName": "BUSINESS COMBINATIONS - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "37", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:Goodwill", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-40", "name": "us-gaap:BusinessCombinationConsiderationTransferred1", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "unique": true } }, "R38": { "role": "http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofFairValueofConsiderationTransferredDetails", "longName": "9955524 - Disclosure - BUSINESS COMBINATIONS - Summary of Fair Value of Consideration Transferred (Details)", "shortName": "BUSINESS COMBINATIONS - Summary of Fair Value of Consideration Transferred (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:Goodwill", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-44", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "unique": true } }, "R39": { "role": "http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofPreliminaryFairValueoftheIdentifiableIntangibleAssetsDetails", "longName": "9955525 - Disclosure - BUSINESS COMBINATIONS - Summary of Preliminary Fair Value of the Identifiable Intangible Assets (Details)", "shortName": "BUSINESS COMBINATIONS - Summary of Preliminary Fair Value of the Identifiable Intangible Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "c-54", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-50", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "unique": true } }, "R40": { "role": "http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofProFormaConsolidatedFinancialInformationDetails", "longName": "9955526 - Disclosure - BUSINESS COMBINATIONS - Summary of Pro Forma Consolidated Financial Information (Details)", "shortName": "BUSINESS COMBINATIONS - Summary of Pro Forma Consolidated Financial Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true } }, "R41": { "role": "http://www.acuren.com/role/STOCKHOLDERSEQUITYPreferredStockNarrativeDetails", "longName": "9955527 - Disclosure - STOCKHOLDERS\u2019 EQUITY - Preferred Stock Narrative (Details)", "shortName": "STOCKHOLDERS\u2019 EQUITY - Preferred Stock Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "c-64", "name": "us-gaap:CommonStockSharesAuthorized", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-64", "name": "us-gaap:CommonStockSharesAuthorized", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true } }, "R42": { "role": "http://www.acuren.com/role/STOCKHOLDERSEQUITYWarrantsNarrativeDetails", "longName": "9955528 - Disclosure - STOCKHOLDERS\u2019 EQUITY - Warrants Narrative (Details)", "shortName": "STOCKHOLDERS\u2019 EQUITY - Warrants Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "us-gaap:CommonStockParOrStatedValuePerShare", "tic:NumberOfAuthorizedSharesNotDisclosed", "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "unique": true } }, "R43": { "role": "http://www.acuren.com/role/EARNINGSPERSHARESummaryofBasicandDilutedEarningsPerShareDetails", "longName": "9955529 - Disclosure - EARNINGS PER SHARE - Summary of Basic and Diluted Earnings Per Share (Details)", "shortName": "EARNINGS PER SHARE - Summary of Basic and Diluted Earnings Per Share (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:UndistributedEarningsDiluted", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "unique": true } }, "R44": { "role": "http://www.acuren.com/role/EARNINGSPERSHARESummaryofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails", "longName": "9955530 - Disclosure - EARNINGS PER SHARE - Summary of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details)", "shortName": "EARNINGS PER SHARE - Summary of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "c-81", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-81", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true } }, "R45": { "role": "http://www.acuren.com/role/ACCOUNTSRECEIVABLEANDCONTRACTASSETSDetails", "longName": "9955531 - Disclosure - ACCOUNTS RECEIVABLE AND CONTRACT ASSETS (Details)", "shortName": "ACCOUNTS RECEIVABLE AND CONTRACT ASSETS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:AccountsReceivableGrossCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:AccountsReceivableGrossCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true } }, "R46": { "role": "http://www.acuren.com/role/PROPERTYANDEQUIPMENTSummaryofPropertyandEquipmentDetails", "longName": "9955532 - Disclosure - PROPERTY AND EQUIPMENT - Summary of Property and Equipment (Details)", "shortName": "PROPERTY AND EQUIPMENT - Summary of Property and Equipment (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:PropertyPlantAndEquipmentTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:PropertyPlantAndEquipmentTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true } }, "R47": { "role": "http://www.acuren.com/role/PROPERTYANDEQUIPMENTDepreciationDetails", "longName": "9955533 - Disclosure - PROPERTY AND EQUIPMENT - Depreciation (Details)", "shortName": "PROPERTY AND EQUIPMENT - Depreciation (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:Depreciation", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:PropertyPlantAndEquipmentTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:Depreciation", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:PropertyPlantAndEquipmentTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true } }, "R48": { "role": "http://www.acuren.com/role/GOODWILLDetails", "longName": "9955534 - Disclosure - GOODWILL (Details)", "shortName": "GOODWILL (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:Goodwill", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfGoodwillTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillAcquiredDuringPeriod", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfGoodwillTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "unique": true } }, "R49": { "role": "http://www.acuren.com/role/INTANGIBLEASSETSSummaryofIntangibleAssetsandAmortizationExpenseDetails", "longName": "9955535 - Disclosure - INTANGIBLE ASSETS - Summary of Intangible Assets and Amortization Expense (Details)", "shortName": "INTANGIBLE ASSETS - Summary of Intangible Assets and Amortization Expense (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true } }, "R50": { "role": "http://www.acuren.com/role/INTANGIBLEASSETSNarrativeDetails", "longName": "9955536 - Disclosure - INTANGIBLE ASSETS - Narrative (Details)", "shortName": "INTANGIBLE ASSETS - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:AmortizationOfIntangibleAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:AmortizationOfIntangibleAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true } }, "R51": { "role": "http://www.acuren.com/role/ACCRUEDEXPENSESANDOTHERLIABILITIESSummaryofAccruedExpensesandOtherLiabilitiesDetails", "longName": "9955537 - Disclosure - ACCRUED EXPENSES AND OTHER LIABILITIES - Summary of Accrued Expenses and Other Liabilities (Details)", "shortName": "ACCRUED EXPENSES AND OTHER LIABILITIES - Summary of Accrued Expenses and Other Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true } }, "R52": { "role": "http://www.acuren.com/role/ACCRUEDEXPENSESANDOTHERLIABILITIESNarrativeDetails", "longName": "9955538 - Disclosure - ACCRUED EXPENSES AND OTHER LIABILITIES - Narrative (Details)", "shortName": "ACCRUED EXPENSES AND OTHER LIABILITIES - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true } }, "R53": { "role": "http://www.acuren.com/role/LONGTERMDEBTSummaryofLongTermDebtDetails", "longName": "9955539 - Disclosure - LONG-TERM DEBT - Summary of Long-Term Debt (Details)", "shortName": "LONG-TERM DEBT - Summary of Long-Term Debt (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfDebtTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfDebtTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true } }, "R54": { "role": "http://www.acuren.com/role/LONGTERMDEBTNarrativeDetails", "longName": "9955540 - Disclosure - LONG-TERM DEBT - Narrative (Details)", "shortName": "LONG-TERM DEBT - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "c-160", "name": "us-gaap:AmortizationOfDebtDiscountPremium", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-160", "name": "us-gaap:AmortizationOfDebtDiscountPremium", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true } }, "R55": { "role": "http://www.acuren.com/role/INCOMETAXESDetails", "longName": "9955541 - Disclosure - INCOME TAXES (Details)", "shortName": "INCOME TAXES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeTaxExpenseBenefit", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "unique": true } }, "R56": { "role": "http://www.acuren.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "longName": "9955542 - Disclosure - STOCK-BASED COMPENSATION - Narrative (Details)", "shortName": "STOCK-BASED COMPENSATION - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "c-68", "name": "tic:RestrictedStockConvertibleConversionRatio", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-68", "name": "tic:RestrictedStockConvertibleConversionRatio", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true } }, "R57": { "role": "http://www.acuren.com/role/STOCKBASEDCOMPENSATIONSummaryofActivitiesofRSUsDetails", "longName": "9955543 - Disclosure - STOCK-BASED COMPENSATION - Summary of Activities of RSUs (Details)", "shortName": "STOCK-BASED COMPENSATION - Summary of Activities of RSUs (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "c-174", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-174", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true } }, "R58": { "role": "http://www.acuren.com/role/STOCKBASEDCOMPENSATIONSummaryofActivitiesofRestrictedStockAwardsDetails", "longName": "9955544 - Disclosure - STOCK-BASED COMPENSATION - Summary of Activities of Restricted Stock Awards (Details)", "shortName": "STOCK-BASED COMPENSATION - Summary of Activities of Restricted Stock Awards (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "c-185", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-185", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true } }, "R59": { "role": "http://www.acuren.com/role/SEGMENTREPORTINGNarrativeDetails", "longName": "9955545 - Disclosure - SEGMENT REPORTING - Narrative (Details)", "shortName": "SEGMENT REPORTING - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NumberOfReportableSegments", "unitRef": "segment", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:NumberOfReportableSegments", "unitRef": "segment", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true } }, "R60": { "role": "http://www.acuren.com/role/SEGMENTREPORTINGSummaryofFinancialInformationForeachoftheCompanysReportableSegmentsDetails", "longName": "9955546 - Disclosure - SEGMENT REPORTING - Summary of Financial Information For each of the Company\u2019s Reportable Segments (Details)", "shortName": "SEGMENT REPORTING - Summary of Financial Information For each of the Company\u2019s Reportable Segments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-38", "name": "us-gaap:Assets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "unique": true } }, "R61": { "role": "http://www.acuren.com/role/SEGMENTREPORTINGSummaryofServiceRevenuesClassificationsbyMajorGeographicAreasDetails", "longName": "9955547 - Disclosure - SEGMENT REPORTING - Summary of Service Revenues Classifications by Major Geographic Areas (Details)", "shortName": "SEGMENT REPORTING - Summary of Service Revenues Classifications by Major Geographic Areas (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-249", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "unique": true } }, "R62": { "role": "http://www.acuren.com/role/RELATEDPARTIESDetails", "longName": "9955548 - Disclosure - RELATED PARTIES (Details)", "shortName": "RELATED PARTIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "c-263", "name": "tic:ConsultingServicesAgreementAutomaticRenewsForSuccessiveTerms", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-263", "name": "tic:ConsultingServicesAgreementAutomaticRenewsForSuccessiveTerms", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "tic-20260331.htm", "first": true, "unique": true } } }, "tag": { "tic_A2024CreditAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.acuren.com/20260331", "localname": "A2024CreditAgreementMember", "presentation": [ "http://www.acuren.com/role/LONGTERMDEBTNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2024 Credit Agreement", "label": "2024 Credit Agreement [Member]", "documentation": "2024 Credit Agreement" } } }, "auth_ref": [] }, "tic_A2025BusinessAcquisitionsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.acuren.com/20260331", "localname": "A2025BusinessAcquisitionsMember", "presentation": [ "http://www.acuren.com/role/BUSINESSCOMBINATIONSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2025 Business Acquisitions", "label": "2025 Business Acquisitions [Member]", "documentation": "2025 Business Acquisitions" } } }, "auth_ref": [] }, "tic_A2026BusinessAcquisitionsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.acuren.com/20260331", "localname": "A2026BusinessAcquisitionsMember", "presentation": [ "http://www.acuren.com/role/ACCRUEDEXPENSESANDOTHERLIABILITIESNarrativeDetails", "http://www.acuren.com/role/BUSINESSCOMBINATIONSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2026 Business Acquisitions", "label": "2026 Business Acquisitions [Member]", "documentation": "2026 Business Acquisitions" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "presentation": [ "http://www.acuren.com/role/ACCRUEDEXPENSESANDOTHERLIABILITIES" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued Expenses and Other Liabilities", "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]", "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period." } } }, "auth_ref": [ "r33", "r36", "r40", "r1216" ] }, "tic_AccountsPayableAndAccruedLiabilitiesExcludingTradePayablesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.acuren.com/20260331", "localname": "AccountsPayableAndAccruedLiabilitiesExcludingTradePayablesCurrent", "crdr": "credit", "calculation": { "http://www.acuren.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 }, "http://www.acuren.com/role/ACCRUEDEXPENSESANDOTHERLIABILITIESSummaryofAccruedExpensesandOtherLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.acuren.com/role/ACCRUEDEXPENSESANDOTHERLIABILITIESSummaryofAccruedExpensesandOtherLiabilitiesDetails", "http://www.acuren.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued expenses and other current liabilities", "totalLabel": "Total accrued expenses and other current liabilities", "label": "Accounts Payable And Accrued Liabilities Excluding Trade Payables, Current", "documentation": "Accounts Payable And Accrued Liabilities Excluding Trade Payables, Current" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://www.acuren.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.acuren.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable", "label": "Accounts Payable, Current", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r33", "r972" ] }, "us-gaap_AccountsPayableTradeCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccountsPayableTradeCurrent", "crdr": "credit", "calculation": { "http://www.acuren.com/role/ACCRUEDEXPENSESANDOTHERLIABILITIESSummaryofAccruedExpensesandOtherLiabilitiesDetails": { "parentTag": "tic_AccountsPayableAndAccruedLiabilitiesExcludingTradePayablesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.acuren.com/role/ACCRUEDEXPENSESANDOTHERLIABILITIESSummaryofAccruedExpensesandOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued trade payables", "label": "Accounts Payable, Trade, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r11", "r33" ] }, "us-gaap_AccountsReceivableGrossCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccountsReceivableGrossCurrent", "crdr": "debit", "calculation": { "http://www.acuren.com/role/ACCOUNTSRECEIVABLEANDCONTRACTASSETSDetails": { "parentTag": "us-gaap_ReceivablesNetCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.acuren.com/role/ACCOUNTSRECEIVABLEANDCONTRACTASSETSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts receivables", "label": "Accounts Receivable, before Allowance for Credit Loss, Current", "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r153", "r265", "r870" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://www.acuren.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.acuren.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts receivable, net", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r1138" ] }, "us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccrualForTaxesOtherThanIncomeTaxesCurrent", "crdr": "credit", "calculation": { "http://www.acuren.com/role/ACCRUEDEXPENSESANDOTHERLIABILITIESSummaryofAccruedExpensesandOtherLiabilitiesDetails": { "parentTag": "tic_AccountsPayableAndAccruedLiabilitiesExcludingTradePayablesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.acuren.com/role/ACCRUEDEXPENSESANDOTHERLIABILITIESSummaryofAccruedExpensesandOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued indirect taxes", "label": "Accrual for Taxes Other than Income Taxes, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r36", "r871", "r1216" ] }, "tic_AccruedOperatingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://www.acuren.com/20260331", "localname": "AccruedOperatingExpenses", "crdr": "credit", "calculation": { "http://www.acuren.com/role/ACCRUEDEXPENSESANDOTHERLIABILITIESSummaryofAccruedExpensesandOtherLiabilitiesDetails": { "parentTag": "tic_AccountsPayableAndAccruedLiabilitiesExcludingTradePayablesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.acuren.com/role/ACCRUEDEXPENSESANDOTHERLIABILITIESSummaryofAccruedExpensesandOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued operating expenses", "label": "Accrued Operating Expenses", "documentation": "Accrued Operating Expenses" } } }, "auth_ref": [] }, "tic_AccruedSalesDiscountsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.acuren.com/20260331", "localname": "AccruedSalesDiscountsCurrent", "crdr": "credit", "calculation": { "http://www.acuren.com/role/ACCRUEDEXPENSESANDOTHERLIABILITIESSummaryofAccruedExpensesandOtherLiabilitiesDetails": { "parentTag": "tic_AccountsPayableAndAccruedLiabilitiesExcludingTradePayablesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.acuren.com/role/ACCRUEDEXPENSESANDOTHERLIABILITIESSummaryofAccruedExpensesandOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued sales discounts", "label": "Accrued Sales Discounts, Current", "documentation": "Accrued Sales Discounts, Current" } } }, "auth_ref": [] }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://www.acuren.com/role/PROPERTYANDEQUIPMENTSummaryofPropertyandEquipmentDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.acuren.com/role/PROPERTYANDEQUIPMENTSummaryofPropertyandEquipmentDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Accumulated depreciation", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services." } } }, "auth_ref": [ "r27", "r143", "r708" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.acuren.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.acuren.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated other comprehensive income (loss)", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r12", "r13", "r52", "r154", "r705", "r736", "r737", "r1241" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://www.acuren.com/role/CondensedConsolidatedStatementsofStockholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated \u2028Other \u2028Comprehensive \u2028Income (Loss)", "label": "AOCI Attributable to Parent [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r2", "r8", "r13", "r588", "r591", "r636", "r732", "r733", "r1108", "r1109", "r1110", "r1123", "r1124", "r1125", "r1126" ] }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "presentation": [ "http://www.acuren.com/role/INTANGIBLEASSETSSummaryofIntangibleAssetsandAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average \u2028Remaining \u2028Life (Years)", "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life", "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r297", "r864" ] }, "us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AcquiredIndefiniteLivedIntangibleAssetsLineItems", "presentation": [ "http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofPreliminaryFairValueoftheIdentifiableIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible Asset, Acquired, Indefinite-Lived [Line Items]", "label": "Intangible Asset, Acquired, Indefinite-Lived [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r298" ] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Additional 402(v) Disclosure", "label": "Additional 402(v) Disclosure [Text Block]" } } }, "auth_ref": [ "r1034" ] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://www.acuren.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.acuren.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Additional paid-in capital", "label": "Additional Paid in Capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r46", "r972", "r1296" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://www.acuren.com/role/CondensedConsolidatedStatementsofStockholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Additional \u2028Paid-In \u2028Capital", "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r751", "r1123", "r1124", "r1125", "r1126", "r1242", "r1298" ] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation, Amount", "label": "Adjustment to Compensation Amount" } } }, "auth_ref": [ "r1047" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation:", "label": "Adjustment to Compensation [Axis]" } } }, "auth_ref": [ "r1047" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote", "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]" } } }, "auth_ref": [ "r1047" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment To PEO Compensation, Footnote", "label": "Adjustment To PEO Compensation, Footnote [Text Block]" } } }, "auth_ref": [ "r1047" ] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "crdr": "credit", "presentation": [ "http://www.acuren.com/role/CondensedConsolidatedStatementsofStockholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based compensation expense", "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement." } } }, "auth_ref": [ "r421" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.acuren.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustments to reconcile net loss to cash flows from operating activities:", "label": "Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]" } } }, "auth_ref": [] }, "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table", "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]" } } }, "auth_ref": [ "r1080" ] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Amount", "label": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r1006", "r1016", "r1026", "r1058" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined", "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]" } } }, "auth_ref": [ "r1009", "r1019", "r1029", "r1061" ] }, "ecd_AggtPnsnAdjsSvcCstMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AggtPnsnAdjsSvcCstMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Pension Adjustments Service Cost", "label": "Aggregate Pension Adjustments Service Cost [Member]" } } }, "auth_ref": [ "r1081" ] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Adjustments to Compensation", "label": "All Adjustments to Compensation [Member]" } } }, "auth_ref": [ "r1047" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Executive Categories", "label": "All Executive Categories [Member]" } } }, "auth_ref": [ "r1054" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Individuals", "label": "All Individuals [Member]" } } }, "auth_ref": [ "r1010", "r1020", "r1030", "r1054", "r1062", "r1066", "r1074" ] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "All Trading Arrangements", "label": "All Trading Arrangements [Member]" } } }, "auth_ref": [ "r1072" ] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "presentation": [ "http://www.acuren.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based compensation expense", "label": "Share-Based Payment Arrangement, Expense", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r451", "r457", "r458" ] }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "crdr": "credit", "calculation": { "http://www.acuren.com/role/ACCOUNTSRECEIVABLEANDCONTRACTASSETSDetails": { "parentTag": "us-gaap_ReceivablesNetCurrent", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.acuren.com/role/ACCOUNTSRECEIVABLEANDCONTRACTASSETSDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Allowance for credit losses", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current." } } }, "auth_ref": [ "r155", "r266", "r270" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AmendmentFlag", "presentation": [ "http://www.acuren.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_AmortizationOfDebtDiscountPremium": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AmortizationOfDebtDiscountPremium", "crdr": "debit", "presentation": [ "http://www.acuren.com/role/LONGTERMDEBTNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization expense related to debt issuance costs", "label": "Amortization of Debt Discount (Premium)", "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense." } } }, "auth_ref": [ "r6", "r58", "r363", "r1248" ] }, "us-gaap_AmortizationOfFinancingCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AmortizationOfFinancingCosts", "crdr": "debit", "calculation": { "http://www.acuren.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.acuren.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization of deferred financing costs", "label": "Amortization of Debt Issuance Costs", "documentation": "Amount of amortization expense attributable to debt issuance costs." } } }, "auth_ref": [ "r58", "r363", "r1114", "r1248" ] }, "us-gaap_AmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AmortizationOfIntangibleAssets", "crdr": "debit", "presentation": [ "http://www.acuren.com/role/INTANGIBLEASSETSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization of intangible assets", "label": "Amortization of Intangible Assets", "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets." } } }, "auth_ref": [ "r6", "r169", "r294", "r301", "r868", "r875", "r876", "r878", "r880" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://www.acuren.com/role/EARNINGSPERSHARESummaryofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Securities excluded from computation of diluted loss per share (in shares)", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r220" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "presentation": [ "http://www.acuren.com/role/EARNINGSPERSHARESummaryofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive Securities [Axis]", "label": "Antidilutive Securities [Axis]", "documentation": "Information by type of antidilutive security." } } }, "auth_ref": [ "r220" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "presentation": [ "http://www.acuren.com/role/EARNINGSPERSHARESummaryofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r220" ] }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AntidilutiveSecuritiesNameDomain", "presentation": [ "http://www.acuren.com/role/EARNINGSPERSHARESummaryofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive Securities, Name [Domain]", "label": "Antidilutive Securities, Name [Domain]", "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "auth_ref": [ "r220" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.acuren.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.acuren.com/role/CondensedConsolidatedBalanceSheets", "http://www.acuren.com/role/SEGMENTREPORTINGSummaryofFinancialInformationForeachoftheCompanysReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "Assets", "documentation": "Amount of asset recognized for present right to economic benefit." } } }, "auth_ref": [ "r77", "r87", "r147", "r177", "r180", "r181", "r224", "r234", "r252", "r256", "r267", "r330", "r331", "r333", "r334", "r335", "r336", "r337", "r339", "r340", "r552", "r555", "r617", "r692", "r693", "r700", "r789", "r890", "r891", "r903", "r972", "r986", "r987", "r997", "r1174", "r1175", "r1251" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AssetsAbstract", "presentation": [ "http://www.acuren.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Assets", "label": "Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://www.acuren.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.acuren.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Assets, Current", "documentation": "Amount of asset recognized for present right to economic benefit, classified as current." } } }, "auth_ref": [ "r139", "r156", "r177", "r180", "r181", "r267", "r330", "r331", "r333", "r334", "r335", "r336", "r337", "r339", "r340", "r552", "r555", "r617", "r972", "r1174", "r1175", "r1251" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AssetsCurrentAbstract", "presentation": [ "http://www.acuren.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Current assets", "label": "Assets, Current [Abstract]" } } }, "auth_ref": [] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise Price", "label": "Award Exercise Price" } } }, "auth_ref": [ "r1069" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value as of Grant Date", "label": "Award Grant Date Fair Value" } } }, "auth_ref": [ "r1070" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardTmgDiscLineItems", "lang": { "en-us": { "role": { "label": "Award Timing Disclosures [Line Items]" } } }, "auth_ref": [ "r1065" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing, How MNPI Considered", "label": "Award Timing, How MNPI Considered [Text Block]" } } }, "auth_ref": [ "r1065" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Method", "label": "Award Timing Method [Text Block]" } } }, "auth_ref": [ "r1065" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Considered", "label": "Award Timing MNPI Considered [Flag]" } } }, "auth_ref": [ "r1065" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Disclosure", "label": "Award Timing MNPI Disclosure [Text Block]" } } }, "auth_ref": [ "r1065" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Predetermined", "label": "Award Timing Predetermined [Flag]" } } }, "auth_ref": [ "r1065" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AwardTypeAxis", "presentation": [ "http://www.acuren.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "http://www.acuren.com/role/STOCKBASEDCOMPENSATIONSummaryofActivitiesofRSUsDetails", "http://www.acuren.com/role/STOCKBASEDCOMPENSATIONSummaryofActivitiesofRestrictedStockAwardsDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type", "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r446", "r447", "r448", "r449", "r450" ] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Securities", "label": "Award Underlying Securities Amount" } } }, "auth_ref": [ "r1068" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Awards Close in Time to MNPI Disclosures, Individual Name" } } }, "auth_ref": [ "r1067" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures", "label": "Awards Close in Time to MNPI Disclosures [Table]" } } }, "auth_ref": [ "r1066" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures, Table", "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]" } } }, "auth_ref": [ "r1066" ] }, "us-gaap_BaseRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BaseRateMember", "presentation": [ "http://www.acuren.com/role/LONGTERMDEBTNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Base Rate", "label": "Base Rate [Member]", "documentation": "Minimum rate investor will accept." } } }, "auth_ref": [ "r1098", "r1172" ] }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BasisOfAccountingPolicyPolicyTextBlock", "presentation": [ "http://www.acuren.com/role/BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Basis of Presentation", "label": "Basis of Accounting, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [ "r1115" ] }, "tic_BuildingAndLeaseholdImprovementsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.acuren.com/20260331", "localname": "BuildingAndLeaseholdImprovementsMember", "presentation": [ "http://www.acuren.com/role/PROPERTYANDEQUIPMENTSummaryofPropertyandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Buildings and leasehold improvements", "label": "Building and Leasehold Improvements [Member]", "documentation": "Building and Leasehold Improvements [Member]" } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessAcquisitionAcquireeDomain", "presentation": [ "http://www.acuren.com/role/BUSINESSCOMBINATIONSNarrativeDetails", "http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofFairValueofConsiderationTransferredDetails", "http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofPreliminaryFairValueoftheIdentifiableIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Combination [Domain]", "label": "Business Combination [Domain]", "documentation": "Business combination or series of individually immaterial business combinations." } } }, "auth_ref": [ "r288", "r295", "r296", "r297", "r298", "r299", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r524", "r525", "r526", "r527", "r528", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r546", "r547", "r548", "r740", "r909", "r910", "r1221", "r1226", "r1228" ] }, "us-gaap_BusinessAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessAcquisitionAxis", "presentation": [ "http://www.acuren.com/role/BUSINESSCOMBINATIONSNarrativeDetails", "http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofFairValueofConsiderationTransferredDetails", "http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofPreliminaryFairValueoftheIdentifiableIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Combination [Axis]", "label": "Business Combination [Axis]", "documentation": "Information by business combination or series of individually immaterial business combinations." } } }, "auth_ref": [ "r288", "r295", "r296", "r297", "r298", "r299", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r524", "r525", "r526", "r527", "r528", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r546", "r547", "r548", "r740", "r909", "r910", "r1221", "r1226", "r1228" ] }, "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued", "presentation": [ "http://www.acuren.com/role/BUSINESSCOMBINATIONSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of shares issued (in shares)", "label": "Business Combination, Consideration Transferred, Equity Interest, Share Issued, Number of Shares", "documentation": "Number of shares of equity interest issued or issuable by acquirer as part of consideration transferred in business combination." } } }, "auth_ref": [ "r914", "r920", "r921", "r955", "r956" ] }, "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessAcquisitionProFormaInformationTextBlock", "presentation": [ "http://www.acuren.com/role/BUSINESSCOMBINATIONSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Pro Forma Consolidated Financial Information Reflects the Results of Operations", "label": "Business Combination, Pro Forma Information [Table Text Block]", "documentation": "Tabular disclosure of pro forma revenue and earnings for business combination or aggregate of series of individually immaterial business combinations." } } }, "auth_ref": [ "r914", "r926", "r1085", "r1086", "r1222" ] }, "us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount", "crdr": "debit", "presentation": [ "http://www.acuren.com/role/BUSINESSCOMBINATIONSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill expected to be tax deductible", "label": "Business Combination, Goodwill, Expected Tax Deductible, Amount", "documentation": "The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes." } } }, "auth_ref": [ "r540", "r544", "r914", "r919" ] }, "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessAcquisitionsProFormaNetIncomeLoss", "crdr": "credit", "presentation": [ "http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofProFormaConsolidatedFinancialInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net Loss", "label": "Business Combination, Pro Forma Information, Pro Forma Income (Loss), after Tax", "documentation": "Amount, after tax, of pro forma income (loss) of combined entity as if acquisition date of business combination occurred as of beginning of period." } } }, "auth_ref": [ "r503", "r504", "r506", "r914", "r926", "r927" ] }, "us-gaap_BusinessAcquisitionsProFormaRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessAcquisitionsProFormaRevenue", "crdr": "credit", "presentation": [ "http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofProFormaConsolidatedFinancialInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net Revenue", "label": "Business Combination, Pro Forma Information, Pro Forma Revenue", "documentation": "Amount of pro forma revenue of combined entity as if acquisition date of business combination occurred as of beginning of period." } } }, "auth_ref": [ "r503", "r504", "r506", "r914", "r926" ] }, "us-gaap_BusinessCombinationAcquisitionRelatedCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationAcquisitionRelatedCosts", "crdr": "debit", "presentation": [ "http://www.acuren.com/role/BUSINESSCOMBINATIONSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Acquisition-related cost, expense", "label": "Business Combination, Acquisition-Related Cost, Expense", "documentation": "Amount of expense for acquisition-related cost incurred to effect business combination. Includes, but is not limited to, finder's fee; advisory, legal, accounting, valuation, and other professional and consulting fees; and general administrative cost, including cost of maintaining internal acquisition department." } } }, "auth_ref": [ "r1218", "r1224" ] }, "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "lang": { "en-us": { "role": { "label": "Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationConsiderationTransferred1", "crdr": "credit", "calculation": { "http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofFairValueofConsiderationTransferredDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.acuren.com/role/BUSINESSCOMBINATIONSNarrativeDetails", "http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofFairValueofConsiderationTransferredDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total consideration", "totalLabel": "Total consideration", "label": "Business Combination, Consideration Transferred", "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer." } } }, "auth_ref": [ "r532", "r544", "r914", "r920" ] }, "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable", "crdr": "credit", "calculation": { "http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofFairValueofConsiderationTransferredDetails": { "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.acuren.com/role/BUSINESSCOMBINATIONSNarrativeDetails", "http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofFairValueofConsiderationTransferredDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity consideration", "label": "Business Combination, Consideration Transferred, Equity Interest", "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination." } } }, "auth_ref": [ "r914", "r920", "r921", "r955", "r956" ] }, "tic_BusinessCombinationConsiderationTransferredFairValueOfExchangedAcquireeEquityAwards": { "xbrltype": "monetaryItemType", "nsuri": "http://www.acuren.com/20260331", "localname": "BusinessCombinationConsiderationTransferredFairValueOfExchangedAcquireeEquityAwards", "crdr": "credit", "calculation": { "http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofFairValueofConsiderationTransferredDetails": { "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.acuren.com/role/BUSINESSCOMBINATIONSNarrativeDetails", "http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofFairValueofConsiderationTransferredDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Replacement of share-based awards", "label": "Business Combination, Consideration Transferred, Fair Value of Exchanged Acquiree Equity Awards", "documentation": "Business Combination, Consideration Transferred, Fair Value of Exchanged Acquiree Equity Awards" } } }, "auth_ref": [] }, "tic_BusinessCombinationConsiderationTransferredFairValueOfExchangedAcquireeShareBasedAwardsUnvested": { "xbrltype": "monetaryItemType", "nsuri": "http://www.acuren.com/20260331", "localname": "BusinessCombinationConsiderationTransferredFairValueOfExchangedAcquireeShareBasedAwardsUnvested", "crdr": "credit", "presentation": [ "http://www.acuren.com/role/BUSINESSCOMBINATIONSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Replacement of unvested", "label": "Business Combination, Consideration Transferred, Fair Value of Exchanged Acquiree, Share Based Awards, Unvested", "documentation": "Business Combination, Consideration Transferred, Fair Value of Exchanged Acquiree, Share Based Awards, Unvested" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurred", "crdr": "credit", "presentation": [ "http://www.acuren.com/role/ACCRUEDEXPENSESANDOTHERLIABILITIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contingent consideration liability incurred", "label": "Business Combination, Consideration Transferred, Liabilities Incurred", "documentation": "Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination." } } }, "auth_ref": [ "r535", "r914", "r920", "r956" ] }, "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1", "crdr": "debit", "presentation": [ "http://www.acuren.com/role/ACCRUEDEXPENSESANDOTHERLIABILITIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contingent consideration, change in contingent consideration, liability, increase (decrease)", "label": "Business Combination, Contingent Consideration, Change in Contingent Consideration, Liability, Increase (Decrease)", "documentation": "Amount of increase (decrease) in value of liability in contingent consideration arrangement in business combination, including, but not limited to, difference arising upon settlement." } } }, "auth_ref": [ "r546", "r1113" ] }, "us-gaap_BusinessCombinationContingentConsiderationLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationContingentConsiderationLiability", "crdr": "credit", "presentation": [ "http://www.acuren.com/role/ACCRUEDEXPENSESANDOTHERLIABILITIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contingent consideration", "label": "Business Combination, Contingent Consideration, Liability", "documentation": "Amount of liability recognized arising from contingent consideration in a business combination." } } }, "auth_ref": [ "r537", "r544", "r602", "r603", "r604", "r914", "r922" ] }, "us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationContingentConsiderationLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.acuren.com/role/ACCRUEDEXPENSESANDOTHERLIABILITIESSummaryofAccruedExpensesandOtherLiabilitiesDetails": { "parentTag": "tic_AccountsPayableAndAccruedLiabilitiesExcludingTradePayablesCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.acuren.com/role/ACCRUEDEXPENSESANDOTHERLIABILITIESNarrativeDetails", "http://www.acuren.com/role/ACCRUEDEXPENSESANDOTHERLIABILITIESSummaryofAccruedExpensesandOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Current portion of contingent consideration", "label": "Business Combination, Contingent Consideration, Liability, Current", "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r1233", "r1234" ] }, "tic_BusinessCombinationContingentConsiderationLiabilityPayment": { "xbrltype": "monetaryItemType", "nsuri": "http://www.acuren.com/20260331", "localname": "BusinessCombinationContingentConsiderationLiabilityPayment", "crdr": "credit", "presentation": [ "http://www.acuren.com/role/ACCRUEDEXPENSESANDOTHERLIABILITIESNarrativeDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Contingent consideration liability payment", "label": "Business Combination, Contingent Consideration, Liability, Payment", "documentation": "Business Combination, Contingent Consideration, Liability, Payment" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationDisclosureTextBlock", "presentation": [ "http://www.acuren.com/role/BUSINESSCOMBINATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Business Combinations", "label": "Business Combination [Text Block]", "documentation": "The entire disclosure for business combination." } } }, "auth_ref": [ "r487", "r488", "r492", "r501", "r505", "r506", "r507", "r508", "r509", "r510", "r512", "r513", "r519", "r522", "r523", "r529", "r530", "r531", "r539", "r543", "r544", "r545", "r547", "r549", "r914", "r915", "r916", "r917", "r922", "r923", "r924" ] }, "tic_BusinessCombinationRecognizedAssetAcquiredContractWithCustomerAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://www.acuren.com/20260331", "localname": "BusinessCombinationRecognizedAssetAcquiredContractWithCustomerAsset", "crdr": "debit", "calculation": { "http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofFairValueofConsiderationTransferredDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofFairValueofConsiderationTransferredDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contract assets", "label": "Business Combination, Recognized Asset Acquired, Contract with Customer, Asset", "documentation": "Business Combination, Recognized Asset Acquired, Contract with Customer, Asset" } } }, "auth_ref": [] }, "tic_BusinessCombinationRecognizedAssetAcquiredContractWithCustomerLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://www.acuren.com/20260331", "localname": "BusinessCombinationRecognizedAssetAcquiredContractWithCustomerLiability", "crdr": "credit", "calculation": { "http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofFairValueofConsiderationTransferredDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0, "order": 11.0 } }, "presentation": [ "http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofFairValueofConsiderationTransferredDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Contract liabilities", "label": "Business Combination, Recognized Asset Acquired, Contract with Customer, Liability", "documentation": "Business Combination, Recognized Asset Acquired, Contract with Customer, Liability" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation", "crdr": "credit", "calculation": { "http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofFairValueofConsiderationTransferredDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0, "order": 13.0 } }, "presentation": [ "http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofFairValueofConsiderationTransferredDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Lease liabilities", "label": "Business Combination, Recognized Liability Assumed, Lease Obligation", "documentation": "Amount of lease obligation assumed in business combination and recognized at acquisition date." } } }, "auth_ref": [ "r1227", "r1229" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "crdr": "debit", "calculation": { "http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofFairValueofConsiderationTransferredDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofFairValueofConsiderationTransferredDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and cash equivalents", "label": "Business Combination, Recognized Asset Acquired, Cash and Cash Equivalent", "documentation": "Amount of cash and cash equivalent acquired in business combination and recognized at acquisition date." } } }, "auth_ref": [ "r1227", "r1229" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets", "crdr": "debit", "calculation": { "http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofFairValueofConsiderationTransferredDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofFairValueofConsiderationTransferredDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid expenses and other current assets", "label": "Business Combination, Recognized Asset Acquired, Prepaid Expense and Other Asset, Current", "documentation": "Amount of prepaid expense and asset classified as other, acquired in business combination and recognized at acquisition date, classified as current." } } }, "auth_ref": [ "r1227", "r1229" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables", "crdr": "debit", "calculation": { "http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofFairValueofConsiderationTransferredDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofFairValueofConsiderationTransferredDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts receivables", "label": "Business Combination, Recognized Asset Acquired, Receivable, Current", "documentation": "Amount of receivable acquired in business combination and recognized at acquisition date, classified as current. Includes, but is not limited to, receivable from customer for product and service." } } }, "auth_ref": [ "r1227", "r1229" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable", "crdr": "credit", "calculation": { "http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofFairValueofConsiderationTransferredDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofFairValueofConsiderationTransferredDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Accounts payable", "label": "Business Combination, Recognized Liability Assumed, Accounts Payable, Current", "documentation": "Amount of accounts payable assumed in business combination and recognized at acquisition date, classified as current." } } }, "auth_ref": [ "r1227", "r1229" ] }, "tic_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpensesAndOtherCurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.acuren.com/20260331", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpensesAndOtherCurrentLiabilities", "crdr": "credit", "calculation": { "http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofFairValueofConsiderationTransferredDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofFairValueofConsiderationTransferredDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Accrued expenses and other current liabilities", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Expenses And Other Current Liabilities", "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Expenses And Other Current Liabilities" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities", "crdr": "credit", "calculation": { "http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofFairValueofConsiderationTransferredDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0, "order": 14.0 } }, "presentation": [ "http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofFairValueofConsiderationTransferredDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Deferred tax liabilities", "label": "Business Combination, Recognized Liability Assumed, Deferred Tax Liability", "documentation": "Amount of deferred tax liability assumed in business combination and recognized at acquisition date." } } }, "auth_ref": [ "r1227", "r1229" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "crdr": "debit", "calculation": { "http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofFairValueofConsiderationTransferredDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofFairValueofConsiderationTransferredDetails", "http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofPreliminaryFairValueoftheIdentifiableIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible assets", "label": "Business Combination, Recognized Asset Acquired, Identifiable Intangible Asset, Excluding Goodwill", "documentation": "Amount of identifiable intangible asset acquired in business combination and recognized at acquisition date. Excludes goodwill and financial asset." } } }, "auth_ref": [ "r914", "r920", "r923", "r1227", "r1229" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "crdr": "debit", "calculation": { "http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofFairValueofConsiderationTransferredDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofFairValueofConsiderationTransferredDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total identifiable net assets acquired", "label": "Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less)", "documentation": "Amount of asset acquired in excess of (less than) liability assumed in business combination and recognized at acquisition date. Excludes goodwill." } } }, "auth_ref": [ "r914", "r920", "r1227", "r1229" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt", "crdr": "credit", "presentation": [ "http://www.acuren.com/role/BUSINESSCOMBINATIONSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term debt", "label": "Business Combination, Recognized Liability Assumed, Long-Term Debt, Noncurrent", "documentation": "Amount of long-term debt assumed in business combination and recognized at acquisition date, classified as noncurrent." } } }, "auth_ref": [ "r1227", "r1229" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther", "crdr": "credit", "calculation": { "http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofFairValueofConsiderationTransferredDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0, "order": 12.0 } }, "presentation": [ "http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofFairValueofConsiderationTransferredDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Other liabilities", "label": "Business Combination, Recognized Liability Assumed, Other Liability, Noncurrent", "documentation": "Amount of liability assumed in business combination and recognized at acquisition date, classified as other and noncurrent." } } }, "auth_ref": [ "r1227", "r1229" ] }, "tic_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://www.acuren.com/20260331", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets", "crdr": "debit", "calculation": { "http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofFairValueofConsiderationTransferredDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofFairValueofConsiderationTransferredDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease right-of-use assets", "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Operating Lease Right Of Use Assets", "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed operating lease right of use assets." } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets", "crdr": "debit", "calculation": { "http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofFairValueofConsiderationTransferredDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofFairValueofConsiderationTransferredDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other assets", "label": "Business Combination, Recognized Asset Acquired, Other Asset, Noncurrent", "documentation": "Amount of asset acquired in business combination and recognized at acquisition date, classified as other and noncurrent." } } }, "auth_ref": [ "r1227", "r1229" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment", "crdr": "debit", "calculation": { "http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofFairValueofConsiderationTransferredDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofFairValueofConsiderationTransferredDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Plant and equipment", "label": "Business Combination, Recognized Asset Acquired, Property, Plant, and Equipment", "documentation": "Amount of property, plant, and equipment acquired in business combination and recognized at acquisition date." } } }, "auth_ref": [ "r914", "r920", "r1227", "r1229" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract", "presentation": [ "http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofFairValueofConsiderationTransferredDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Recognized amounts of identifiable assets acquired and liabilities assumed:", "label": "Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less), and Goodwill [Abstract]" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationSeparatelyRecognizedTransactionsLineItems", "presentation": [ "http://www.acuren.com/role/BUSINESSCOMBINATIONSNarrativeDetails", "http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofFairValueofConsiderationTransferredDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Combination, Separately Recognized Transaction [Line Items]", "label": "Business Combination, Separately Recognized Transaction [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r492", "r493", "r494", "r495", "r496", "r506", "r914", "r920" ] }, "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationSeparatelyRecognizedTransactionsTable", "presentation": [ "http://www.acuren.com/role/BUSINESSCOMBINATIONSNarrativeDetails", "http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofFairValueofConsiderationTransferredDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Combination, Separately Recognized Transaction [Table]", "label": "Business Combination, Separately Recognized Transaction [Table]", "documentation": "Disclosure of information about transaction recognized separately from acquisition of asset and assumption of liability in business combination." } } }, "auth_ref": [ "r492", "r493", "r494", "r495", "r496", "r506", "r914", "r920" ] }, "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock", "presentation": [ "http://www.acuren.com/role/BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIES" ], "lang": { "en-us": { "role": { "terseLabel": "BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES", "label": "Business Description and Basis of Presentation [Text Block]", "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [ "r1094", "r1115" ] }, "country_CA": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2025", "localname": "CA", "presentation": [ "http://www.acuren.com/role/SEGMENTREPORTINGSummaryofServiceRevenuesClassificationsbyMajorGeographicAreasDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Canada", "label": "CANADA" } } }, "auth_ref": [] }, "us-gaap_CapitalExpendituresIncurredButNotYetPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CapitalExpendituresIncurredButNotYetPaid", "crdr": "credit", "presentation": [ "http://www.acuren.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Purchases of property and equipment accrued and not yet paid", "label": "Capital Expenditures Incurred but Not yet Paid", "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred." } } }, "auth_ref": [ "r19", "r20", "r21" ] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://www.acuren.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.acuren.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and cash equivalents", "label": "Cash and Cash Equivalent", "documentation": "Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate." } } }, "auth_ref": [ "r17", "r141", "r869" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "presentation": [ "http://www.acuren.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning of period", "periodEndLabel": "End of period", "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation", "documentation": "Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate." } } }, "auth_ref": [ "r17", "r62", "r176" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://www.acuren.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.acuren.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net change in cash and cash equivalents", "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation", "documentation": "Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate." } } }, "auth_ref": [ "r1", "r62" ] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Changed Peer Group, Footnote", "label": "Changed Peer Group, Footnote [Text Block]" } } }, "auth_ref": [ "r1045" ] }, "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year", "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]" } } }, "auth_ref": [ "r1042" ] }, "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested", "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]" } } }, "auth_ref": [ "r1040" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CityAreaCode", "presentation": [ "http://www.acuren.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ClassOfStockDomain", "presentation": [ "http://www.acuren.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss", "http://www.acuren.com/role/EARNINGSPERSHARESummaryofBasicandDilutedEarningsPerShareDetails", "http://www.acuren.com/role/RELATEDPARTIESDetails", "http://www.acuren.com/role/STOCKHOLDERSEQUITYPreferredStockNarrativeDetails", "http://www.acuren.com/role/STOCKHOLDERSEQUITYWarrantsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Domain]", "label": "Class of Stock [Domain]", "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r96", "r150", "r151", "r152", "r177", "r181", "r209", "r210", "r216", "r219", "r226", "r227", "r267", "r330", "r333", "r334", "r335", "r339", "r340", "r373", "r374", "r376", "r377", "r379", "r382", "r385", "r386", "r389", "r392", "r398", "r617", "r742", "r743", "r744", "r745", "r751", "r753", "r754", "r755", "r756", "r757", "r758", "r759", "r760", "r761", "r762", "r763", "r777", "r797", "r819", "r839", "r840", "r841", "r842", "r843", "r1084", "r1118", "r1120", "r1127" ] }, "us-gaap_ClassOfWarrantOrRightAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ClassOfWarrantOrRightAxis", "presentation": [ "http://www.acuren.com/role/STOCKHOLDERSEQUITYWarrantsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Warrant or Right [Axis]", "label": "Class of Warrant or Right [Axis]", "documentation": "Information by type of warrant or right issued." } } }, "auth_ref": [ "r1182" ] }, "us-gaap_ClassOfWarrantOrRightDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ClassOfWarrantOrRightDomain", "presentation": [ "http://www.acuren.com/role/STOCKHOLDERSEQUITYWarrantsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Warrant or Right [Domain]", "label": "Class of Warrant or Right [Domain]", "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months." } } }, "auth_ref": [] }, "tic_ClassOfWarrantOrRightExerciseBeneficialOwnershipPercentage": { "xbrltype": "percentItemType", "nsuri": "http://www.acuren.com/20260331", "localname": "ClassOfWarrantOrRightExerciseBeneficialOwnershipPercentage", "presentation": [ "http://www.acuren.com/role/STOCKHOLDERSEQUITYWarrantsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum beneficial ownership percentage", "label": "Class Of Warrant Or Right, Exercise, Beneficial Ownership Percentage", "documentation": "Class Of Warrant Or Right, Exercise, Beneficial Ownership Percentage" } } }, "auth_ref": [] }, "tic_ClassOfWarrantOrRightExerciseChangeInBeneficialOwnershipPercentageNoticePeriod": { "xbrltype": "durationItemType", "nsuri": "http://www.acuren.com/20260331", "localname": "ClassOfWarrantOrRightExerciseChangeInBeneficialOwnershipPercentageNoticePeriod", "presentation": [ "http://www.acuren.com/role/STOCKHOLDERSEQUITYWarrantsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Notice period", "label": "Class Of Warrant Or Right, Exercise, Change in Beneficial Ownership Percentage, Notice Period", "documentation": "Class Of Warrant Or Right, Exercise, Change in Beneficial Ownership Percentage, Notice Period" } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "presentation": [ "http://www.acuren.com/role/STOCKHOLDERSEQUITYWarrantsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise price of warrants (in dollars per share)", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "documentation": "Exercise price per share or per unit of warrants or rights outstanding." } } }, "auth_ref": [ "r177", "r183", "r399" ] }, "us-gaap_ClassOfWarrantOrRightLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ClassOfWarrantOrRightLineItems", "presentation": [ "http://www.acuren.com/role/STOCKHOLDERSEQUITYPreferredStockNarrativeDetails", "http://www.acuren.com/role/STOCKHOLDERSEQUITYWarrantsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Warrant or Right [Line Items]", "label": "Class of Warrant or Right [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight", "presentation": [ "http://www.acuren.com/role/STOCKHOLDERSEQUITYWarrantsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of securities called by each warrant (in shares)", "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right", "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares." } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "presentation": [ "http://www.acuren.com/role/STOCKHOLDERSEQUITYWarrantsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Warrant conversion shares ratio (in shares)", "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights", "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares." } } }, "auth_ref": [ "r399" ] }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ClassOfWarrantOrRightOutstanding", "presentation": [ "http://www.acuren.com/role/STOCKHOLDERSEQUITYWarrantsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vested warrants outstanding (in shares)", "label": "Class of Warrant or Right, Outstanding", "documentation": "Number of warrants or rights outstanding." } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ClassOfWarrantOrRightTable", "presentation": [ "http://www.acuren.com/role/STOCKHOLDERSEQUITYPreferredStockNarrativeDetails", "http://www.acuren.com/role/STOCKHOLDERSEQUITYWarrantsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Warrant or Right [Table]", "label": "Class of Warrant or Right [Table]", "documentation": "Disclosure of information about warrant or right issued that give holder right to purchase security from issuer at specific price within certain time frame." } } }, "auth_ref": [ "r1182" ] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Amount", "label": "Company Selected Measure Amount" } } }, "auth_ref": [ "r1046" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Name", "label": "Company Selected Measure Name" } } }, "auth_ref": [ "r1046" ] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommitmentsAndContingencies", "crdr": "credit", "calculation": { "http://www.acuren.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.acuren.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and contingencies (Note\u00a015)", "label": "Commitments and Contingencies", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r41", "r80", "r702", "r776" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://www.acuren.com/role/COMMITMENTSANDCONTINGENCIES" ], "lang": { "en-us": { "role": { "terseLabel": "COMMITMENTS AND CONTINGENCIES", "label": "Commitments and Contingencies Disclosure [Text Block]", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r69", "r320", "r321", "r850", "r1162", "r1167" ] }, "tic_CommonStockAndSeriesAPreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://www.acuren.com/20260331", "localname": "CommonStockAndSeriesAPreferredStockMember", "presentation": [ "http://www.acuren.com/role/STOCKHOLDERSEQUITYWarrantsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock And Series A Preferred Stock", "label": "Common Stock And Series A Preferred Stock [Member]", "documentation": "Common Stock And Series A Preferred Stock" } } }, "auth_ref": [] }, "us-gaap_CommonStockDividendsPerShareDeclared": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommonStockDividendsPerShareDeclared", "presentation": [ "http://www.acuren.com/role/STOCKHOLDERSEQUITYPreferredStockNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, dividends, per share, declared", "label": "Common Stock, Dividends, Per Share, Declared", "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding." } } }, "auth_ref": [ "r74" ] }, "us-gaap_CommonStockDividendsShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommonStockDividendsShares", "presentation": [ "http://www.acuren.com/role/RELATEDPARTIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock dividends, (in shares)", "label": "Common Stock Dividends, Shares", "documentation": "Number of shares of common stock issued as dividends during the period. Excludes stock splits." } } }, "auth_ref": [ "r9" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommonStockMember", "presentation": [ "http://www.acuren.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss", "http://www.acuren.com/role/CondensedConsolidatedStatementsofStockholdersEquity", "http://www.acuren.com/role/EARNINGSPERSHARESummaryofBasicandDilutedEarningsPerShareDetails", "http://www.acuren.com/role/STOCKHOLDERSEQUITYWarrantsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock", "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r988", "r989", "r990", "r992", "r993", "r994", "r995", "r1123", "r1124", "r1126", "r1242", "r1294", "r1298" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://www.acuren.com/role/CondensedConsolidatedBalanceSheetsParentheticals", "http://www.acuren.com/role/STOCKHOLDERSEQUITYPreferredStockNarrativeDetails", "http://www.acuren.com/role/STOCKHOLDERSEQUITYWarrantsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, par value (in dollars per share)", "label": "Common Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r44" ] }, "tic_CommonStockSharePriceBaseForCalculatingAnnualDividendAmount": { "xbrltype": "perShareItemType", "nsuri": "http://www.acuren.com/20260331", "localname": "CommonStockSharePriceBaseForCalculatingAnnualDividendAmount", "presentation": [ "http://www.acuren.com/role/STOCKHOLDERSEQUITYPreferredStockNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share price baseline for calculating annual dividends (in dollars per share)", "label": "Common Stock, Share Price Base For Calculating Annual Dividend Amount", "documentation": "Common Stock, Share Price Base For Calculating Annual Dividend Amount" } } }, "auth_ref": [] }, "tic_CommonStockSharePriceThresholdPreferredStockDividendThresholdConsecutiveTradingDays": { "xbrltype": "integerItemType", "nsuri": "http://www.acuren.com/20260331", "localname": "CommonStockSharePriceThresholdPreferredStockDividendThresholdConsecutiveTradingDays", "presentation": [ "http://www.acuren.com/role/STOCKHOLDERSEQUITYPreferredStockNarrativeDetails", "http://www.acuren.com/role/STOCKHOLDERSEQUITYWarrantsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share price threshold for Preferred stock dividends consecutive trading days", "label": "Common Stock, Share Price Threshold, Preferred Stock Dividend, Threshold Consecutive Trading Days", "documentation": "Common Stock, Share Price Threshold, Preferred Stock Dividend, Threshold Consecutive Trading Days" } } }, "auth_ref": [] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://www.acuren.com/role/STOCKHOLDERSEQUITYPreferredStockNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares authorized (in shares)", "label": "Common Stock, Shares Authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r44", "r777" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommonStockSharesIssued", "presentation": [ "http://www.acuren.com/role/CondensedConsolidatedBalanceSheetsParentheticals", "http://www.acuren.com/role/STOCKHOLDERSEQUITYPreferredStockNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares issued (in shares)", "label": "Common Stock, Shares, Issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r44" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://www.acuren.com/role/CondensedConsolidatedBalanceSheetsParentheticals", "http://www.acuren.com/role/CondensedConsolidatedStatementsofStockholdersEquity", "http://www.acuren.com/role/STOCKHOLDERSEQUITYPreferredStockNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Balance at the beginning of the period (in shares) (Successor)", "periodStartLabel": "Balance at the beginning of the period (in shares)", "periodEndLabel": "Balance at the end of the period (in shares)", "verboseLabel": "Common stock, shares outstanding (in shares)", "label": "Common Stock, Shares, Outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r9", "r44", "r777", "r795", "r1298", "r1299" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://www.acuren.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.acuren.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, $0.0001 par value, 221,039,674 and 220,485,045 shares issued and outstanding as of March\u00a031, 2026 and December\u00a031, 2025, respectively", "label": "Common Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r44", "r374", "r381", "r704", "r972" ] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Company Selected Measure", "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]" } } }, "auth_ref": [ "r1051" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Net Income", "label": "Compensation Actually Paid vs. Net Income [Text Block]" } } }, "auth_ref": [ "r1050" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Other Measure", "label": "Compensation Actually Paid vs. Other Measure [Text Block]" } } }, "auth_ref": [ "r1052" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return", "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]" } } }, "auth_ref": [ "r1049" ] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "calculation": { "http://www.acuren.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.acuren.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Total other comprehensive loss", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r14", "r159", "r161", "r165", "r689", "r713", "r714" ] }, "tic_ComputerSoftwareAndOfficeEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.acuren.com/20260331", "localname": "ComputerSoftwareAndOfficeEquipmentMember", "presentation": [ "http://www.acuren.com/role/PROPERTYANDEQUIPMENTSummaryofPropertyandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Computer, software, and office equipment", "label": "Computer, Software, And Office Equipment [Member]", "documentation": "Computer, Software, And Office Equipment" } } }, "auth_ref": [] }, "srt_ConsolidatedEntitiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "ConsolidatedEntitiesAxis", "presentation": [ "http://www.acuren.com/role/ACCRUEDEXPENSESANDOTHERLIABILITIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidated Entities [Axis]", "label": "Consolidated Entities [Axis]", "documentation": "Information by consolidated entity or group of entities." } } }, "auth_ref": [ "r97", "r111", "r178", "r188", "r552", "r553", "r554", "r555", "r556", "r644", "r696", "r855", "r1088", "r1091", "r1092", "r1173", "r1176", "r1177" ] }, "srt_ConsolidatedEntitiesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "ConsolidatedEntitiesDomain", "presentation": [ "http://www.acuren.com/role/ACCRUEDEXPENSESANDOTHERLIABILITIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidated Entities [Domain]", "label": "Consolidated Entities [Domain]", "documentation": "Entity or group of entities consolidated into reporting entity." } } }, "auth_ref": [ "r97", "r111", "r178", "r188", "r552", "r553", "r554", "r555", "r556", "r644", "r696", "r855", "r1088", "r1091", "r1092", "r1173", "r1176", "r1177" ] }, "srt_ConsolidationEliminationsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "ConsolidationEliminationsMember", "presentation": [ "http://www.acuren.com/role/SEGMENTREPORTINGSummaryofFinancialInformationForeachoftheCompanysReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Corporate and Eliminations", "label": "Consolidation, Eliminations [Member]", "documentation": "Eliminating entries used in consolidating a parent entity and its subsidiaries." } } }, "auth_ref": [ "r177", "r185" ] }, "srt_ConsolidationItemsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "ConsolidationItemsAxis", "presentation": [ "http://www.acuren.com/role/SEGMENTREPORTINGSummaryofFinancialInformationForeachoftheCompanysReportableSegmentsDetails", "http://www.acuren.com/role/SEGMENTREPORTINGSummaryofServiceRevenuesClassificationsbyMajorGeographicAreasDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidation Items [Axis]", "label": "Consolidation Items [Axis]", "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments." } } }, "auth_ref": [ "r85", "r97", "r121", "r122", "r123", "r124", "r125", "r126", "r127", "r128", "r129", "r177", "r178", "r185", "r188", "r224", "r236", "r250", "r251", "r252", "r253", "r254", "r256", "r257", "r258", "r330", "r331", "r332", "r333", "r335", "r336", "r337", "r338", "r339", "r696", "r890", "r891", "r1089", "r1090", "r1174", "r1175" ] }, "srt_ConsolidationItemsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "ConsolidationItemsDomain", "presentation": [ "http://www.acuren.com/role/SEGMENTREPORTINGSummaryofFinancialInformationForeachoftheCompanysReportableSegmentsDetails", "http://www.acuren.com/role/SEGMENTREPORTINGSummaryofServiceRevenuesClassificationsbyMajorGeographicAreasDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidation Items [Domain]", "label": "Consolidation Items [Domain]", "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments." } } }, "auth_ref": [ "r85", "r97", "r121", "r122", "r123", "r124", "r125", "r126", "r127", "r128", "r129", "r177", "r178", "r185", "r188", "r224", "r236", "r250", "r251", "r252", "r253", "r254", "r256", "r257", "r258", "r330", "r331", "r332", "r333", "r335", "r336", "r337", "r338", "r339", "r696", "r890", "r891", "r1089", "r1090", "r1174", "r1175" ] }, "us-gaap_ConstructionInProgressMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ConstructionInProgressMember", "presentation": [ "http://www.acuren.com/role/PROPERTYANDEQUIPMENTSummaryofPropertyandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Construction in progress", "label": "Construction in Progress [Member]", "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service." } } }, "auth_ref": [] }, "tic_ConsultingEngineeringSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.acuren.com/20260331", "localname": "ConsultingEngineeringSegmentMember", "presentation": [ "http://www.acuren.com/role/BUSINESSCOMBINATIONSNarrativeDetails", "http://www.acuren.com/role/GOODWILLDetails", "http://www.acuren.com/role/SEGMENTREPORTINGSummaryofFinancialInformationForeachoftheCompanysReportableSegmentsDetails", "http://www.acuren.com/role/SEGMENTREPORTINGSummaryofServiceRevenuesClassificationsbyMajorGeographicAreasDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consulting Engineering", "label": "Consulting Engineering Segment [Member]", "documentation": "Consulting Engineering Segment" } } }, "auth_ref": [] }, "tic_ConsultingServicesAgreementAdvisoryFees": { "xbrltype": "monetaryItemType", "nsuri": "http://www.acuren.com/20260331", "localname": "ConsultingServicesAgreementAdvisoryFees", "crdr": "debit", "presentation": [ "http://www.acuren.com/role/RELATEDPARTIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Advisory fees", "label": "Consulting Services Agreement, Advisory Fees", "documentation": "Consulting Services Agreement, Advisory Fees" } } }, "auth_ref": [] }, "tic_ConsultingServicesAgreementAutomaticRenewsForSuccessiveTerms": { "xbrltype": "durationItemType", "nsuri": "http://www.acuren.com/20260331", "localname": "ConsultingServicesAgreementAutomaticRenewsForSuccessiveTerms", "presentation": [ "http://www.acuren.com/role/RELATEDPARTIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Automatic renews for successive terms (in years)", "label": "Consulting Services Agreement, Automatic Renews for Successive Terms", "documentation": "Consulting Services Agreement, Automatic Renews for Successive Terms" } } }, "auth_ref": [] }, "tic_ConsultingServicesAgreementPriorToExpirationOfTerm": { "xbrltype": "durationItemType", "nsuri": "http://www.acuren.com/20260331", "localname": "ConsultingServicesAgreementPriorToExpirationOfTerm", "presentation": [ "http://www.acuren.com/role/RELATEDPARTIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prior to expiration of term (in days)", "label": "Consulting Services Agreement, Prior to Expiration of Term", "documentation": "Consulting Services Agreement, Prior to Expiration of Term" } } }, "auth_ref": [] }, "us-gaap_ContractWithCustomerAssetNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ContractWithCustomerAssetNetCurrent", "crdr": "debit", "calculation": { "http://www.acuren.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.acuren.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "verboseLabel": "Contract assets, net", "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Current", "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current." } } }, "auth_ref": [ "r401", "r403", "r404", "r416" ] }, "us-gaap_ContractWithCustomerBasisOfPricingAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ContractWithCustomerBasisOfPricingAxis", "presentation": [ "http://www.acuren.com/role/SEGMENTREPORTINGSummaryofServiceRevenuesClassificationsbyMajorGeographicAreasDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contract with Customer, Basis of Pricing [Axis]", "label": "Contract with Customer, Basis of Pricing [Axis]", "documentation": "Information by basis of pricing for contract representing right to consideration in exchange for good or service transferred to customer." } } }, "auth_ref": [ "r905", "r908" ] }, "us-gaap_ContractWithCustomerBasisOfPricingDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ContractWithCustomerBasisOfPricingDomain", "presentation": [ "http://www.acuren.com/role/SEGMENTREPORTINGSummaryofServiceRevenuesClassificationsbyMajorGeographicAreasDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contract with Customer, Basis of Pricing [Domain]", "label": "Contract with Customer, Basis of Pricing [Domain]", "documentation": "Basis of pricing for contract with customer. Includes, but is not limited to, fixed-price and time-and-materials contracts." } } }, "auth_ref": [ "r905", "r908" ] }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ContractWithCustomerLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.acuren.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.acuren.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Contract liabilities", "label": "Contract with Customer, Liability, Current", "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current." } } }, "auth_ref": [ "r401", "r402", "r404", "r416" ] }, "us-gaap_CostOfRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CostOfRevenue", "crdr": "debit", "calculation": { "http://www.acuren.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.acuren.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss", "http://www.acuren.com/role/SEGMENTREPORTINGSummaryofFinancialInformationForeachoftheCompanysReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of revenue", "label": "Cost of Revenue", "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period." } } }, "auth_ref": [ "r55", "r177", "r180", "r181", "r267", "r330", "r331", "r333", "r334", "r335", "r336", "r337", "r339", "r340", "r617", "r890", "r1174" ] }, "us-gaap_CostOfSalesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CostOfSalesMember", "presentation": [ "http://www.acuren.com/role/PROPERTYANDEQUIPMENTDepreciationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of revenue", "label": "Cost of Sales [Member]", "documentation": "Primary financial statement caption encompassing cost of sales." } } }, "auth_ref": [ "r959" ] }, "tic_CostReimbursableContractsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.acuren.com/20260331", "localname": "CostReimbursableContractsMember", "presentation": [ "http://www.acuren.com/role/SEGMENTREPORTINGSummaryofServiceRevenuesClassificationsbyMajorGeographicAreasDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cost-reimbursable contracts", "label": "Cost-Reimbursable Contracts [Member]", "documentation": "Cost-Reimbursable Contracts" } } }, "auth_ref": [] }, "srt_CounterpartyNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "CounterpartyNameAxis", "presentation": [ "http://www.acuren.com/role/RELATEDPARTIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Counterparty Name [Axis]", "label": "Counterparty Name [Axis]", "documentation": "Information by name of counterparty. A counterparty is the other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution." } } }, "auth_ref": [ "r130", "r131", "r177", "r186", "r187", "r345", "r387", "r642", "r647", "r699", "r872", "r873", "r874", "r1099", "r1100", "r1101", "r1102", "r1103", "r1104", "r1105", "r1106", "r1107", "r1236", "r1237", "r1238", "r1239" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "us-gaap_CreditFacilityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CreditFacilityAxis", "presentation": [ "http://www.acuren.com/role/BUSINESSCOMBINATIONSNarrativeDetails", "http://www.acuren.com/role/LONGTERMDEBTNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Facility [Axis]", "label": "Credit Facility [Axis]", "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [ "r329", "r1171" ] }, "us-gaap_CreditFacilityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CreditFacilityDomain", "presentation": [ "http://www.acuren.com/role/BUSINESSCOMBINATIONSNarrativeDetails", "http://www.acuren.com/role/LONGTERMDEBTNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Facility [Domain]", "label": "Credit Facility [Domain]", "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [ "r329", "r1171" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.acuren.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Current Fiscal Year End Date", "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_CustomerListsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CustomerListsMember", "presentation": [ "http://www.acuren.com/role/BUSINESSCOMBINATIONSNarrativeDetails", "http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofPreliminaryFairValueoftheIdentifiableIntangibleAssetsDetails", "http://www.acuren.com/role/INTANGIBLEASSETSSummaryofIntangibleAssetsandAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer backlog", "label": "Customer Lists [Member]", "documentation": "Information about customers such as their name and contact information; it may also be an extensive database that includes other information about the customers such as their order history and demographic information." } } }, "auth_ref": [ "r934", "r1151", "r1152", "r1153", "r1154", "r1156", "r1158", "r1160", "r1161" ] }, "us-gaap_CustomerRelationshipsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CustomerRelationshipsMember", "presentation": [ "http://www.acuren.com/role/BUSINESSCOMBINATIONSNarrativeDetails", "http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofPreliminaryFairValueoftheIdentifiableIntangibleAssetsDetails", "http://www.acuren.com/role/INTANGIBLEASSETSSummaryofIntangibleAssetsandAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer relationships", "label": "Customer Relationships [Member]", "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships." } } }, "auth_ref": [ "r936", "r1151", "r1152", "r1153", "r1154", "r1156", "r1158", "r1160", "r1161" ] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtDisclosureTextBlock", "presentation": [ "http://www.acuren.com/role/LONGTERMDEBT" ], "lang": { "en-us": { "role": { "terseLabel": "LONG-TERM DEBT", "label": "Debt Disclosure [Text Block]", "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants." } } }, "auth_ref": [ "r70", "r177", "r179", "r311", "r312", "r313", "r314", "r315", "r328", "r329", "r341", "r347", "r348", "r349", "r350", "r351", "r352", "r357", "r364", "r365", "r367", "r585", "r629" ] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtInstrumentAxis", "presentation": [ "http://www.acuren.com/role/LONGTERMDEBTNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument [Axis]", "label": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r10", "r35", "r36", "r78", "r79", "r342", "r343", "r344", "r345", "r346", "r348", "r353", "r354", "r355", "r356", "r358", "r359", "r360", "r361", "r362", "r363", "r898", "r899", "r900", "r901", "r902", "r971", "r1116", "r1117", "r1119", "r1122", "r1163", "r1164", "r1165", "r1247", "r1249", "r1259" ] }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "presentation": [ "http://www.acuren.com/role/LONGTERMDEBTNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basis spread on variable rate", "label": "Debt Instrument, Basis Spread on Variable Rate", "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtInstrumentCarryingAmount", "crdr": "credit", "presentation": [ "http://www.acuren.com/role/LONGTERMDEBTNarrativeDetails", "http://www.acuren.com/role/LONGTERMDEBTSummaryofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term debt", "label": "Long-Term Debt, Gross", "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt." } } }, "auth_ref": [ "r10", "r79", "r368" ] }, "tic_DebtInstrumentCovenantComplianceEventsOfDefaultThresholdAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.acuren.com/20260331", "localname": "DebtInstrumentCovenantComplianceEventsOfDefaultThresholdAmount", "crdr": "credit", "presentation": [ "http://www.acuren.com/role/LONGTERMDEBTNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Covenant compliance, debt default, threshold amount", "label": "Debt Instrument, Covenant Compliance, Events Of Default, Threshold Amount", "documentation": "Debt Instrument, Covenant Compliance, Events Of Default, Threshold Amount" } } }, "auth_ref": [] }, "tic_DebtInstrumentCovenantFirstLienNetLeverageRatio": { "xbrltype": "pureItemType", "nsuri": "http://www.acuren.com/20260331", "localname": "DebtInstrumentCovenantFirstLienNetLeverageRatio", "presentation": [ "http://www.acuren.com/role/LONGTERMDEBTNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Covenant compliance, first lien net leverage ratio", "label": "Debt Instrument, Covenant, First Lien Net Leverage Ratio", "documentation": "Debt Instrument, Covenant, First Lien Net Leverage Ratio" } } }, "auth_ref": [] }, "tic_DebtInstrumentCovenantUndrawnLetterOfCreditThresholdPercent": { "xbrltype": "pureItemType", "nsuri": "http://www.acuren.com/20260331", "localname": "DebtInstrumentCovenantUndrawnLetterOfCreditThresholdPercent", "presentation": [ "http://www.acuren.com/role/LONGTERMDEBTNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Covenant compliance, undrawn letter of credit threshold, percent (greater than)", "label": "Debt Instrument, Covenant, Undrawn Letter of Credit Threshold, Percent", "documentation": "Debt Instrument, Covenant, Undrawn Letter of Credit Threshold, Percent" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentFaceAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtInstrumentFaceAmount", "crdr": "credit", "presentation": [ "http://www.acuren.com/role/LONGTERMDEBTNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt instrument face amount", "label": "Debt Instrument, Face Amount", "documentation": "Face (par) amount of debt instrument at time of issuance." } } }, "auth_ref": [ "r342", "r629", "r630", "r899", "r900", "r971" ] }, "us-gaap_DebtInstrumentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtInstrumentLineItems", "presentation": [ "http://www.acuren.com/role/LONGTERMDEBTNarrativeDetails", "http://www.acuren.com/role/LONGTERMDEBTSummaryofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument [Line Items]", "label": "Debt Instrument [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r342", "r343", "r344", "r345", "r346", "r348", "r353", "r354", "r355", "r356", "r358", "r359", "r360", "r361", "r362", "r363", "r366", "r585", "r696", "r898", "r899", "r900", "r901", "r902", "r971", "r1116", "r1117", "r1119", "r1122", "r1247", "r1249" ] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://www.acuren.com/role/LONGTERMDEBTNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument, Name [Domain]", "label": "Debt Instrument, Name [Domain]", "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r10", "r342", "r343", "r344", "r345", "r346", "r348", "r353", "r354", "r355", "r356", "r358", "r359", "r360", "r361", "r362", "r363", "r898", "r899", "r900", "r901", "r902", "r971", "r1116", "r1117", "r1119", "r1122", "r1163", "r1164", "r1165", "r1247", "r1249", "r1259" ] }, "us-gaap_DebtInstrumentPeriodicPayment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtInstrumentPeriodicPayment", "crdr": "debit", "presentation": [ "http://www.acuren.com/role/LONGTERMDEBTNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Quarterly installments", "label": "Debt Instrument, Periodic Payment", "documentation": "Amount of the required periodic payments including both interest and principal payments." } } }, "auth_ref": [ "r10", "r32" ] }, "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtInstrumentPeriodicPaymentPrincipal", "crdr": "debit", "presentation": [ "http://www.acuren.com/role/LONGTERMDEBTNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Principal payment", "label": "Debt Instrument, Periodic Payment, Principal", "documentation": "Amount of the required periodic payments applied to principal." } } }, "auth_ref": [ "r10" ] }, "us-gaap_DebtInstrumentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtInstrumentTable", "presentation": [ "http://www.acuren.com/role/LONGTERMDEBTNarrativeDetails", "http://www.acuren.com/role/LONGTERMDEBTSummaryofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Long-Term Debt Instruments [Table]", "label": "Schedule of Long-Term Debt Instruments [Table]", "documentation": "Disclosure of information about long-term debt instrument or arrangement." } } }, "auth_ref": [ "r10", "r29", "r30", "r31", "r72", "r73", "r342", "r343", "r344", "r345", "r346", "r348", "r353", "r354", "r355", "r356", "r358", "r359", "r360", "r361", "r362", "r363", "r366", "r585", "r696", "r898", "r899", "r900", "r901", "r902", "r971", "r1116", "r1117", "r1119", "r1122", "r1247", "r1249" ] }, "us-gaap_DebtInstrumentTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtInstrumentTerm", "presentation": [ "http://www.acuren.com/role/LONGTERMDEBTNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt instrument, term (in years)", "label": "Debt Instrument, Term", "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet", "crdr": "debit", "presentation": [ "http://www.acuren.com/role/LONGTERMDEBTSummaryofLongTermDebtDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Less: Unamortized deferred financing costs", "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net", "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs." } } }, "auth_ref": [ "r353", "r369", "r628", "r629", "r630", "r899", "r900", "r971" ] }, "us-gaap_DebtWeightedAverageInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtWeightedAverageInterestRate", "presentation": [ "http://www.acuren.com/role/LONGTERMDEBTNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average interest rate (as a percent)", "label": "Debt, Weighted Average Interest Rate", "documentation": "Weighted average interest rate of debt outstanding." } } }, "auth_ref": [] }, "us-gaap_DeferredFinanceCostsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredFinanceCostsGross", "crdr": "debit", "presentation": [ "http://www.acuren.com/role/LONGTERMDEBTNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt issuance costs", "label": "Debt Issuance Costs, Gross", "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs." } } }, "auth_ref": [ "r1247", "r1249" ] }, "us-gaap_DeferredFinanceCostsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredFinanceCostsNet", "crdr": "debit", "presentation": [ "http://www.acuren.com/role/BUSINESSCOMBINATIONSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt issuance costs", "label": "Debt Issuance Costs, Net", "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs." } } }, "auth_ref": [ "r1179", "r1246", "r1247", "r1249" ] }, "us-gaap_DeferredIncomeTaxAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredIncomeTaxAssetsNet", "crdr": "debit", "calculation": { "http://www.acuren.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.acuren.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax assets", "label": "Deferred Income Tax Assets, Net", "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting." } } }, "auth_ref": [ "r463", "r464" ] }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredIncomeTaxLiabilitiesNet", "crdr": "credit", "calculation": { "http://www.acuren.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.acuren.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax liabilities", "label": "Deferred Income Tax Liabilities, Net", "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting." } } }, "auth_ref": [ "r463", "r464", "r701" ] }, "us-gaap_DeferredIncomeTaxesAndTaxCredits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredIncomeTaxesAndTaxCredits", "crdr": "debit", "calculation": { "http://www.acuren.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.acuren.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred taxes", "label": "Deferred Income Taxes and Tax Credits", "documentation": "Amount of deferred income tax expense (benefit) and income tax credits." } } }, "auth_ref": [ "r64" ] }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredTaxAssetsValuationAllowance", "crdr": "credit", "presentation": [ "http://www.acuren.com/role/INCOMETAXESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Valuation allowance", "label": "Deferred Tax Assets, Valuation Allowance", "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized." } } }, "auth_ref": [ "r471" ] }, "us-gaap_Depreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "Depreciation", "crdr": "debit", "presentation": [ "http://www.acuren.com/role/PROPERTYANDEQUIPMENTDepreciationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total depreciation expense", "label": "Depreciation", "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation." } } }, "auth_ref": [ "r6", "r26", "r168", "r875", "r876", "r878", "r880" ] }, "us-gaap_DepreciationAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DepreciationAndAmortization", "crdr": "debit", "calculation": { "http://www.acuren.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.acuren.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation and amortization", "label": "Depreciation, Depletion and Amortization, Nonproduction", "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production." } } }, "auth_ref": [ "r6", "r26" ] }, "us-gaap_DepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DepreciationDepletionAndAmortization", "crdr": "debit", "calculation": { "http://www.acuren.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.acuren.com/role/CondensedConsolidatedStatementsofCashFlows", "http://www.acuren.com/role/SEGMENTREPORTINGSummaryofFinancialInformationForeachoftheCompanysReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation and amortization", "label": "Depreciation, Depletion and Amortization", "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets." } } }, "auth_ref": [ "r6", "r170", "r224", "r239", "r256", "r875", "r890", "r891" ] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "presentation": [ "http://www.acuren.com/role/FINANCIALINSTRUMENTS" ], "lang": { "en-us": { "role": { "terseLabel": "FINANCIAL INSTRUMENTS", "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]", "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts." } } }, "auth_ref": [ "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r586", "r597", "r958", "r959", "r960", "r961", "r962" ] }, "us-gaap_DevelopedTechnologyRightsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DevelopedTechnologyRightsMember", "presentation": [ "http://www.acuren.com/role/BUSINESSCOMBINATIONSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Developed technology", "label": "Developed Technology Rights [Member]", "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property." } } }, "auth_ref": [ "r1151", "r1152", "r1153", "r1154", "r1156", "r1158", "r1160", "r1161", "r1231" ] }, "srt_DirectorMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "DirectorMember", "presentation": [ "http://www.acuren.com/role/STOCKHOLDERSEQUITYWarrantsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non Founder Director", "label": "Director [Member]", "documentation": "Person serving on board of directors." } } }, "auth_ref": [ "r1093", "r1137", "r1295" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "presentation": [ "http://www.acuren.com/role/STOCKBASEDCOMPENSATION" ], "lang": { "en-us": { "role": { "terseLabel": "STOCK-BASED COMPENSATION", "label": "Share-Based Payment Arrangement [Text Block]", "documentation": "The entire disclosure for share-based payment arrangement." } } }, "auth_ref": [ "r419", "r423", "r452", "r453", "r455", "r912" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DividendsCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DividendsCommonStock", "crdr": "debit", "presentation": [ "http://www.acuren.com/role/STOCKHOLDERSEQUITYPreferredStockNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dividends, common stock (in dollars per share)", "label": "Dividends, Common Stock", "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK)." } } }, "auth_ref": [ "r3", "r74" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.acuren.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Period Focus", "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.acuren.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Year Focus", "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.acuren.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentQuarterlyReport", "presentation": [ "http://www.acuren.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Quarterly Report", "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r1001" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentTransitionReport", "presentation": [ "http://www.acuren.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Transition Report", "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r1033" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentType", "presentation": [ "http://www.acuren.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year", "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]" } } }, "auth_ref": [ "r1044" ] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EarningsPerShareAbstract", "presentation": [ "http://www.acuren.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss" ], "lang": { "en-us": { "role": { "terseLabel": "Basic and diluted loss per share:", "label": "Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EarningsPerShareBasic", "presentation": [ "http://www.acuren.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss", "http://www.acuren.com/role/EARNINGSPERSHARESummaryofBasicandDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Basic loss per common stock and Series A Preferred Stock (in dollars per share)", "label": "Earnings Per Share, Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r136", "r166", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r206", "r209", "r216", "r218", "r219", "r223", "r372", "r456", "r485", "r551", "r600", "r601", "r690", "r715", "r882" ] }, "us-gaap_EarningsPerShareBasicLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EarningsPerShareBasicLineItems", "presentation": [ "http://www.acuren.com/role/EARNINGSPERSHARESummaryofBasicandDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]", "label": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r209", "r210", "r216", "r219" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EarningsPerShareDiluted", "presentation": [ "http://www.acuren.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss", "http://www.acuren.com/role/EARNINGSPERSHARESummaryofBasicandDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Diluted loss per common stock and Series A Preferred Stock (in dollars per share)", "label": "Earnings Per Share, Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r136", "r166", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r209", "r216", "r218", "r219", "r223", "r372", "r456", "r485", "r551", "r600", "r601", "r690", "r715", "r882" ] }, "us-gaap_EarningsPerShareDilutedAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EarningsPerShareDilutedAbstract", "presentation": [ "http://www.acuren.com/role/EARNINGSPERSHARESummaryofBasicandDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Add: dilutive securities", "label": "Earnings Per Share, Diluted [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://www.acuren.com/role/EARNINGSPERSHARE" ], "lang": { "en-us": { "role": { "verboseLabel": "EARNINGS PER SHARE", "label": "Earnings Per Share [Text Block]", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r205", "r220", "r221", "r222" ] }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://www.acuren.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.acuren.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Net effect of exchange rate fluctuations on cash and cash equivalents", "label": "Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation", "documentation": "Amount of increase (decrease) from effect of exchange rate change on cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; held in foreign currency; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate." } } }, "auth_ref": [ "r621" ] }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EffectiveIncomeTaxRateContinuingOperations", "presentation": [ "http://www.acuren.com/role/INCOMETAXESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Effective income tax rate, percent", "label": "Effective Income Tax Rate Reconciliation, Percent", "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r466", "r913" ] }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EmployeeRelatedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.acuren.com/role/ACCRUEDEXPENSESANDOTHERLIABILITIESSummaryofAccruedExpensesandOtherLiabilitiesDetails": { "parentTag": "tic_AccountsPayableAndAccruedLiabilitiesExcludingTradePayablesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.acuren.com/role/ACCRUEDEXPENSESANDOTHERLIABILITIESSummaryofAccruedExpensesandOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued salaries, wages and related employee benefits", "label": "Employee-related Liabilities, Current", "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r36" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "presentation": [ "http://www.acuren.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average period (in shares)", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r454" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions", "crdr": "debit", "presentation": [ "http://www.acuren.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecognized compensation expense", "label": "Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount", "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [ "r1213" ] }, "us-gaap_EmployeeStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EmployeeStockMember", "presentation": [ "http://www.acuren.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Employee Stock", "label": "Employee Stock [Member]", "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock." } } }, "auth_ref": [] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EmployeeStockOptionMember", "presentation": [ "http://www.acuren.com/role/EARNINGSPERSHARESummaryofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Option", "label": "Share-Based Payment Arrangement, Option [Member]", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [ "r1186", "r1187", "r1188", "r1189", "r1190", "r1191", "r1192", "r1193", "r1194", "r1195", "r1196", "r1198", "r1199", "r1200", "r1201", "r1202", "r1203", "r1204", "r1205", "r1206", "r1207", "r1208", "r1209", "r1210", "r1211", "r1212" ] }, "tic_EmployeeStockPurchasePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.acuren.com/20260331", "localname": "EmployeeStockPurchasePlanMember", "presentation": [ "http://www.acuren.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Employee Stock Purchase Plan", "label": "Employee Stock Purchase Plan [Member]", "documentation": "Employee Stock Purchase Plan" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.acuren.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressAddressLine2", "presentation": [ "http://www.acuren.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line Two", "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.acuren.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.acuren.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.acuren.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.acuren.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r999" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://www.acuren.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Common Stock, Shares Outstanding", "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://www.acuren.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Current Reporting Status", "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.acuren.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r999" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityFileNumber", "presentation": [ "http://www.acuren.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityFilerCategory", "presentation": [ "http://www.acuren.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Filer Category", "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r999" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.acuren.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://www.acuren.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Interactive Data Current", "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r1083" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityRegistrantName", "presentation": [ "http://www.acuren.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r999" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityShellCompany", "presentation": [ "http://www.acuren.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Shell Company", "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r999" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntitySmallBusiness", "presentation": [ "http://www.acuren.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Small Business", "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r999" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.acuren.com/role/Coverpage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r999" ] }, "ecd_EqtyAwrdsAdjFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "EqtyAwrdsAdjFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Awards Adjustments, Footnote", "label": "Equity Awards Adjustments, Footnote [Text Block]" } } }, "auth_ref": [ "r1038" ] }, "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table", "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]" } } }, "auth_ref": [ "r1079" ] }, "ecd_EqtyAwrdsAdjsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "EqtyAwrdsAdjsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Awards Adjustments", "label": "Equity Awards Adjustments [Member]" } } }, "auth_ref": [ "r1079" ] }, "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table", "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]" } } }, "auth_ref": [ "r1079" ] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EquityComponentDomain", "presentation": [ "http://www.acuren.com/role/CondensedConsolidatedStatementsofStockholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Component [Domain]", "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r9", "r134", "r135", "r136", "r162", "r163", "r164", "r189", "r190", "r191", "r193", "r200", "r202", "r204", "r225", "r268", "r269", "r308", "r371", "r400", "r456", "r475", "r476", "r482", "r483", "r484", "r486", "r550", "r551", "r587", "r588", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r599", "r622", "r623", "r624", "r625", "r626", "r627", "r631", "r632", "r636", "r712", "r732", "r733", "r734", "r751", "r819" ] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Valuation Assumption Difference, Footnote", "label": "Equity Valuation Assumption Difference, Footnote [Text Block]" } } }, "auth_ref": [ "r1048" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneous Compensation Analysis", "label": "Erroneous Compensation Analysis [Text Block]" } } }, "auth_ref": [ "r1006", "r1016", "r1026", "r1058" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneously Awarded Compensation Recovery", "label": "Erroneously Awarded Compensation Recovery [Table]" } } }, "auth_ref": [ "r1003", "r1013", "r1023", "r1055" ] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Executive Category:", "label": "Executive Category [Axis]" } } }, "auth_ref": [ "r1054" ] }, "us-gaap_FairValueDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueDisclosuresAbstract", "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FairValueDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueDisclosuresTextBlock", "presentation": [ "http://www.acuren.com/role/FAIRVALUEMEASUREMENTS" ], "lang": { "en-us": { "role": { "terseLabel": "FAIR VALUE MEASUREMENTS", "label": "Fair Value Disclosures [Text Block]", "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information." } } }, "auth_ref": [ "r602", "r606", "r608", "r609", "r610", "r612", "r613", "r614", "r615", "r616", "r687", "r963", "r967" ] }, "tic_FinanceLeasePrincipalPaymentsAndOther": { "xbrltype": "monetaryItemType", "nsuri": "http://www.acuren.com/20260331", "localname": "FinanceLeasePrincipalPaymentsAndOther", "crdr": "credit", "calculation": { "http://www.acuren.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.acuren.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Payments on finance lease obligations and other long-term debt", "label": "Finance Lease, Principal Payments And Other", "documentation": "Finance Lease, Principal Payments And Other" } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FiniteLivedIntangibleAssetUsefulLife", "presentation": [ "http://www.acuren.com/role/BUSINESSCOMBINATIONSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average \u2028remaining \u2028life (in years)", "label": "Finite-Lived Intangible Asset, Useful Life", "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "crdr": "credit", "calculation": { "http://www.acuren.com/role/INTANGIBLEASSETSSummaryofIntangibleAssetsandAmortizationExpenseDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.acuren.com/role/INTANGIBLEASSETSSummaryofIntangibleAssetsandAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Accumulated \u2028Amortization", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r145", "r271", "r300", "r868" ] }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://www.acuren.com/role/INTANGIBLEASSETSSummaryofIntangibleAssetsandAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "documentation": "Information by major type or class of finite-lived intangible assets." } } }, "auth_ref": [ "r293", "r295", "r296", "r297", "r299", "r300", "r303", "r304", "r651", "r652", "r740", "r864", "r868", "r928", "r929", "r930", "r931", "r932", "r933", "r934", "r935", "r936", "r937", "r938", "r939", "r940", "r941", "r942", "r943", "r944", "r945", "r946", "r947", "r948", "r949", "r950", "r951", "r952", "r953", "r954" ] }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FiniteLivedIntangibleAssetsGross", "crdr": "debit", "calculation": { "http://www.acuren.com/role/INTANGIBLEASSETSSummaryofIntangibleAssetsandAmortizationExpenseDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.acuren.com/role/INTANGIBLEASSETSSummaryofIntangibleAssetsandAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross Carrying Amount", "label": "Finite-Lived Intangible Assets, Gross", "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r271", "r300", "r652", "r868" ] }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FiniteLivedIntangibleAssetsLineItems", "presentation": [ "http://www.acuren.com/role/INTANGIBLEASSETSSummaryofIntangibleAssetsandAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets [Line Items]", "label": "Finite-Lived Intangible Assets [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r293", "r300", "r303", "r304", "r306", "r651", "r864", "r868", "r928", "r929", "r930", "r931", "r932", "r933", "r934", "r935", "r936", "r937", "r938", "r939", "r940", "r941", "r942", "r943", "r944", "r945", "r946", "r947", "r948", "r949", "r950", "r951", "r952", "r953", "r954" ] }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://www.acuren.com/role/INTANGIBLEASSETSSummaryofIntangibleAssetsandAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "auth_ref": [ "r293", "r295", "r296", "r297", "r299", "r300", "r303", "r304", "r740", "r864", "r868", "r928", "r929", "r930", "r931", "r932", "r933", "r934", "r935", "r936", "r937", "r938", "r939", "r940", "r941", "r942", "r943", "r944", "r945", "r946", "r947", "r948", "r949", "r950", "r951", "r952", "r953", "r954" ] }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FiniteLivedIntangibleAssetsNet", "crdr": "debit", "calculation": { "http://www.acuren.com/role/INTANGIBLEASSETSSummaryofIntangibleAssetsandAmortizationExpenseDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.acuren.com/role/INTANGIBLEASSETSSummaryofIntangibleAssetsandAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net Carrying Amount", "label": "Finite-Lived Intangible Assets, Net", "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r651", "r1158" ] }, "tic_FixedUnitPriceContractsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.acuren.com/20260331", "localname": "FixedUnitPriceContractsMember", "presentation": [ "http://www.acuren.com/role/SEGMENTREPORTINGSummaryofServiceRevenuesClassificationsbyMajorGeographicAreasDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fixed-unit price contracts", "label": "Fixed-Unit Price Contracts [Member]", "documentation": "Fixed-Unit Price Contracts" } } }, "auth_ref": [] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount", "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r1010", "r1020", "r1030", "r1062" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount", "label": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r1010", "r1020", "r1030", "r1062" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount", "label": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r1010", "r1020", "r1030", "r1062" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery, Explanation of Impracticability", "label": "Forgone Recovery, Explanation of Impracticability [Text Block]" } } }, "auth_ref": [ "r1010", "r1020", "r1030", "r1062" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Forgone Recovery, Individual Name" } } }, "auth_ref": [ "r1010", "r1020", "r1030", "r1062" ] }, "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year", "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]" } } }, "auth_ref": [ "r1043" ] }, "tic_GeospatialSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.acuren.com/20260331", "localname": "GeospatialSegmentMember", "presentation": [ "http://www.acuren.com/role/BUSINESSCOMBINATIONSNarrativeDetails", "http://www.acuren.com/role/GOODWILLDetails", "http://www.acuren.com/role/SEGMENTREPORTINGSummaryofFinancialInformationForeachoftheCompanysReportableSegmentsDetails", "http://www.acuren.com/role/SEGMENTREPORTINGSummaryofServiceRevenuesClassificationsbyMajorGeographicAreasDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geospatial", "label": "Geospatial Segment [Member]", "documentation": "Geospatial Segment" } } }, "auth_ref": [] }, "us-gaap_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://www.acuren.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.acuren.com/role/BUSINESSCOMBINATIONSNarrativeDetails", "http://www.acuren.com/role/BUSINESSCOMBINATIONSSummaryofFairValueofConsiderationTransferredDetails", "http://www.acuren.com/role/CondensedConsolidatedBalanceSheets", "http://www.acuren.com/role/GOODWILLDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill", "periodStartLabel": "Balance at December 31, 2025", "periodEndLabel": "Balance at March 31, 2026", "label": "Goodwill", "documentation": "Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized." } } }, "auth_ref": [ "r144", "r273", "r688", "r891", "r896", "r914", "r918", "r920", "r957", "r964", "r972", "r1141", "r1148", "r1235" ] }, "us-gaap_GoodwillAcquiredDuringPeriod": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "GoodwillAcquiredDuringPeriod", "crdr": "debit", "presentation": [ "http://www.acuren.com/role/GOODWILLDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Acquisitions", "label": "Goodwill, Acquired During Period", "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination." } } }, "auth_ref": [ "r276", "r541", "r544", "r548", "r896" ] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_GoodwillDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "GoodwillDisclosureTextBlock", "presentation": [ "http://www.acuren.com/role/GOODWILL" ], "lang": { "en-us": { "role": { "terseLabel": "GOODWILL", "label": "Goodwill Disclosure [Text Block]", "documentation": "The entire disclosure for goodwill." } } }, "auth_ref": [ "r272", "r274", "r284", "r286", "r287", "r289", "r290", "r291", "r896" ] }, "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "GoodwillForeignCurrencyTranslationGainLoss", "crdr": "credit", "presentation": [ "http://www.acuren.com/role/GOODWILLDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Currency adjustments", "label": "Goodwill, Foreign Currency Translation, Gain (Loss)", "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) asset representing future economic benefit from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized." } } }, "auth_ref": [ "r280", "r548" ] }, "us-gaap_GoodwillLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "GoodwillLineItems", "presentation": [ "http://www.acuren.com/role/GOODWILLDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill [Line Items]", "label": "Goodwill [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r285", "r896" ] }, "us-gaap_GoodwillPurchaseAccountingAdjustments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "GoodwillPurchaseAccountingAdjustments", "crdr": "debit", "presentation": [ "http://www.acuren.com/role/GOODWILLDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement period adjustments", "label": "Goodwill, Measurement Period Adjustment", "documentation": "Amount of increase (decrease) from measurement period adjustment of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized." } } }, "auth_ref": [ "r1147", "r1217", "r1223", "r1230", "r1235" ] }, "us-gaap_GoodwillRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "GoodwillRollForward", "presentation": [ "http://www.acuren.com/role/GOODWILLDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill [Roll Forward]", "label": "Goodwill [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://www.acuren.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.acuren.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss", "http://www.acuren.com/role/SEGMENTREPORTINGSummaryofFinancialInformationForeachoftheCompanysReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Gross profit", "label": "Gross Profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r53", "r55", "r86", "r177", "r180", "r181", "r267", "r330", "r331", "r333", "r334", "r335", "r336", "r337", "r339", "r340", "r617", "r885", "r890", "r1130", "r1132", "r1133", "r1134", "r1135", "r1174" ] }, "us-gaap_